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A B S T R A C T
Background
There are controversies about the amount of calories and the type of nutritional support that should be given to critically-ill people.
Several authors advocate the potential benefits of hypocaloric nutrition support, but the evidence is inconclusive.
Objectives
To assess the effects of prescribed hypocaloric nutrition support in comparison with standard nutrition support for critically-ill adults
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL, Cochrane Library), MEDLINE, Embase and LILACS
(from inception to 20 June 2017) with a specific strategy for each database. We also assessed three websites, conference proceedings
and reference lists, and contacted leaders in the field and the pharmaceutical industry for undetected/unpublished studies. There was
no restriction by date, language or publication status.
Selection criteria
We included randomized and quasi-randomized controlled trials comparing hypocaloric nutrition support to normo- or hypercaloric
nutrition support or no nutrition support (e.g. fasting) in adults hospitalized in intensive care units (ICUs).
Data collection and analysis
We used standard methodological procedures expected by Cochrane. We meta-analysed data for comparisons in which clinical hetero-
geneity was low. We conducted prespecified subgroup and sensitivity analyses, and post hoc analyses, including meta-regression. Our
primary outcomes were: mortality (death occurred during the ICU and hospital stay, or 28- to 30-day all-cause mortality); length of
stay (days stayed in the ICU and in the hospital); and Infectious complications. Secondary outcomes included: length of mechanical
ventilation. We assessed the quality of evidence with GRADE.
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Main results
We identified 15 trials, with a total of 3129 ICU participants from university-associated hospitals in the USA, Colombia, Saudi Arabia,
Canada, Greece, Germany and Iran. There are two ongoing studies. Participants suffered from medical and surgical conditions, with a
variety of inclusion criteria. Four studies used parenteral nutrition and nine studies used only enteral nutrition; it was unclear whether
the remaining two used parenteral nutrition. Most of them could not achieve the proposed caloric targets, resulting in small differences
in the administered calories between intervention and control groups. Most studies were funded by the US government or non-
governmental associations, but three studies received funding from industry. Five studies did not specify their funding sources.
The included studies suffered from important clinical and statistical heterogeneity. This heterogeneity did not allow us to report pooled
estimates of the primary and secondary outcomes, so we have described them narratively.
When comparing hypocaloric nutrition support with a control nutrition support, for hospital mortality (9 studies, 1775 participants),
the risk ratios ranged from 0.23 to 5.54; for ICU mortality (4 studies, 1291 participants) the risk ratios ranged from 0.81 to 5.54, and
for mortality at 30 days (7 studies, 2611 participants) the risk ratios ranged from 0.79 to 3.00. Most of these estimates included the
null value. The quality of the evidence was very low due to unclear or high risk of bias, inconsistency and imprecision.
Participants who received hypocaloric nutrition support compared to control nutrition support had a range of mean hospital lengths
of stay of 15.70 days lower to 10.70 days higher (10 studies, 1677 participants), a range of mean ICU lengths of stay 11.00 days lower
to 5.40 days higher (11 studies, 2942 participants) and a range of mean lengths of mechanical ventilation of 13.20 days lower to 8.36
days higher (12 studies, 3000 participants). The quality of the evidence for this outcome was very low due to unclear or high risk of
bias in most studies, inconsistency and imprecision.
The risk ratios for infectious complications (10 studies, 2804 participants) of each individual study ranged from 0.54 to 2.54. The
quality of the evidence for this outcome was very low due to unclear or high risk of bias, inconsistency and imprecision
We were not able to explain the causes of the observed heterogeneity using subgroup and sensitivity analyses or meta-regression.
Authors’ conclusions
The included studies had substantial clinical heterogeneity. We found very low-quality evidence about the effects of prescribed
hypocaloric nutrition support on mortality in hospital, in the ICU and at 30 days, as well as in length of hospital and ICU stay,
infectious complications and the length of mechanical ventilation. For these outcomes there is uncertainty about the effects of prescribed
hypocaloric nutrition, since the range of estimates includes both appreciable benefits and harms.
Given these limitations, results must be interpreted with caution in the clinical field, considering the unclear balance of the risks and
harms of this intervention. Future research addressing the clinical heterogeneity of participants and interventions, study limitations
and sample size could clarify the effects of this intervention.
P L A I N L A N G U A G E S U M M A R Y
Does the prescription of low-calorie (hypocaloric) nutrition support improve the recovery of critically-ill adult patients?
Review question
Does low-calorie nutrition delivered into the stomach or small intestine (enteral), or into a vein (parenteral) improve clinical outcomes
in critically-ill adults admitted to an intensive care unit (ICU), when compared with standard calorie nutrition support?
The main outcomes were death (in the hospital, in the ICU and at 30 days); length of ICU and hospital stay; infectious complications
and length of time the person was mechanically ventilated (a machine used in ICU to help a person breath) .
Background
Critically-ill people experience major metabolic changes (one chemical is transformed through a series of steps into another chemical)
during injury or sepsis (a life-threatening condition in which the body’s response to infection causes injury to its own organs). They
receive nutritional support to prevent or minimize some adverse effects. Nevertheless, both overfeeding and starvation can be harmful.
There is currently no agreement about the amount of calories we should give to these critically-ill people. Normal caloric feeding
provides the estimated caloric needs. Hypocaloric feeding provides an intentionally lower amount of calories.
2Prescribed hypocaloric nutrition support for critically-ill adults (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Study characteristics
We included 15 trials with 3129 ICU surgical or medical participants from academic hospitals. Four studies used parenteral nutrition
and nine studies used only enteral nutrition. The route was unclear in the remaining two studies. While the studies planned to give
different amounts of calories in the experimental and control groups, the actual difference in calories was small. Most studies were
funded by the US government or non-governmental associations, but three studies received funding from the industry. Five studies did
not state how they were funded.
Key results
The differences in the type of nutrition and type of participants across studies did not allow us to combine study results, so we describe
the range of results across the individual studies.
The number of deaths at the hospital, in the ICU and at 30 days in those who received low-calorie nutrition was similar to those in the
control group. The length of hospital and ICU stay and the length of mechanical ventilation varied across studies, sometimes shorter
and sometimes longer when compared to the control group. The number of infections also varied across studies. We tried to analyse
subgroups of participants in order to clarify this variation, but the results were not consistent.
Quality of evidence
The overall quality of evidence for each outcome according to GRADE classification varied from very low to low. This was due to
problems in the design and conduct of the studies, the variation in the study results (inconsistency between studies) and the wide range
of possible results (imprecision).
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Hypocaloric nutrition compared to control for critically- ill adults
Patient or population: crit ically-ill adults
Settings: Hospitals (intensive care units), eight in USA, two in Colombia, one in Saudi Arabia and Canada, and one each in Saudi Arabia, Germany, Greece and Iran
Intervention: hypocaloric nutrit ion
Comparison: control nutrit ional support with a higher caloric intake than the ’intervent ion’ group
Outcomes Effect estimate (range of results of indi-
vidual studies)
N of Participants
(studies)
Quality of the evidence
(GRADE)
Mortality in hospital: death occurring dur-
ing the hospital stay
Range of risk rat ios f rom 0.23 to 5.54a 1775
(9 studies)
⊕⊕©©
very lowb,c,d
Mortality in ICU: death occurred during the
ICU stay
Range of risk rat ios f rom 0.81 to 5.54a 1291
(4 studies)
⊕⊕©©
very lowb,c,d
Mortality at 30 days: 28 to 30 days all-
cause mortality
Range of risk rat ios f rom 0.79 to 3.00a 2611
(7 studies)
⊕⊕©©
very lowb,c,d
Length of hospital stay: days stayed in the
hospital
Range of length of hospital stay f rom 15.
70 days lower to 10.70 days highera
1677
(10 studies)
⊕©©©
very lowb,c,e
Length of ICU stay: days stayed in the ICU Range of length of ICU stay f rom 11.00
days lower to 5.40 days highera
2942
(11 studies)
⊕©©©
very lowb,c,e
Infectious complications: events of any
type of infect ious complicat ions occurred
during the hospital stay, registered by the
study authors according to their diagnost ic
criteria of infect ions
Range of risk rat ios f rom 0.54 to 2.54a 2804
(10 studies)
⊕©©©
very lowb,c,e
Length of mechanical ventilation: days on
mechanical vent ilat ion during ICU stay
Range of mean dif ferences: 13.20 days
lower to 8.36 days highera
3000
(12 studies)
⊕©©©
very lowb,c,e
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GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aResults were not combined due to clinical heterogeneity.
bDowngraded one level due to risk of bias: most studies had unclear or high risk of bias.
cDowngraded one level due to imprecision issues: very wide conf idence intervals.
dDowngraded one level due to inconsistency: wide variance of point est imates across studies.
eDowngraded one level due to inconsistency: high stat ist ical heterogeneity I2 > 50%.
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B A C K G R O U N D
Description of the condition
Most critically-ill people treated for injury or sepsis have some
degree of hypermetabolism and hypercatabolism and are also un-
able to feed themselves. For these reasons, it was recommended
to provide them with nutrition support by enteral or parenteral
routes, in order to prevent or minimize depletion of protein and
caloric stores; to enhance protein synthesis; and to avoid deficien-
cies in essential and semi-essential nutrients (Cerra 1997). How-
ever, there are several aspects of nutrition support for the criti-
cally-ill that are still under debate, such as: the time at which to
initiate nutrition support; the route (enteral, parenteral or com-
bined); the caloric and protein requirements; the amount and
type of protein to give; the composition of lipids; the supple-
mentation of some amino acids and micronutrients; and the oc-
currence and type of some complications. Several of these top-
ics were recently discussed (Berger 2012; Biolo 2002; Bost 2014;
Heyland 2003; Kreymann 2006;Preiser 2015; Wischmeyer 2012;
Wischmeyer 2013), and some of these aspects are included in
Cochrane Reviews on adults (Alkhawaja 2015; Allingstrup 2015;
Fuentes Padilla 2016; Lewis 2016; Tao 2014), and children (Joffe
2016), as well as in aCochrane protocol (Dushianthan 2016). This
current review focuses on the prescription of hypocaloric versus
normocaloric feeding debate in nutrition support for critically-ill
adults.
During the 1970s, the proposed goal of nutrition support was to
provide sufficient calories to match the measured increased resting
energy expenditure (hypermetabolism) in order to prevent pro-
tein depletion. As indirect calorimetry (the gold standard) is not
available in most intensive care units (ICUs) or it is not possible
to perform it in certain patients, it is usual to estimate the daily
caloric requirements using formulae. For years themost frequently
used one was the Long equation (resting metabolic expenditure
calculated by theHarris-Benedict equation with the addition of an
injury factor and an activity factor; Long 1979). This approach of-
ten led to overestimation of caloric requirements (compared with
the values obtained by indirect calorimetry), mainly in ventilated
and sedated patients (McClave 1992). It also induced some de-
gree of overfeeding with nutrition support, which was associated
with several metabolic complications (Klein 1998), such as hyper-
triglyceridaemia, increased production of CO2, hepatic steatosis
and hyperglycaemia, which also behaves as an independent fac-
tor for increased mortality in critically-ill patients (Badawi 2012;
Krinsley 2003).
It is currently known that the caloric requirements for nutrition
support of a critically-ill person could differ from the estimated
resting or total energy expenditure (Reid 2004).Wemust take into
account variability due to several factors: the presence of injury or
sepsis (type, severity and metabolic response of the host) (Hoffer
2003); the time course of the disease or the elapsed time in the ICU
(Monk 1996; Uehara 1999); current ICU care and treatments
(Boulanger 1994); the nutrition state or the fat-free mass (Zauner
2006); the complications and some factors associated with the
disease states (Magnuson 2011; Stahel 2010), and comorbidities.
This variability contributes to the difficulty in estimating energy
needs for the nutrition support of these patients (Frankenfield
2011). The use of predictive equations (Cooney 2012) could be
one of the causes of underfeeding or overfeeding in some critically-
ill people (Reid 2006).
There is consensus about some aspects of caloric and protein re-
quirements for nutrition support of the critically-ill ventilated per-
son:
a) the degree of hypermetabolism due to injury or sepsis is lower
than that reported at the beginning of the 1970s (Liggett 1990),
particularly during the first days in the ICU (Biolo 2002; Heyland
2003; Kreymann 2006);
b) positive or neutral energy balance failed to decrease the pro-
tein catabolic rate or nitrogen loss and did not prevent negative
nitrogen balance and protein depletion (Frankenfield 1997; Plank
2003);
c) positive energy balance is associated with increased fat mass,
without changes in lean body mass (Hart 2002; Streat 1987);
d) the main determinant of a positive, or less negative, nitrogen
balance during nutrition support seems to be the nitrogen intake
(Iapichino 1984; Weijs 2013);
e) nutrition support did not modify the rate of protein catabolism,
but was able to preserve some nitrogen loss (less negative nitrogen
balance) by promoting whole-body protein synthesis, with protein
intake of up to 1.5 g/kg/day (Shaw 1987).
The well-known clinical guidelines for the nutrition support of
critically-ill people (ASPEN / SCCM guidelines 2016; ASPEN
/ SCCM guidelines 2009; ESPEN guidelines 2009) sometimes
disagreed with each other, and in the literature there are some
open debates. For example, when and how to initiate the nu-
trition support; when to begin lipid administration by the par-
enteral route and the type of lipids to be used; the role and tim-
ing for supplemental parenteral nutrition; the amount of protein
or the non-protein calories/nitrogen ratio to prescribe; the dose
and type of supplemental trace elements and antioxidant vitamins;
the best way to estimate the caloric requirements; if caloric pro-
vision should be optimized to prevent a caloric deficit during the
first days of ICU in order to minimize the initial or delayed com-
plications associated with undernutrition (Dvir 2006; Heidegger
2013; Rubinson 2004; Wischmeyer 2013), or if it is better to give
hypocaloric nutrition during the first days of intense inflamma-
tory response (and metabolic changes) induced by injury or sepsis
(Berger 2007; Berger 2012;Casaer 2014;Cooney 2012;Dickerson
2011; Kreymann 2012; Singer 2010; Weijs 2013; Wischmeyer
2012). This review focuses only on the clinical results of providing
hypocaloric nutrition support compared to normocaloric nutri-
tion to critically-ill adults.
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Description of the intervention
More than 20 years ago, Zaloga 1994 proposed a short period
of dietary restriction during the first few days of acute injury or
sepsis, originally designated “permissive underfeeding” and later
“hypocaloric nutrition support” (Patiño 1999). The provision of
hypocaloric nutrition support with high-protein content was suc-
cessfully used in a group of obese stressed patients (Dickerson
1986). This approach was first reviewed (Kushner 2011), sug-
gested by a group of experts for critically-ill people (McClave
2011), and recommended in some clinical guidelines (ASPEN
guidelines 2013; ASPEN / SCCM guidelines 2016). The use of
hypocaloric nutrition support in critically-ill people, mainly dur-
ing the first days of ICU stay, has been frequently mentioned in
the literature; some evidence and opinions were reported in several
narrative reviews ( Boitano 2006; Berger 2007; Jeejeebhoy 2004;
Malone 2007; Stapleton 2007).
How the intervention might work
Severely critically-ill people experiencing major metabolic changes
during the acute phase of systemic inflammatory response in-
duced by injury or sepsis could benefit from this approach. This
may be explained by: avoidance of the well-known deleterious ef-
fects of overfeeding or the consequences of starvation; diminishing
metabolic disturbances, especially hyperglycaemia, and the level
of inflammatory cytokines. In certain animal models, hypocaloric
nutrition during acute stress seemed to lower morbidity and mor-
tality. This could also be possible in critically-ill people, but the
available data are not conclusive about the potential benefits of
hypocaloric feeding. On the contrary, there is some evidence that
underfeeding could be associated with complications and worse
outcomes for critically-ill people (Dvir 2006; Villet 2005), and
that the effect of hypocaloric nutrition support could be different
inmalnourished andwell-nourished people (Braunschweig 2001).
The possible role of starvation-induced autophagy is currently un-
der consideration (Marik 2016a).
Why it is important to do this review
We do not so far have conclusive evidence for how many calories
we should give to critically-ill people in order to improve outcomes
and diminish complications. However, today we certainly know
that caloric requirements are rather less than that proposed in the
1970s or 1980s (Krishnan 2003; Rubinson 2004). Currently, in
several countries there are intensive care or nutrition support spe-
cialists providing hypocaloric nutrition support to most of their
critically-ill patients during the first few days of illness, or toler-
ating the administration of less than prescribed enteral nutrition
(fewer calories than the estimated ones) for their patients. This is
based more on observational evidence or expert opinions than on
scientific data.
Several authors consider it important to optimize the energy pro-
vision, targeting measured or estimated requirements, in order to
avoid caloric deficits (“caloric debt”) during the first days of ICU
stay (Faysy 2008; Singer 2010; Singer 2011; Wischmeyer 2013;
Wischmeyer 2015), or, even more importantly, to also target the
protein supply (Weijs 2012; Weijs 2014; Hoffer 2012; Nicolo
2016), or give some supplementary protein (Alberda 2009).
Due to these unanswered questions, the controversial data and
the different interpretations of it, it is necessary to perform sys-
tematic reviews of each contentious topic and to analyse the clin-
ical significance of each nutritional approach. We have therefore
conducted this systematic review to explore the effects of pre-
scribed hypocaloric enteral or parenteral nutrition on clinical and
metabolic outcomes in critically-ill adults.
O B J E C T I V E S
To assess the effects of prescribed hypocaloric nutrition support
in comparison with standard nutrition support for critically-ill
adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomized and quasi-randomized controlled trials.
We considered the inclusion of quasi-randomized controlled trials
in order to enlarge the evidence about the efficacy and safety of
hypocaloric nutrition support (Schneider 2007; Shadish 2002).
Types of participants
We included all adult participants (aged 18 years or more) hos-
pitalized for different diseases and severity at medical, surgical or
disease-specific (burns, trauma, neurological, etc.) intensive care
units (ICUs) and requiring any type of nutrition support.
Exclusion criteria: none.
Types of interventions
The experimental intervention evaluated was: hypocaloric nutri-
tion support with fewer total calories thanmeasured resting energy
expenditure (REE) by indirect calorimetry or, if not measured, less
than 25 kcal/kg/day. This could be done through restricted doses
of carbohydrates or lipids, or both, with either normal or increased
protein dose. The control intervention was:
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1. Normo- or hypercaloric nutrition support: equal to or more
than the measured REE or than 25 kcal/kg/day (with the same
characteristics as above); or
2. No nutrition support at all: fasting or dextrose solutions.
We evaluated the results of trials designed to compare prescribed
hypocaloric enteral or parenteral nutrition support (or permissive
underfeeding) with standard nutrition support, or with no nutri-
tion, even if those trials did not reach their caloric goals in the
intervention or control groups (intention-to-treat analysis). Fur-
thermore, we did not include trials that planned to provide full
nutrition support but resulted in unintended hypocaloric provi-
sion (for any reason).
Types of outcome measures
Primary outcomes
The primary outcomes were the following clinical outcomes:
1. Mortality. Death occurring during the ICU and hospital
stay, or 28- to 30-day all-cause mortality.
2. Length of stay. Days stayed in the ICU and in the hospital.
3. Infectious complications. Events of any type of infectious
complications occurring during the hospital stay, registered by
the study authors according to their diagnostic criteria of
infections.
Secondary outcomes
The secondary outcomes were one or more of the following out-
comes:
1. Length of mechanical ventilation. Days on mechanical
ventilation during ICU stay.
2. Non-infectious complications. Events of any non-infectious
complication during the hospital stay, potentially associated with
the nutrition status or the nutrition support, according the
criteria of the study authors (for example: wound dehiscence,
decubitus ulcers, etc.)
3. Carbohydrate metabolic outcomes. Events of
hyperglycaemia (glycaemia higher than 150 mg/dl) during ICU
stay. Events of hypoglycaemia (glycaemia lower than 70 mg/dl)
during ICU stay.
4. Lipid metabolic outcomes. Events of hypertriglyceridaemia
(higher than 200 mg/dl) or any lipid metabolic complication
associated with the nutrition support according to the criteria of
the study authors.
5. Protein metabolic outcomes. Nitrogen balance (positive or
negative in grams/day) or any protein metabolic complication
associated with the nutrition support according to the criteria of
the study authors.
6. Nutrition status or clinical condition at ICU discharge.
Nutrition or functional evaluation, made at the time of ICU
discharge with any method of assessment used by the study
authors.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL) (Cochrane Library Issue 5, 2017);MEDLINE/Ovid
(1946 to 20 June 2017); Embase (1980 to 20 June 2017), and
LILACS (1992 to 20 June 2017). We developed a specific strat-
egy for each database (see Appendix 1 for CENTRAL, Appendix
2 for MEDLINE, Appendix 3 for Embase and Appendix 4 for
LILACS).
We combined the MEDLINE search strategy with the Cochrane
Highly Sensitive Search Strategy phases one and two, as suggested
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). The filter used to identify randomized controlled
trials (RCTs) in the search strategy for MEDLINE was from
Glanville 2006. For Embase we applied the trial filter for ther-
apy maximizing sensitivity developed by Health Information Re-
search Unit (HIRU) at McMaster University: hiru.mcmaster.ca/
hiru/HIRU Hedges EMBASE Strategies.aspx).
We did not apply restrictions by language or by publication status.
We also searched (up to 20 June 2017) for relevant ongoing trials
in specific trial registries:
1. ClinicalTrials.Gov: clinicaltrials.gov/
2. International Clinical Trials Registry Platform:
apps.who.int/trialsearch/
3. ISRCTN Registry: www.isrctn.com/
Searching other resources
We searched the Conference Proceedings of the annual congresses
of the following four societies, as published in their respective
journals, in order to find papers presented at different meetings:
1. American Society for Parenteral and Enteral Nutrition
(ASPEN), through the Journal of Parenteral and Enteral
Nutrition (1990 to 30 June 2017).
2. European Society for Clinical Nutrition and Metabolism
(ESPEN), through the journal Clinical Nutrition (1990 to 30
June 2017).
3. Society of Critical Care Medicine (SCCM), through the
journal Critical Care Medicine (1990 to 30 June 2017).
4. European Society of Intensive Care Medicine (ESICM),
through the journal Intensive Care Medicine (1997 to 30 June
2017).
We also handsearched the original papers published in the follow-
ing journals:
1. Journal of Parenteral and Enteral Nutrition (1990 to 30
June, 2017).
2. Clinical Nutrition (1990 to 30 June 2017).
3. Nutrition (1990 to 30 June 2017).
4. Nutrition Clinique et Métabolisme (1994 to 30 June 2017).
We also checked the reference list and citations of the relevant
articles and reviews related to hypocaloric feeding and to caloric
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and protein requirements of critically-ill people (1970 to 30 June
2017).
Correspondence
Wecontactedmain authors of relevant trials and reviews to identify
any additional studies, and relevant pharmaceutical companies for
published and unpublished reports.
Data collection and analysis
Selection of studies
Three review authors (MP, ACr and CL) independently scanned
the titles and abstracts of reports identified by electronic searching,
manual searching, snowballing and by contacts with clinical ex-
perts and the pharmaceutical industry. We retrieved and evaluated
potentially relevant studies, chosen by at least one review author,
in full-text versions. These review authors independently selected
trials that met the inclusion criteria using a checklist designed in
advance for that purpose. We resolved any disagreement through
consultation with a fourth review author (GP). We rejected arti-
cles at the initial screening only if we could determine from the
title and abstract that the study was not a report of a randomized
or quasi-randomized controlled trial; or that it did not address en-
teral and/or parenteral nutrition in critically-ill adults. When we
could not reject a study with certainty, we obtained the full text
of the article for further evaluation.
Data extraction and management
Two review authors (ACr and CL) independently extracted data
using a standardized checklist. We registered it in the data extrac-
tion form. We resolved any disagreement through consultation
with a third review author (MP).
Assessment of risk of bias in included studies
Two review authors (GP and CL) independently assessed risks
of bias for each study using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
We resolved any disagreement through discussion and consulta-
tion with a third assessor (ACi).
(1) Sequence generation (checking for possible selection
bias)
We looked for the description of methods used in each included
study to generate the allocation sequence, and assessed if they were
adequate to produce comparable groups (unbiased selection). We
classified methods as being at low, high or unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We looked for the description of methods used in each included
study to conceal the allocation sequence and assessed if they were
adequate to avoid the intervention allocation being foreseen or
changed. We classified methods as being at low, high or unclear
risk of bias.
(3) Blinding (checking for possible performance bias)
We looked for the description of methods used, if any, in each
included study to blind study participants and personnel from
knowledge of which intervention a participant received. We also
considered partial blinding (e.g. where it had not been feasible to
blind participants but outcome assessment was carried out without
knowledge of group assignment). Where blinding was not pos-
sible we assessed whether the lack of blinding was likely to have
introduced bias. We classified methods as being at low, high or
unclear risk of bias.
We also assessed any information about whether the intended
blinding was effective.
(4) Incomplete outcome data (checking for possible attrition
bias through withdrawals, dropouts, protocol deviations)
We looked for the completeness of outcome data in each included
study, for each main outcome, including attrition and exclusions
from the analysis. We assessed whether attrition and exclusions
were reported, the numbers included in the analysis at each stage
(compared with the total randomized participants), reasons for
attrition/exclusion, and any re-inclusions in analyses.We classified
methods as being at low, high or unclear risk of bias.
(5) Selective reporting bias
We assessed this by comparing the study protocol, when available,
and all of the study’s pre-specified outcomes that are of interest in
the review. We classified methods as being at low, high or unclear
risk of bias.
(6) Other sources of bias
We looked for any important concerns about other possible sources
of bias in each included study. For example, was there a potential
source of bias related to the specific study design? Was the trial
stopped early due to some data-dependent process? Was there ex-
treme baseline imbalance? Has the study been claimed to be fraud-
ulent? Has the researcher gained sponsorship from agencies with
a vested interest in the findings? We assessed whether each study
was free of other problems that could put it at risk of bias. We
classified methods as being at low, high or unclear risk of bias.
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(7) Overall risk of bias
We made an explicit judgement about whether studies were at an
overall high, low or unclear risk of bias, according to the following
criteria: low risk if all six ’Risk of bias’ domains were rated low for
that study; unclear risk if at least one domain was rated at unclear
risk; high risk if at least one domain was rated at high risk of bias.
We assessed the likely magnitude and direction of identified risks
of bias, and whether we considered this could have a significant
effect on the findings. We explored the impact of the level of bias
through sensitivity analyses.
Measures of treatment effect
For dichotomous outcomes we calculated risk ratios (RRs) and
95% confidence intervals (95% CIs). We calculated the mean
difference (MD) for continuous outcomes measured using the
same scales, or the standardized mean difference (SMD) if they
used different scales.
Unit of analysis issues
The unit of analysis was the participant in each trial arm. All
included studies had a parallel-group design, so there was no need
for adjustment for a cluster or cross-over design.
Dealing with missing data
We obtained missing data from study authors, if feasible, and per-
formed intention-to-treat analyses if data were available; other-
wise, we performed available-case analyses. We investigated attri-
tion rates, such as dropouts, losses to follow-up and withdrawals,
and we critically appraised issues of missing data. We did not im-
pute missing data.
We contacted by email the first authors of the following included
and ongoing trials:
1. Ahrens 2005. The first author sent the estimates of
continuous outcomes as means and standard deviations for
length of hospital and ICU stay and for length of mechanical
ventilation.
2. Arabi 2015 The first author sent us the length of hospital
and ICU stay and of mechanical ventilation in means and
standard deviation.
3. Charles 2014 The first author sent us mean and standard
deviation of days on mechanical ventilation, and additional
information to complete the ’Risk of bias’ table.
4. NHLBI 2012 and Rice 2011 The corresponding author
sent us all the information required to render their data
compatible, and also some additional unpublished results: length
of hospital stay, ICU and mechanical ventilation in means and
standard deviations, number of participants with infections and
hyperglycaemic episodes, and amount of calories received by
participants in both groups.
5. Ochoa 2017 We contacted the lead author. He replied that
he would try to recover and send the requested study results, but
we have not received them yet.
6. Petros 2016. The study was initially published only in
abstract form. The first author sent us all the information we
required from its finished but unpublished pilot study. The full
paper of the pilot trial was recently published (Petros 2016).
7. Rugeles 2013 We initially identified the study before
publication. The first author sent us the full paper ready to be
published in advance of publication, and some additional
considerations to better assess the risk of bias and the number of
participants with hyperglycaemia.
8. Rugeles 2016 The first author sent us the full paper of this
clinical trial before it was indexed in MEDLINE (It was
registered in clinicaltrials.gov as NCT02577211). The second
author gave us the means and standard deviations for length of
ICU stay and of mechanical ventilation, and also some
additional information to complete the ’Risk of bias’ table.
9. Theodorakopoulou 2016 We did not received an answer to
several questions about the abstract of the trial.
Assessment of heterogeneity
In cases of statistical heterogeneity, i.e. a Chi2 test with a P value
less than 0.10 or an I2 greater than 30% (Higgins 2002), we ex-
amined the potential causes of the heterogeneity by prespecified
subgroup and sensitivity analyses. We followed the suggestions in
Section 9.5.2 of the Cochrane Handbook for Systematic Reviews of
Interventions and interpreted and rated heterogeneity according to
the I2 value as follows: ’not important’ if 40% or less, ’moderate’
with I2 between 30% and 60%, ’substantial’ with I2 between 50%
and 90%, and ’considerable’ if I2 is higher than 75% (see Data
synthesis section for levels of I2 that allowed us to report numerical
results or not) (Higgins 2002).
We assessed clinical heterogeneity by considering different param-
eters of clinical practice.We considered the objectives andmethod-
ology of the trials, the type/severity of the participants (surgical,
medical and others), and several aspects of the nutrition support,
such as time to initiation, route, duration and amount of calories
and protein received by the intervention and the control groups.
The most important parameters of this pragmatic and subjective
assessment were the amount of calories received by each group of
participants, and the difference in calories received by the inter-
vention and control groups. We defined clinical heterogeneity as
’low’, ’moderate’ or ’important’, according to a clinical judgement
about the possibility of comparing trials with small, moderate or
important differences according to the above parameters.
Some of the parameters we used to define clinical heterogene-
ity were also used for subgroup and sensitivity analyses, to inves-
tigate the heterogeneity (Subgroup analysis and investigation of
heterogeneity). In addition, where we identified important sta-
tistical or clinical heterogeneity we performed meta-regression in
order to explore the possible causes.
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Assessment of reporting biases
The search strategy included consultation with leaders in the field,
the pharmaceutical industry, conference and congress proceedings
and snowballing techniques to maximize the possibility of finding
unpublished studies. We performed funnel plot analyses when
eight or more studies were included in each outcome analysis.
Data synthesis
We first reviewed the data from included studies qualitatively.
Then, if possible, we combined them quantitatively by popula-
tion, intervention and outcome, using Cochrane statistical soft-
ware (Review Manager 2014). We based the quantitative analyses
of outcomes on intention-to-treat (ITT) results.
In case of unimportant statistical heterogeneity between studies (I2
of 30% or less), we performed meta-analyses using the fixed-effect
model. In case of I2 between 30% and 50%, we used a random-
effects model to produce more conservative confidence intervals.
If the I2 was above 50%, we did not report pooled estimates of
the meta-analysis. In cases of important clinical heterogeneity we
did not report pooled estimates of the meta-analyses, even in the
absence of statistical heterogeneity.
In the subgroup analyses we reported results using a random-ef-
fects model if one or more of the subgroups had an I2 between
30% and 50%, for a more conservative analysis. If the total statis-
tical heterogeneity test showed I2 above 50% or if the clinical het-
erogeneity was important, we did not report summary estimates
of the meta-analysis.
In all cases where it was not possible to perform or report total or
subtotal analyses, we produced a short descriptive comment about
the results of the studies for each outcome.
Subgroup analysis and investigation of heterogeneity
The prespecified possible causes of heterogeneity were the follow-
ing:
1. Age: 18 to 65 years old, 66 to 75 years old, and more than
75 years old.
2. Primary disease of the participants: major surgery, trauma,
sepsis, medical diseases.
3. Disease severity with or without organ failure: acute
physiology and chronic health evaluation II (APACHE II);
simplified acute physiology score II (SAPS II); sequential organ
failure assessment (SOFA); multiple organ dysfunction score
(MODS); logistic organ dysfunction system (LODS), other
scores.
4. With or without comorbidities: assessed by the Charlson
score or similar.
5. Nutrition status: obese, malnourished or well-nourished.
6. Level of inflammation (by determination of plasma level of
C reactive protein or other acute phase reactants) or
hypermetabolism (by indirect calorimetry) or hypercatabolism
(by measured or estimated total urinary nitrogen).
7. Amount of calories in the intervention group: low versus
very low amount of calories.
After retrieval of studies, we acknowledged that there were impor-
tant differences among them that we should consider in the as-
sessment of clinical heterogeneity. We therefore added other non-
prespecified explorations of heterogeneity:
1. Subgroup analysis by route of nutrition support: enteral or
parenteral nutrition.
2. Meta-regressions (using STATA 14.1; Stata), to explore the
effect of the following variables on the main outcomes: type of
participants, the calories received, and the difference in calories
received by the intervention and control groups.
To investigate differences between two or more subgroups we used
the test for heterogeneity across subgroup results rather than across
individual study results. We also calculated an I2 statistic for sub-
group differences (Higgins 2011). We considered a P value less
than 0.05 as statistically significant.
Sensitivity analysis
1. Trial design: we performed three prespecified sensitivity
analyses: 1) excluding the quasi-randomized trials: 2) excluding
those studies with at least one high ’Risk of bias’ criterion; and 3)
in all the outcomes performed with the fixed-effect model, we
also conducted the analysis with the random-effects model.
2. We undertook two more non-prespecified sensitivity
analyses, excluding trials with a primary goal different from
prescribed hypocaloric enteral or parenteral nutrition.
’Summary of findings’ table and GRADE
Wepresent the overall quality of the evidence for selected outcomes
using the GRADE approach (Schünemann 2011). This approach
takes into account five criteria:
1. Risk of bias
2. Inconsistency
3. Imprecision
4. Directness
5. Publication bias
For each comparison, two review authors (JVAF, ACi) indepen-
dently rated the quality of evidence for each outcome as ’high’,
’moderate’, ’low’, or ’very low’, using GRADEpro GDT software.
We resolved any discrepancies by consensus, or, if needed, by ar-
bitration by a third review author (MP).
We present the results for the comparison of hypocaloric nutrition
versus control for the following outcomes:
1. Mortality in hospital
2. Mortality in ICU
3. Mortality at 30 days
4. Length of hospital stay (days)
5. Length of ICU stay (days)
6. Infectious complications
7. Length of mechanical ventilation (days)
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Since meta-analysis was not possible in most cases due to both
statistical and clinical heterogeneity, we present the range of effect
estimates of the individual studies along with the number of par-
ticipants, number of included studies and confidence in the effect
estimates (Guyatt 2011; Schünemann 2011).
R E S U L T S
Description of studies
See Characteristics of included studies and Characteristics of
excluded studies.
Results of the search
The search strategy from electronic databases, updated to 20 June
2017, retrieved 5055 records. We found four more studies by
handsearching. One full paper was sent by the first author before it
was indexed inMEDLINE (original reference in clinicaltrials.gov,
with the identifier NCT02577211). After removing duplicates we
screened the remaining 4880 records. After title and abstract eval-
uation, we eliminated 4840 records as irrelevant. We found two
ongoing trials. We assessed 47 full-text reports for eligibility and
excluded 20 of them for different reasons (see Characteristics of
excluded studies). We therefore included the remaining 15 studies
(18 reports, Characteristics of included studies). See the updated
flow diagram of the studies in Figure 1.
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Figure 1. Updated study flow diagram, 20 June 2017
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Included studies
Fifteen studies fulfilled the inclusion criteria (Ahrens 2005;
Arabi 2011; Arabi 2015; Battistella 1997; Charles 2014;
Choban 1997; Ibrahim 2002; McCowen 2000; NHLBI 2012;
Norouzy 2013; Petros 2016; Rice 2011; Rugeles 2013; Rugeles
2016; Theodorakopoulou 2016). Two studies (Norouzy 2013;
Theodorakopoulou 2016), were available as abstract only, so some
of the study characteristics are missing.
Sample sizes
The total number of ICU participants included was 3129. The
range of number of ICU participants included in the trials varied
from 13 to 1000.
Setting
Eight included studies were performed in theUSA, two inColom-
bia, one in Saudi Arabia and Canada, and one in each of the fol-
lowing countries: Saudi Arabia, Greece, Germany and Iran. Four-
teen of the included studies were RCTs and one was a quasi-ran-
domized trial (Ibrahim 2002). The setting was mostly university-
associated hospitals.
Participants
Two studies (Ahrens 2005; Choban 1997), reported data of par-
ticipants in the ICU and on a regular patient care floor. In those
studies we only included the data of the ICU participants. The
rest of the trials only included ICU participants. The type of
ICU was reported in the studies as medical, medical-surgical or
trauma ICU, but after evaluating the reported diagnoses of the
included participants, we considered only two categories: sur-
gical participants in five trials (Ahrens 2005; Battistella 1997;
Charles 2014; Choban 1997; McCowen 2000;), and medical par-
ticipants in 10 trials (Arabi 2011; Arabi 2015, Ibrahim 2002;
NHLBI 2012; Norouzy 2013; Petros 2016; Rice 2011; Rugeles
2013; Rugeles 2016; Theodorakopoulou 2016). Some inclusion
criteria considered participants with specific conditions, such as
hyperglycaemia (Arabi 20111), obesity (Choban 1997), sepsis
(Theodorakopoulou 2016), or mechanical ventilation for at least
24 hours (Ibrahim 2002; Rice 2011). In four studies the par-
ticipants received parenteral nutrition (Ahrens 2005; Battistella
1997; Choban 1997; McCowen 2000). Nine studies used only
enteral nutrition (Arabi 2011; Arabi 2015; Ibrahim 2002; NHLBI
2012; Norouzy 2013; Rice 2011; Rugeles 2013; Rugeles 2016;
Theodorakopoulou 2016). In two studies the indication was en-
teral nutrition, but if this was not possible they used parenteral
nutrition (Petros 2016; Charles 2014), (see Table 1).
Interventions and study design
All studies had a parallel-group design, except for two (Arabi 2011;
NHLBI 2012) which had a factorial design. These also evaluated,
respectively, intensive insulin treatment versus standard insulin
treatment, and a nutritional supplement containing omega-3 fatty
acids and antioxidants versus an isocaloric formula. The 15 in-
cluded studies had a control group with prescribed normocaloric
nutrition support. None of the included studies had fasting or
only hydration as a comparator. See Table 1; Table 2. Most of the
included studies did not achieve the proposed caloric target, with a
difference in calories between the intervention and control groups
in the range of 2 to 14 kcal/kg/day.
Outcomes
For full details of the reported outcomes see Table 3 and
Characteristics of included studies.
Funding
Studies were funded by non-governmental associations or foun-
dations (Arabi 2015; Choban 1997; Ibrahim 2002), or by the US
government (Battistella 1997; Charles 2014; NHLBI 2012; Rice
2011). Three studies received funding from the industry (Arabi
2011; Rugeles 2013; Rugeles 2016), and five studies did not spec-
ified their sources of funding (Ahrens 2005; McCowen 2000;
Norouzy 2013; Petros 2016; Theodorakopoulou 2016).
Excluded studies
Out of the 47 full papers we initially assessed for eligibility, we
finally excluded 20 for the following reasons:
1. Three were not randomized or quasi-randomized controlled
trials (Alberda 2009; Arabi 2010; Müller 1995).
2. Three were retrospective studies (Casadei 2006; Dickerson
2002; Lau 2010).
3. Ten studies did not assess hypocaloric nutrition (Desachy
2008; Dissanaike 2007; Doig 2013; Fiaccadori 2005; Garrel
1995; Mackenzie 2005; Moses 2009; Rodríguez 2005; Esterle
2010; Wewalka 2010).
4. Two studies did not include critically-ill participants or only
some of them without disaggregated results (Owais 2014;
Schricker 2005).
5. Two studies did not report clinical results (Berg 2013;
Iapichino 1990).
Refer to the Characteristics of excluded studies for further details.
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Studies awaiting classification
There are no studies awaiting classification.
Ongoing studies
There are two ongoing studies.
We identified one study (NCT01665664) through clinical trial
registries. It is set in Israel, and plans to include adult participants
with mechanical ventilation and to compare hypocaloric nutrition
to normocaloric nutrition. The study outcomes include all-cause
mortality, ICUmortality, hospital mortality, length of stay (hospi-
tal and ICU), length of mechanical ventilation, rate of infections,
ventilator-free days and rate of ventilator-associated pneumonia.
This study was last verified in 2012 in ClinicalTrials.gov and was
“not recruiting”. We were unsuccessful in contacting the study
author.
We identified the secondongoing study in a conference proceeding
(Ochoa 2017). This multicentre RCT includes adult, obese, criti-
cally-ill and mechanically ventilated participants requiring enteral
nutrition, and compares hypocaloric versus normocaloric enteral
nutrition support. The study outcomes include events of hyper-
glycaemia and hypoglycaemia. Since the abstract included limited
information about a preliminary interim analysis we contacted
the study author for further information. This study is funded by
Nestlé Health Science.
Refer to the Characteristics of ongoing studies
Risk of bias in included studies
We assessed seven domains of possible biases, according to pre-
specified criteria. Details for each included study are provided in
their corresponding ’Risk of bias’ table in the Characteristics of
included studies. A graphical summary can be seen in Figure 2
and Figure 3 (showing overall percentages of risk level for each
domain, and levels of risk of bias for each study, respectively).
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias domain presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias domain for each
included study. Red colour represents high risk of bias; green, low risk of bias; and yellow, unclear risk of bias.
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Overall, only one study had low risk of bias in all the evaluated do-
mains (Ahrens 2005). Six studies had at least one high ’Risk of bias’
criterion (Arabi 2015; Charles 2014; Ibrahim 2002; McCowen
2000; Rugeles 2013; Rugeles 2016). The eight remaining studies
had at least one unclear ’Risk of bias’ criterion. In six of them (Arabi
2011; Battistella 1997,NHLBI 2012;Norouzy 2013; Petros2016;
Rice 2011), this was attributable to an unblinded study design.
In these cases, although most outcomes were objective or well-
defined with low risk of detection bias, the descriptions of the
processes of care by clinical personnel did not have enough detail
to assess whether this could have led to a performance bias.
For publication bias, the funnel plots for the outcomes with at
least eight trials did not show significant asymmetry.
Allocation
The random sequence generation and the allocation conceal-
ment were appropriately performed in 10 studies (Ahrens 2005;
Arabi 2011; Arabi 2015; Charles 2014; Choban 1997; NHLBI
2012; Petros 2016; Rice 2011; Rugeles 2013; Rugeles 2016). One
study was quasi-randomized (Ibrahim 2002), and therefore had a
high risk of bias. Four studies (Battistella 1997; McCowen 2000;
Norouzy 2013; Theodorakopoulou 2016) did not clearly describe
these processes, and we classified them as being at unclear risk of
bias.
Blinding
Lack of blinding (open-label or blinding only participants) was
the main driver of the high or unclear risks of bias in most studies
(Arabi 2011; Arabi 2015; Battistella 1997; Charles 2014; Ibrahim
2002; McCowen 2000; NHLBI 2012; Petros 2016; Rice 2011;
Norouzy 2013; Rugeles 2016; Theodorakopoulou 2016). The in-
herent difficulty of blinding a nutrition support strategy in criti-
cally-ill people explains the fact that 80% of the studies could not
blind the healthcare personnel. Nevertheless, three studies man-
aged to do it (Ahrens 2005; Choban 1997; Rugeles 2013).
Incomplete outcome data
Only two studies had a high risk of attrition bias (McCowen 2000;
Rugeles 2013). They excluded participants because they did not
fulfil the prespecified follow-up criteria. Nevertheless, they should
have reported all included participants in an intention-to-treat
analysis. We classified two studies as being at unclear risk, due to
a lack of information in these trials which were only published as
conference abstracts (Norouzy 2013; Theodorakopoulou 2016).
The other 11 studies reported outcomes for all included partici-
pants .
Selective reporting
Three studies had a high risk of reporting bias (Ibrahim 2002;
McCowen 2000; Rugeles 2013). For Ibrahim 2002, some pre-
specified secondary outcomes (duration of mechanical ventila-
tion, need for gastrostomy tube) were not reported. ForMcCowen
2000, “nitrogen balance was only measured in 12 participants
(57%) in the hypocaloric and 10 (53%) of the control group, usu-
ally because of an error during collection”. Rugeles 2013 did not
report mortality. The authors justified this by explaining that they
excluded participants who did not fulfil the 96 hours of enteral
nutrition requirement. They therefore did not report mortality
because this result would have been biased (they only measured
mortality in participants who completed the 96 hours). A better
approach would have been to perform an intention-to-treat anal-
ysis and also to report premature deaths. In Norouzy 2013 and
Theodorakopoulou 2016, the information was not provided, so
we classified them as being at unclear risk. We rated all the other
studies at low risk of reporting bias.
Other potential sources of bias
Choban 1997 was partially funded by a corporation. Since we
could not guarantee that this sponsorship had no material interest
in the findings of the study, we classified it as being at unclear risk
of bias.
The lack of detail in the description of the methods section of
McCowen 2000 could not warrant a ’low risk’ rating for Other
sources of bias. We therefore classified it as being at unclear risk of
bias. Due to the lack of information in the abstracts of Norouzy
2013 andTheodorakopoulou 2016we also classified themas being
at unclear risk of Other potential sources of bias.
Effects of interventions
See:Summary of findings for themain comparisonHypocaloric
nutrition compared to control for critically-ill adults
The 15 included studies showed significant clinical heterogeneity
between them, mainly related to the amount of calories provided
to the intervention and control groups (Table 2), and also to some
differences in trials methodology, the target participants and the
feeding strategies. As stated in Assessment of heterogeneity and in
Data synthesis, the degree of clinical or statistical heterogeneity
precluded us from reporting the numerical summary results of
the meta-analysis for all the primary and secondary outcomes (
Analysis 1.1 to Analysis 1.11). We used similar criteria to report
the sensitivity or subgroup analyses.
When we could not report results due to clinical or statistical
heterogeneity or both, we did a qualitative synthesis of the trial
results. We also reported trial results of the included studies in
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tabular form: percentages and means of the hypocaloric and the
control group of the seven main outcomes (Table 3).
Primary outcomes
1.1 Mortality in hospital
For this outcome we found nine relevant trials (1775 par-
ticipants) (Arabi 2011; Arabi 2015; Battistella 1997; Charles
2014; Choban 1997; Ibrahim 2002; McCowen 2000; Petros
2016; Rice 2011).We found no statistical heterogeneity (I2 = 0%)
but important clinical heterogeneity due to the differences in the
underlying diagnoses of the medical or surgical ICU participants
and the route/characteristics of administration of enteral or par-
enteral nutrition or both, but mainly to the wide differences in
calories and protein received by the participants in the included
trials (Table 1; Table 2). We therefore did not pool the point es-
timates in meta-analysis (Analysis 1.1). There were 210 deaths in
the 881 participants who received hypocaloric nutrition, and 235
deaths in the 894 participants who received the control interven-
tion. All studies suffered from imprecision and their confidence
intervals included the null value (Analysis 1.1). The central esti-
mates of risk ratios for hospital mortality of each individual studies
ranged from 0.23 to 5.54. When we excluded Battistella 1997,
the range of risk ratio estimates was narrower, since this study has
a more extreme estimate due to small sample size and zero events
in the control group. The quality of the evidence for this outcome
was very low, due to high risk of attrition bias, imprecision and
inconsistency (wide variance of point estimates across studies) (
Summary of findings table 1).
1.2 Mortality in the intensive care unit (ICU)
We found four relevant trials for this outcome (1291 participants)
(Arabi 2011; Arabi 2015; Battistella 1997; Petros 2016).We found
no statistical heterogeneity (I2 = 0%) but important clinical het-
erogeneity due to the type of participants, the nutrition methodol-
ogy and the amount of calories received by the participants (Table
1; Table 2). We therefore have not pooled the point estimates
(Analysis 1.2). There were 105 deaths in the 641 participants who
received hypocaloric nutrition, and 123 deaths in the 650 partic-
ipants who received the control intervention. All studies suffered
from imprecision and their confidence intervals included the null
value (Analysis 1.2). The central estimates of risk ratios for ICU
mortality of each individual studies ranged from 0.81 to 5.54.
When we excluded Battistella 1997, the range of risk ratio esti-
mates was narrower, since this study has a more extreme estimate
due to small sample size and zero events in the control group. The
quality of the evidence for this outcome was very low, due to a high
risk of attrition bias, imprecision and inconsistency (wide variance
of point estimates across studies) (Summary of findings table 1).
1.3 Mortality at 30 days
For this outcome we found seven relevant trials (2611 partici-
pants) (Arabi 2011; Arabi 2015; NHLBI 2012; Norouzy 2013;
Petros 2016; Rice 2011; Rugeles 2016). We found the abstract
of an additional trial (Theodorakopoulou 2016), with mortality
reported narratively for 38 participants. We found no statistical
heterogeneity (I2 = 0%) but important clinical heterogeneity due
to participants’ diagnoses, type and characteristics of the nutri-
tion support, the amount of calories and the differences in calories
received by the participants of both groups in the analysed trials
(Table 1; Table 2). We therefore did not pool the point estimates
(Analysis 1.3). There were 275 deaths in the 1309 participants
who received hypocaloric nutrition, and 275 deaths in the 1302
participants who received the control intervention. All studies suf-
fered from imprecision and their confidence intervals included the
null value (Analysis 1.3). The central estimates of risk ratios for
mortality at 30 days of the individual studies ranged from 0.79
to 3.00. The quality of the evidence for this outcome was very
low, due to a high risk of attrition bias, imprecision and inconsis-
tency (wide variance of point estimates across studies) (Summary
of findings table 1).
2. 1 Length of hospital stay (days)
We found 10 relevant trials for this outcome (1677 participants)
(Ahrens 2005; Arabi 2011; Arabi 2015; Battistella 1997; Charles
2014; Choban 1997; Ibrahim 2002; McCowen 2000; Norouzy
2013; Petros 2016). We found considerable statistical heterogene-
ity (I2 = 78%) and important clinical heterogeneity due to differ-
ences in participants, nutrition methodology, and calories received
by the participants of the intervention and control groups (Table
1; Table 2). We therefore did not pool the estimates (Analysis
1.4). Participants who received hypocaloric nutrition support had
a mean length of stay of 15.70 days lower to 10.70 days higher
compared to thosewith normocaloric nutrition support. The qual-
ity of the evidence for this outcome was very low, due to unclear
or high risk of bias in most studies, inconsistency and imprecision
(Summary of findings table 1).
2. 2 Length of ICU stay (days)
For this outcome we found 11 relevant trials (2942 participants)
(Ahrens 2005; Arabi 2011; Arabi 2015; Battistella 1997; Charles
2014; Ibrahim 2002; NHLBI 2012; Petros 2016; Rice 2011;
Rugeles 2013; Rugeles 2016). We found considerable statistical
heterogeneity (I2 = 81%) and important clinical heterogeneity
due to differences in the type of participants, nutrition method-
ology and the differences in total amount of calories and protein
received by the participants, as well as the caloric difference be-
tween the groups in each trial ( Table 1; Table 2). We therefore
have not pooled the effect estimates (Analysis 1.5). Participants
who received hypocaloric nutrition support had a mean length
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of stay 11.00 days lower to 5.40 days higher compared to those
with normocaloric nutrition support. The quality of the evidence
for this outcome was very low, due to unclear or high risk of
bias in most studies, inconsistency and imprecision (Summary of
findings table 1).
3. Infectious complications. Events of any type of infectious
complications occurring during the hospital stay, registered
by the study authors according to their diagnostic criteria of
infections
Ten studies reported this outcome (2804 participants) (Ahrens
2005; Arabi 2011; Arabi 2015; Battistella 1997; Charles 2014;
Ibrahim 2002; McCowen 2000; NHLBI 2012; Petros 2016; Rice
2011). We found moderate statistical heterogeneity (I2 = 49%)
and important clinical heterogeneity due to the type of partici-
pants, study methodology and amount of calories and protein re-
ceived by the participants (Table 1; Table 2). We therefore have
not pooled the estimates. There were 423 participants with in-
fections in the 1404 participants who received hypocaloric nutri-
tion, and 438 infections in the 1400 participants who received
the control intervention. Most studies suffered from imprecision
and their confidence intervals included the null value (Analysis
1.6). The range of the central estimate of risk ratios for infectious
complications of the individual studies ranged from 0.54 to 2.54.
The quality of the evidence for this outcome was very low, due
to unclear or high risk of bias, inconsistency and imprecision (
Summary of findings table 1).
Secondary outcomes
1. Length of mechanical ventilation. Days on mechanical
ventilation during ICU stay
For this outcome we found 12 relevant trials (3000 participants)
(Ahrens 2005; Arabi 2011; Arabi 2015; Battistella 1997; Charles
2014; Ibrahim 2002; NHLBI 2012; Norouzy 2013; Petros 2016;
Rice 2011; Rugeles 2013; Rugeles 2016). We found substantial
statistical heterogeneity (I2 = 69%) and important clinical het-
erogeneity due to the type of participants, nutrition methodology
and the differences in the amount of calories and protein received
by the participants, as well as the caloric difference between the
groups in each trial (Table 1; Table 2). We therefore did not pool
the effect estimates. Participants who received hypocaloric nutri-
tion support had amean length of mechanical ventilation of 13.20
days lower to 8.36 days higher compared with those with nor-
mocaloric nutrition support. The quality of the evidence for this
outcome was very low, due to unclear or high risk of bias in most
studies, inconsistency and imprecision (Analysis 1.7; Summary of
findings for the main comparison).
2. Non-infectious complications. Events of any non-
infectious complication during the hospital stay, potentially
associated with the nutrition status or the nutrition support,
according to the criteria of the study authors (diarrhoea)
Three studies reported this outcome (1994 participants) (Arabi
2015; NHLBI 2012; Petros 2016). We found considerable statis-
tical heterogeneity (I2 = 76%) and important clinical heterogene-
ity due to the type of participants, nutrition methodology and the
differences in the amount of calories and protein received by the
participants, as well as the caloric difference between the groups
in each trial (Table 1, Table 2). We therefore did not pool the
effect estimates. There were 187 participants with non-infectious
complications (diarrhoea) in the 1002 participants who received
hypocaloric nutrition, and 242 participants with non-infectious
complications in the 992 participants who received the control
intervention. Most studies suffered from imprecision and their
confidence intervals included the null value. The range of the cen-
tral estimate of risk ratios for non-infectious complications of the
individual studies ranged from 0.32 to 0.85. The quality of the
evidence for this outcome was very low, due to unclear or high
risk of bias, inconsistency and imprecision (Analysis 1.8).
3.1 Carbohydrate metabolic outcomes: hyperglycaemia
(glycaemia higher than 150 mg/dl) during ICU stay
For this outcome we found six relevant trials (1380 participants)
(Ahrens 2005; McCowen 2000; NHLBI 2012; Petros 2016;
Rugeles 2013; Rugeles 2016).We found substantial statistical het-
erogeneity (I2 = 62%) with moderate clinical heterogeneity due
to the type of participants, nutrition methodology and the differ-
ences in the amount of calories and protein received by the partic-
ipants, as well as the caloric difference between the groups in each
trial (Table 1; Table 2). We therefore did not pool the effect esti-
mates. There were 205 participants who suffered hyperglycaemia
in the 695 participants who received hypocaloric nutrition, and
279 participants who suffered hyperglycaemia in the 685 partici-
pants who received the control intervention. Most studies suffered
from imprecision and their confidence intervals included the null
value. The central estimate of risk ratios for hyperglycaemia of the
individual studies ranged from 0.36 to 0.93. The quality of the
evidence for this outcome was very low, due to unclear or high
risk of bias, inconsistency and imprecision (Analysis 1.9).
3.2 Carbohydrate metabolic outcomes: events of
hypoglycaemia (glycaemia lower than 70 mg/dl) during ICU
stay
We found five relevant trials for this outcome (1394 participants)
(Ahrens 2005; Arabi 2011; Arabi 2015; Petros 2016; Rugeles
2016). We found no statistical heterogeneity (I2 = 0%) but im-
portant clinical heterogeneity due to the type of participants, nu-
trition methodology and the differences in the amount of calories
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and protein received by the participants , as well as the caloric
difference between the groups in each trial (Table 1; Table 2). We
therefore did not pool the effect estimates. There were 46 partic-
ipants who suffered hypoglycaemia in the 694 participants who
received hypocaloric nutrition, and 38 participants who suffered
hypoglycaemia in the 700 participants who received the control
intervention. Most studies suffered from imprecision and their
confidence intervals included the null value. The central estimate
of risk ratios for hypoglycaemia of the individual studies ranged
from 0.85 to 1.76. In Rugeles 2016, a risk ratio was not estimable
due to no events in either group. The quality of the evidence for
this outcome was low, due to unclear or high risk of bias and im-
precision (Analysis 1.10).
4. Lipid metabolic outcomes. Events of
hypertriglyceridaemia (higher than 200 mg/dl) or any lipid
metabolic complication associated with the nutrition
support according to the criteria of the study authors
None of the included trials reported this outcome
5. Protein metabolic outcomes: nitrogen balance
For this outcome we found three relevant trials (92 participants)
(Battistella 1997; Choban 1997;McCowen 2000).We found sub-
stantial statistical heterogeneity (I2 = 72%) with moderate clinical
heterogeneity due to the type of participants, nutrition method-
ology and the differences in the amount of calories and protein
received by the participants, as well as the caloric difference be-
tween the groups in each trial (Table 1; Table 2). We therefore
did not pool the effect estimates (Analysis 1.11). Participants who
received hypocaloric nutrition support had a mean nitrogen bal-
ance of −7.70 g/day to +2.00 g/day compared to those with nor-
mocaloric nutrition support. The quality of the evidence for this
outcome was very low, due to unclear or high risk of bias in most
studies, inconsistency and imprecision (Analysis 1.11).
6. Nutrition status or clinical condition at ICU discharge.
Nutrition or functional evaluation, made at the time of ICU
discharge with any method of assessment used by the study
authors.
None of the included trials reported this outcome
Subgroup analyses
We focused our subgroup analyses on the seven outcomes reported
in Summary of findings for the main comparison. Out of these
seven outcomes only four had considerable statistical heterogene-
ity: length of hospital and ICU stay, infectious complications and
length of mechanical ventilation. We explored sources of statisti-
cal heterogeneity and assessed whether meta-analysis was possible,
considering clinical heterogeneity in the predefined subgroups.
Due to insufficient information available, we were unable to per-
form subgroup analysis by: age, disease severity, presence of co-
morbidities, nutrition status (malnourished or well-nourished),
level of inflammation, hypermetabolism or hypercatabolism. It
was only possible to perform prespecified subgroup analyses by:
obesity status (as a condition of nutrition status), type of under-
lying medical condition (surgical or medical), amount of calories
actually received by participants in the intervention and control
groups. During the process of data extraction we realized that
the included trials had several methodological differences between
them. At this time (before any analysis of results), we decided to
perform two additional analyses not prespecified in the protocol
(Subgroup analysis and investigation of heterogeneity): subgroup
analysis by route of nutrition support (enteral or parenteral) and
meta-regression (see below). The I2 values for these subgroup anal-
yses are shown in Table 4. Most of the subgroup analyses were
unable to explain the statistical heterogeneity of the results across
studies:
1. In the subgroup analysis by nutrition status, limited to
obesity, we did not observe subgroup differences in length of
hospital stay.
2. In the subgroup analysis by route of nutrition support
we found considerable subgroup differences in length of stay in
ICU and in duration of mechanical ventilation.
3. In the subgroup analysis by the type of participant we
did not find subgroup differences between the surgical or
medical participants in any of the outcomes analysed
4. In the subgroup analysis by the amount of calories
received by each study group we found considerable subgroup
differences in length of hospital stay and in duration of
mechanical ventilation.
Sensitivity analyses
1. Excluding quasi-randomized trials. The sensitivity
analysis after excluding the only quasi-randomized trial (Ibrahim
2002) did not show major changes in the overall results for the
outcomes of mortality in hospital, length of hospital stay, length
of ICU stay and infectious complications. We only observed a
change in the outcome of duration of mechanical ventilation.
After excluding this trial, the statistically significant difference in
favour of the hypocaloric group disappeared. However, this result
should be interpreted with caution due to the substantial
statistical heterogeneity (I2 = 69%) and important clinical
heterogeneity.
2. Excluding trials with at least one high ’Risk of bias’
criterion. The sensitivity analysis after excluding the six trials
with at least one high ’Risk of bias’ criterion ( Arabi 2015;
Charles 2014; Ibrahim 2002; McCowen 2000; Rugeles 2013;
Rugeles 2016) did not show major changes in the results of the
primary and secondary outcomes analysed, nor in the subgroup
analyses. We only observed some minor changes in the statistical
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heterogeneity of several subgroups analysed.
3. By fixed-effect or random-effects models. We analysed
the primary and secondary outcomes by fixed-effect or random-
effects models according to the value of I2, as stated in Data
synthesis. In all the analyses where the pooled estimates were
done with the fixed-effect model, we conducted a sensitivity
analysis with the random-effects model to explore the robustness
of results. No primary or secondary outcomes or subgroup
analyses showed a major change in their statistical significance or
heterogeneity.
4. By different primary goal of enteral nutrition trials. We
performed a post hoc sensitivity analysis (see Sensitivity analysis),
excluding the three studies (Ibrahim 2002; NHLBI 2012; Rice
2011) with a primary goal to assess the effects of early initiation
of trophic (hypocaloric) enteral nutrition or standard
(normocaloric) enteral feeding from the beginning. We did not
find major differences in the primary or secondary outcomes,
except for minor changes in two unreported outcomes due to the
heterogeneity: length of mechanical ventilation and
hyperglycaemia.
5. By different primary goal of parenteral nutrition trial.
Another post hoc sensitivity analysis was the exclusion of the
Battistella 1997 trial, because its primary goal was the evaluation
of parenteral nutrition with or without lipids (equivalent to
normocaloric or hypocaloric nutrition, respectively). After
excluding this trial, we did not see major changes in the primary
and secondary outcomes evaluated, with the exception of the
length of mechanical ventilation: loss of statistical significance in
favour of the hypocaloric group (result not reported due to the
substantial statistical heterogeneity).
Meta-regression
Considering that we found high levels of clinical and statistical het-
erogeneity, we performed non-prespecified meta-regressions using
STATA 14.1 to explore the effect of covariates for which we had
data (Table 2; Table 3):
1. Type of participants (medical or surgical participants)
2. The calories received in the hypocaloric group, based on the
three aforementioned categories (see Subgroup analysis by the
amount of calories received by each study group): normo-
hypercaloric, hypocaloric or very low hypocaloric.
3. The difference in calories received between study groups
(control minus intervention groups).
We performed meta-regression on the primary outcomes with re-
sults of nine or more trials: hospital mortality, infectious compli-
cations, hospital length of stay and ICU length of stay. We did
not find significant results explaining sources of heterogeneity us-
ing this analysis. None of the analysed explanatory variables influ-
enced the size of the intervention effect of the outcome variables.
The details on the definition of variables, dataset and outcome
measures are available in Appendix 5 and Appendix 6.
Table 3: In order to show some aspects of the heterogeneous results,
in Table 3 we present crude results of the primary outcomes and
of length of mechanical ventilation for the 15 included studies.
The files of the table were ordered from top to bottom by the
difference in the amount of calories receive by the control groups
minus those received by the hypocaloric groups (second column
from the left).
Assessment of reporting bias
Weperformed a funnel plot for the outcomeswithmore than eight
included studies (Analysis 1.1; Analysis 1.4; Analysis 1.5; Analysis
1.6; Analysis 1.7). We did not see important asymmetries in the
funnel plots, suggesting publication bias (we give one example in
Figure 4).
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Figure 4. Funnel plot of comparison: 1 Hypocaloric nutrition (intervention) vs. Control, outcome: 1.1
Mortality in hospital.
D I S C U S S I O N
Summary of main results
We identified 15 trials including a total of 3129 ICU participants.
The included trials had different objectives, participant charac-
teristics and methodology for the administration of the nutrition
support. The consequence of this was important methodological
diversity between the included trials (Table 1). Due to the high
clinical and statistical heterogeneity, we did not report summary
estimates for the primary and secondary outcome analyses. Of all
the causes of clinical heterogeneity, the most relevant ones pre-
cluding the report of summary estimates were the disparity in the
amount of calories/protein received by the intervention and con-
trol groups, and the disparity in the differences in the calories re-
ceived between the study groups in the included trials (Table 2;
Table 3). For the same reason, we did not report total estimates of
subgroup analyses (See Table 4).
In a descriptive analysis of the results of the included trials
for the main outcomes (See Summary of findings for the main
comparison), we can summarize the following:
1. We found very low-quality evidence for the outcomes
related to mortality (in hospital, in ICU and at 30 days), with
no statistical but important clinical heterogeneity. Most studies
did not find differences in the incidence of mortality between
hypocaloric and control groups. The reasons for downgrading
the evidence were unclear or high risk of bias in the included
studies, inconsistency and imprecision.
2. We found very low-quality evidence for the outcome
length of hospital and ICU stay, with both clinical and
statistical heterogeneity. In smaller studies, there was a tendency
towards a shorter length of stay in participants in the hypocaloric
group, but the results across studies were inconsistent, some
favouring hypocaloric nutrition support and some control. The
reasons for downgrading the evidence were unclear or high risk
of bias in the included studies, inconsistency and imprecision.
3. We found very low-quality evidence for the outcome
infectious complications, with moderate statistical and
important clinical heterogeneity. The results across studies were
inconsistent, some favouring hypocaloric nutrition support and
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some control. The reasons for downgrading the evidence were
unclear or high risk of bias in the included studies, inconsistency
and imprecision.
4. We found very low-quality evidence for the outcome length
of mechanical ventilation, with both clinical and statistical
heterogeneity. The results across studies were inconsistent, some
favouring hypocaloric nutrition support and some control. The
reasons for downgrading the evidence were unclear or high risk
of bias in the included studies, inconsistency and imprecision.
Other outcomes
1. For diarrhoea (non-infectious complications) the
statistical heterogeneity was considerable and the clinical
heterogeneity important. The central estimates of the individual
studies favoured hypocaloric nutrition support, but the quality
of this evidence was very low, due to unclear or high risk of bias
in the included studies, inconsistency and imprecision.
2. For hyperglycaemia the statistical heterogeneity was
substantial and the clinical heterogeneity moderate. The central
estimates of the individual studies favoured hypocaloric nutrition
support, but the quality of this evidence was very low, due to
unclear or high risk of bias in the included studies, inconsistency
and imprecision.
3. For hypoglycaemia, the clinical heterogeneity was
important, but with no statistical heterogeneity. The individual
studies did not find differences in the incidence of
hypoglycaemia between hypocaloric and control groups, but the
quality of this evidence was low, due to unclear or high risk of
bias in the included studies and imprecision.
4. For nitrogen balance, the statistical heterogeneity was
substantial and the clinical heterogeneity moderate. The results
were inconsistent, some favouring hypocaloric nutrition support
and some control; the quality of evidence was very low, due to
unclear or high risk of bias in the included studies, inconsistency
and imprecision.
We did not find data to perform several of the subgroup analyses
proposed in the review protocol. We performed subgroup analy-
ses for the main outcomes, but these could not comprehensively
explain the statistical heterogeneity (See Table 4).
In the three prespecified sensitivity analyses (excluding the quasi-
randomized trial; the three trials with at least one high ’Risk of
bias’ domain; or the change of results from fixed-effect to random-
effects model) we did not see major changes in the results, nor
in the post hoc sensitivity analysis excluding three studies with a
primary goal to assess hypocaloric trophic enteral nutrition versus
standard enteral feeding. In the other post hoc sensitivity analysis
excludingBattistella 1997, in the primary and secondary outcomes
we only observed the loss of an unreported significant difference
in length of mechanical ventilation.
As we established in the subgroup and sensitivity analyses, Ahrens
2005 and Battistella 1997 had very dissimilar results compared to
the other included studies. In both trials, the control groups re-
ceived a high caloric dose, a median 37 total kcal/kg/day in Ahrens
2005, and 34.4 total kcal/kg ideal body weight/day in Battistella
1997.Moreover, in Ahrens 2005, the control participants not only
received hypercaloric parenteral nutrition but also more dextrose
than currently recommended for critically-ill participants (ASPEN
/ SCCMguidelines 2009; ESPENguidelines 2009), with amedian
(interquartile (IQ) range) of 4.9 (4.79 to 5.07) mg dextrose/kg/
min. (The authors also reported that the administration of more
dextrose than 4 mg/kg/min behaved as a predictor of hypergly-
caemia). Finally, It is also important to remember that Battistella
1997 compared parenteral nutrition with and without lipid emul-
sions. It is therefore difficult to discriminate whether the observed
results were due to the amount of calories administered, to the
withholding of soy-derived lipid emulsions in the parenteral nu-
trition, or both.
In order to evaluate causes of heterogeneity or to formulate hy-
potheses about them, we performed a non-prespecified meta-re-
gression with the available covariates for the primary outcomes
with nine ormore trials.We did not find significant results explain-
ing sources of heterogeneity (Appendix 5; Appendix 6). However,
the results of the meta-regression should be considered cautiously,
due to the fact of post hoc analysis, and to the limited number of
studies for the number of covariates in the model.
Overall completeness and applicability of
evidence
The research strategy was comprehensive and inclusive. Given the
scarcity of evidence, it sought to include all possible trials with a
design and goal to evaluate hypocaloric versus normocaloric nutri-
tion support in critically-ill people. This is why we also included
quasi-randomized controlled trials, different types of ICU settings
(medical, surgical, mixed), types of participants (age, medical con-
dition, etc.), administration routes (enteral, parenteral or both),
and also considered trials with a different primary goal or method-
ology to achieve prescribed hypocaloric feeding. We therefore be-
lieve that the included studies represent a complete set of up-
to-date evidence on hypocaloric nutrition support in critically-ill
adults.
Nevertheless, breadth of scope was at the expense of clinical and
statistical heterogeneity. Some of these differences in participants,
interventions and outcomes of the included trials can be seen in
Table 1 and Table 2. In addition, all studies were performed at
university-associated or teaching hospitals, which are probably dif-
ferent from other clinical settings. It is therefore arguable whether
our results could be generalized. The clinical and statistical het-
erogeneity precluded a quantitative synthesis of all the outcomes
and most of the subgroup analyses. In the clinical field, the results
should be interpreted with caution, considering all these issues.
When we analyse the amount of calories actually received by the
groups in each trial (many of them different from those prespec-
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ified in their study protocols), we find that most of the included
studies did not really evaluate the administration of hypocaloric
versus normocaloric nutrition support, but a wide range of calo-
ries administered (Table 2). Moreover, the difference in calories
received by the control minus the hypocaloric group was quite
small in some of the included trials (Table 3). Both factors not
only contributed to the clinical heterogeneity, but could also have
been associated with the lack of statistically significant differences
(if any) between the study groups.
Most of the included trials did not analyse the role of protein ad-
ministration in the outcomes evaluation. The amount of protein
administered to the intervention and control groups was reported
in 12 trials: quite diverse in three of them, rather similar in four,
and more or less the same in the other five (Table 2). There is
wide consensus that obese critically-ill people should receive hy-
perproteic hypocaloric feeding (ASPEN / SCCMguidelines 2016;
Choban 2013; Dickerson 1986), but there is a current debate
about the best protein dose for the non-obese people: higher doses
of proteins seemed to be associated with better outcomes in the
critically-ill people (Dickerson 2012;Weijs 2012;Weijs 2013; Van
Zanten 2016). The different daily protein administered to the
study groups in the included trials should be considered as another
component of the clinical heterogeneity.
Even though our results did not find conclusive significant ev-
idence in favour of the hypocaloric nutrition support, it is also
interesting to note that we did not find high-quality evidence for
harms. This is in contrast to two observational studies that re-
ported some poorer clinical outcomes or complications when cer-
tain levels of calories were not achieved (Rubinson 2004; Villet
2005).
Quality of the evidence
According to GRADE, the quality of evidence for the primary
outcomes was very low (see Summary of findings for the main
comparison).
Six out of 15 included studies presented one or more high ’Risk of
bias’ criteria and eight studies had one ormore unclear ’Risk of bias’
criteria. Given the complexity of nutrition support in critically-
ill people, blinding the personnel (the major driver for high risk
of bias in this systematic review) is challenging, although some
studies were able to do it. Only one included trial (Ahrens 2005)
had low risk of bias in all predefined criteria (Figure 3). The quality
of evidence according to GRADE was low to very low for all the
primary outcomes.
Another reason for downgrading the quality of evidence was in-
consistency. We explored the qualitative characteristics that could
explain inconsistency, but we were unable to identify them in sub-
group analyses (Table 4), sensitivity analyses and meta-regression.
Inconsistency was also evident in the wide variance of point esti-
mates for mortality.
Imprecision affected the quality of all main outcomes, especially
mortality, due to the low number of events. The confidence in-
tervals were wide and we could not improve precision by pooling
results in most cases, due to the clinical heterogeneity.
For publication bias, the funnel plots for the outcomes with at
least eight trials did not show significant asymmetry.
Potential biases in the review process
We followed the procedures of the Cochrane Handbook for System-
atic Reviews of Interventions (Higgins 2011), in order to minimize
biases in the review process. The search strategy was defined by
a senior librarian and evaluated by another independent expert.
Our search strategy was comprehensive, including consultation
with opinion leaders, the pharmaceutical industry, conference and
congress proceedings and snowballing techniques to maximize the
chances of retrieving all existing studies, published or unpublished.
Three review authors independently screened the trials, and data
extraction and assessment of risks of bias were also done by two in-
dependent review authors. We resolved any disagreement through
consultation with a third review author.
We strictly followed the inclusion-exclusion criteria of our pro-
tocol (Perman 2009). Our included trials are non-homogeneous,
with different objectives and methodologies. The main differ-
ences related to the type and conditions of the participants and
the methodology for the administration of the nutrition support
(goals, time of initiation, route, strategy of delivery and calories
administered, among others) (Table 1). This clinical and method-
ological heterogeneity added complexity to the analysis of data and
the interpretation of results. It was not possible to report summary
estimates due to the clinical or statistical heterogeneity or both.
We acknowledge that the multiplicity of subgroup analyses and
post hoc analyses could have yielded false positive results. We
added these post hoc analyses in order to explore the clinical het-
erogeneity found in the included studies. We tried to reduce the
risk of false-positive results by restricting the exploration of sub-
groups to those outcomes in which we found statistical hetero-
geneity, as we had defined in our protocol.
Agreements and disagreements with other
studies or reviews
There are eight previous systematic reviews and meta-analyses di-
rectly or indirectly related to the topic of this review. They have
similar purposes, but different review questions and inclusion cri-
teria.
The first review (Jiang 2011), evaluated randomized controlled
trials comparing hypocaloric parenteral nutrition (≤ 20 non-pro-
tein kcal/kg/day) versus standard or high-energy parenteral nu-
trition (≥ 25 or > 30 non-protein kcal/kg/day, respectively) in
surgical or trauma participants. According to their inclusion-ex-
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clusion criteria, they included five trials, two of which (Ahrens
2005; Battistella 1997) we also include. The other three studies
(in the Chinese language) were trials of postoperative, not crit-
ically-ill participants (according to the titles and one abstract of
the studies) (Jiang 2003;Mao 2015; Zhan 2007). They reported a
statistically significant reduction in infectious complications and
length of hospital stay, with moderate heterogeneity, in the surgi-
cal participants receiving hypocaloric parenteral nutrition. Those
results were more consistent andwith less heterogeneity when they
excluded the small-sample size trials. The calories administered to
the participants seemed to be more homogeneous, but the authors
did the analysis with administered non-protein calories. If we add
the caloric content of the administered protein, the intervention
group received an average of 24.0 (range 20.5 to 27.0) total kcal/
kg/day and the control group 34.5 (range 32.5 to 36.0) total kcal/
kg/day. This means that the study compared almost normocaloric
versus normo- to hypercaloric parenteral nutrition. The favourable
effects of the lower-caloric parenteral nutrition on infectious com-
plications and length of hospital stay reported in this meta-anal-
ysis should therefore be limited to surgical participants receiving
parenteral nutrition with higher than recommended caloric dose.
In our subgroup analyses we observed similar results with the anal-
yses of Ahrens 2005 and Battistella 1997.
In 2015 the Canadian Critical Care Nutrition Clinical Practice
Guidelines Committee updated the Canadian Clinical Practice
Guidelines for nutrition support for critically-ill adults. They pro-
duced three different but related systematic reviews andmeta-anal-
yses, with the following titles: Intentional Underfeeding: Trophic
Feeds vs. Full Feeds (Canadian Guideline 3.3a 2015); Intentional
Underfeeding: Hypocaloric Enteral Nutrition (Canadian Guideline
3.3b 2015); and Strategies to Optimize Parenteral Nutrition and
Minimize Risks: Dose of PN (Canadian Guideline 10.1 2015). This
approach was guidelines-oriented, but also served to diminish the
clinical heterogeneity of the included trials and the statistical het-
erogeneity in some analyses.
For the evaluation of trophic (hypocaloric) versus full (nor-
mocaloric) feeding (Canadian Guideline 3.3a 2015), theCanadian
group evaluated two studies, also included in our review (NHLBI
2012; Rice 2011), but they did not include a quasi-randomized
trial with a similar goal and methodology (Ibrahim 2002). The
meta-analysis did not show statistical differences in mortality or
ventilator-associated pneumonia between the study groups. They
did not report results of length of hospital stay, of ICU stay or of
mechanical ventilation, due to the way the data were reported in
the trials. However, we could analyse these results after receiving
the information from the first author of each trial. We did not find
statistically significant differences between the study groups.
To update the 2015 guideline Intentional Underfeeding:
Hypocaloric Enteral Nutrition (Canadian Guideline 3.3b 2015),
the Canadian Committee included four trials in themeta-analysis.
We included all four of them in our review (Arabi 2011; Arabi
2015; Charles 2014; Petros 2016). They found that hypocaloric
enteral nutrition was associated with a trend towards lower hos-
pital and ICU mortality, and a statistically significant reduction
in the length of mechanical ventilation. They did not find signif-
icant differences for infectious complications or length of hospi-
tal and ICU stay. In the enteral nutrition subgroup analysis we
were prevented from reporting summary estimates of the six out-
comes evaluated, due to the high clinical or statistical heterogene-
ity. When we did the same analysis as they did, the results were
almost the same (some minor numerical differences).
The Canadian group included four trials in their meta-analysis
of parenteral nutrition (Canadian Guideline 10.1 2015), which
we also included in our review (Ahrens 2005; Battistella 1997;
Choban 1997; McCowen 2000). (They included results from an
“unpublished Ahrens 2003” trial, which were the same as our in-
cluded Ahrens 2005 trial). They did not find statistically signifi-
cant differences between the intervention and control groups for
hospital mortality or infectious complications. In our subgroup
analysis of parenteral nutrition, we found some minor numerical
differences from the Canadian Guideline in the same two out-
comes, but the results were essentially the same. They also reported
some additional results (sensitivity analysis and results of individ-
ual studies), but not significant ones.
Another systematic review and meta-analysis (Choi 2015), com-
pared the effect of initial enteral nutrition with an underfeeding
dose versus initial full-feeding dose of enteral nutrition in criti-
cally-ill adults. They included four trials, three of which we also
included in our review (Arabi 2011; NHLBI 2012; Rice 2011),
and one which we excluded due to a different primary objective
(Desachy 2008). They did not find significant differences in over-
all mortality and other clinical outcomes between the underfeed-
ing and the full-feeding groups. In the subgroup analysis, the un-
derfeeding subgroup that received 33.3% or more of the standard
caloric requirement showed a significantly lower overall mortality,
compared with the full-feeding group. This was not seen in the
underfeeding subgroup that received less than a 33.3% dose of
enteral nutrition. This suggests the possibility that a moderate un-
derfeeding enteral nutrition, but not a minimal intake, could be
associated with a better prognosis. Nevertheless, the included tri-
als showed clinical heterogeneity, as well as our subgroup analysis
of enteral nutrition, where we did not see differences in hospital
mortality.
The Tian 2015 meta-analysis included eight randomized trials
showing significantly different calories administered by the enteral
route. We included four of these trials in our review (Arabi 2011;
Charles 2014; NHLBI 2012; Rice 2011). They did not find sig-
nificant differences between the low- and high-energy groups for
mortality; infectious complications; pneumonia; gastrointestinal
intolerance and the length of hospital stay, of ICU stay and of
mechanical ventilation. In the subgroup analysis, the low-energy
groups who received between 33.3% and 66.6% of the caloric
goal had a significantly lower mortality compared with the high-
energy group. In the subgroup analysis with different amount of
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protein administration, they found that high protein administra-
tion (more than 0.85 g/kg/day) plus high energy could decrease
the rate of infectious complication. In our subgroup analysis with
three categories of calories administered, we did not find any sig-
nificant result, but it is necessary to keep in mind the results of the
Choi 2015 and Tian 2015 meta-analyses for the dose of calories
with enteral nutrition, as well as the dose of protein (Tian 2015).
The Marik 2016b systematic review and meta-analysis compared
normocaloric (80% to 100% of daily energy expenditure) with
intentional hypocaloric enteral nutrition, dividing it into two dif-
ferent strategies: ’permissive underfeeding’ (less than 70% of daily
energy expenditure) and ’trophic’ (20% of the dose during the first
week). They included six trials, whichwe also include in our review,
but analysed them separately in the subgroup ’trophic’ (NHLBI
2012; Rice 2011), and ’permissive underfeeding’ (Arabi 2011;
Arabi 2015; Charles 2014; Petros 2016). In the meta-analysis the
statistical heterogeneity was low and they did not find significant
differences between the study groups for infectious complications,
length of ICU stay and hospital mortality (only a trend towards
a lower mortality in the permissive underfeeding subgroup) and
ventilator-free days. In line with our protocol, we performed dif-
ferent subgroup and sensitivity analyses, with conceptually similar
results. However, their subgroups approach should be considered
in future systematic reviews.
In a second systematic review and meta-analysis (Tian 2017), the
authors included 11 studies comparing low- and high-energy en-
teral nutrition (in two studies also enteral plus supplemental par-
enteral nutrition), administered to adults who were critically-ill
but notmalnourished.We also included five of these studies (Arabi
2011; Arabi 2015; Charles 2014; NHLBI 2012; Rice 2011). In
the meta-analysis, they did not find statistically significant differ-
ences between low- and high-energy groups for mortality, infec-
tious complications, pneumonia, length of hospital and ICU stay,
and length of mechanical ventilation. They found significantly
less gastrointestinal intolerance in the low-energy group. In the
subgroup analysis for mortality, they observed significantly less
mortality in the low-energy group but only within the range of
33.3% to 66.6% of the goal calories. In another subgroup anal-
ysis, the incidence of infectious complications was significantly
lower in the high-energy group, but only when the enteral nutri-
tion also provided higher amounts of protein. Even though one
might question their decision to perform meta-analysis with such
high clinical heterogeneity, we should consider in future studies
the role of the enteral nutrition dose between 33.3% and 66.6%
of the caloric goal and the amount of protein administered.
It is important to emphasize that, in linewith our protocol (Perman
2009), we only included trials comparing any type of ’prescribed’
hypocaloric nutrition support with different control groups in crit-
ically-ill adults. Although there are several reports in the literature
of critically-ill people receiving hypocaloric enteral nutrition due
to difficulties, intolerance or complications during the administra-
tion (occurring in 59%of the cases, as reported in the international
survey done in 158 ICUs by Cahill 2010), we did not include any
study assessing this ’non- prescribed’, unintentional hypocaloric
nutrition support. Nevertheless, we point out that many trials in-
cluded in our study could not achieve their prespecified caloric
goals.
We included three studies that indirectly assessed our review ques-
tion by the intentional administration of trophic (hypocaloric)
enteral feeding during the first five or six days in ICU versus full
enteral (normocaloric) feeding from the beginning of the ICU
stay (Ibrahim 2002; NHLBI 2012; Rice 2011). In order to be as
inclusive as possible, we also included Battistella 1997 (primary
objective to evaluate parenteral nutrition with or without soy-lipid
emulsions). It is important to highlight that the results of the latter
trial could be associated with the less-caloric parenteral nutrition,
with the lack of lipids, or a combination of both factors (ASPEN
2012; Ren 2013). When we did a sensitivity analysis excluding
those trials, we found only minor differences in the results.
We did not include studies evaluating enteral nutrition optimized
with supplemental parenteral nutrition to reach the ’target energy’
(measured by indirect calorimetry or estimated by formulae) to
avoid “caloric debts” (Heidegger 2013), or to assesswhen to initiate
supplemental parenteral nutrition (Doig 2013). Both topics are
the subject of currently debate.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The inclusion criteria and the data analyses by intention-to-treat
defined in the protocol resulted in important clinical and statis-
tical heterogeneity of the included trials. This heterogeneity did
not allow us to report pooled estimates of the primary and sec-
ondary outcomes, sowe have described them in anarrative fashion.
We found very low-quality evidence for the effects of prescribed
hypocaloric nutrition support onmortality in hospital, in the ICU
and at 30 days, as well as in length of hospital and ICU stay, infec-
tious complications and the length of mechanical ventilation. The
reasons for downgrading this evidence were unclear or high risk
of bias in the included studies, imprecision and inconsistency. For
these outcomes there is uncertainty about the effects of prescribed
hypocaloric nutrition, since the range of estimates includes both
appreciable benefits and harms. Using subgroup and sensitivity
analyses, as well as meta-regression, we were not able to explain
the causes of the observed heterogeneity.
Implications for research
The evidence available is sparse, heterogeneous, and with limita-
tions in its quality. It is important to have more well-designed,
well-powered and well-conducted randomized controlled trials to
assess the effects of hypocaloric nutrition support in critical out-
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comes such as mortality, infectious complications, length of stay
and length of mechanical ventilation.
To minimize heterogeneity and to improve external validity, it is
important for future studies to better categorize the participants
and their nutritional treatments. The adequate report of these cat-
egorizations could help us understand the inconsistencies in the
findings. Considering that nutrition support is a complex inter-
vention, study authors should consider the following factors:
a) the clinical characteristic of included participants (diagnostic
category, severity of disease,metabolic changes, acute or prolonged
critical state, nutritional status, comorbidities, and other factors
according to the goals of the trials);
b) the methods of nutrition support (early or late initiation, du-
ration, amount of prescribed and administered calories to the in-
tervention and control groups, reported in kcal/kg/day);
c) the detailed amount of prescribed proteins and the amounts ef-
fectively administered to participants (reported in grams/kg/day).
Individual-patient data (IPD) meta-analysis could be applied to
model the effect of the interventions considering these covariables.
Furthermore, it is important to properly report all research meth-
ods (avoiding ’unclear’ domains in ’Risk of bias’ assessments) and
ideally to conductmasked studies, taking into account the difficul-
ties in effectively implementing a prescribed hypocaloric nutrition
(performance bias) and in assessing outcomes subject to bias, such
as lengths of stay and length of mechanical ventilation (detection
bias).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahrens 2005
Methods Study design: prospective, randomized controlled trial.
Study dates: “study dates not available”
Setting: level-1 trauma centre. Department of Surgery, Detroit Receiving Hospital,
Wayne State University, Detroit, Michigan
Country: USA
Participants Inclusion criteria
1. Surgical patients, ≥ 18 years old, with requirement for parenteral nutrition by a
central catheter due to contraindication or intolerance to enteral nutrition
Exclusion criteria
1. Baseline blood glucose level > 200 mg/dl
2. Expectation of receiving parenteral nutrition for < 4 days
3. Severily underweight (< 75% of ideal body weight)
4. Morbid obesity (> twice their ideal body weight
5. Currently receiving corticosteroid therapy
6. Admitting diagnosis of burn
7. Receiving parenteral nutrition on admission
8. Not able to provide informed consent
Sample size: calculated sample size of 26 participants to detect an absolute difference in
glucose area under the curve of 50 mg hr/dl with 80% power (P = 0.05). 40 participants
were randomized: 20 to each group. Only 18 were ICU participants (8 of the low caloric
and 10 of the standard group). At baseline both groupswere well matched, with exception
of lower creatinine clearance in the standard group
Age (years mean ± SD) group 1: 45.3 ± 17.2; group 2: 53.1 ± 17.9
Sex (male, %) group 1: 75; group 2: 80
Most frequent admitting diagnosis (groups 1 and 2 respectively): pancreatitis 6 & 6,
trauma 7 & 3, bowel obstruction 4 & 5
ICU participants (n). group 1: 8; S group 2: 10
APACHE II score (mean ± SD of participants in ICU). Group 1: 20.1 ± 9.1; Group 2:
18.6 ± 11.1
Mechanical ventilation (n). 8 participants in each group
Baseline nutrition status No major differences between ideal and actual body weight in
both groups
Duration of parenteral nutrition (days; median (interquartile range)). group 1 6 (4 to
10); group 2 7 (5 to 10)
Interventions Group 1, low caloric parenteral nutrition (n = 20)
1. 20 non-protein calories/kg ideal body weight/day
Group 2, standard parenteral nutrition (n = 20)
1. 30 non protein calories/kg ideal body weight/day
In both groups, parenteral nutrition was administered by amultiple-bottle system. Lipids
administration was standardized to 1000 kcal 3 times weekly. Proteins administered
according the levels of estimated metabolic stress of the disease (mild 1.2 - 1.4; moderate
1.5 - 1.7; or severe 1.8 - 2.2 gr/kg/day)
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Ahrens 2005 (Continued)
Outcomes Primary outcomes
1. Incidence and severity of hyperglycaemia and daily insulin requirements during
parenteral nutrition
Incidence of hyperglycaemia was calculated as the number of assessments of glycaemia
≥ 200 mg/dl divided by the total number of assessments
Severity of hyperglycaemia was assessed by measuring the area under the curve
Secondary outcomes
1. Infectious complications (new-onset infections according to established criteria)
2. Hospital charges (charges for hospital room, diagnostic services, medication,
nursing services, direct expenses)
Funding sources Not available
Declarations of interest The authors have no financial interests to disclose
Notes Total calories administered/kg (median (interquartile range)) were: 26.6 (26.2 to 27.5)
and 37.0 (36.6 to 38.4); the amount of protein administered and the duration of PN
therapy were similar. The first author sent the data of continuous outcomes expressed as
mean and standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned by
means of a computer-generated random-
numbers
Allocation concealment (selection bias) Low risk Central allocation (pharmacist)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Clinicians were blinded to which caloric
group participants were randomized to,
with the exception of the critical care phar-
macist who calculated the formula
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Clinicians were blinded to which caloric
group participants were randomized to,
with the exception of the critical care phar-
macist who calculated the formula
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes: outcome data were available
for all participants
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk No evidence of other bias
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Arabi 2011
Methods Study design: prospective, randomized controlled trial
Study dates: April 2006 to January 2008
Setting: 1 tertiary care academic hospital
Country: Saudi Arabia
Participants Inclusion criteria
1. Participants aged 18 to 80 years, admitted to an ICU, blood glucose
concentration of > 110 mg/dl, expected to remain in ICU ≥ 48 hours
Exclusion criteria
1. Type 1 diabetes
2. Diabetic ketoacidosis
3. Hypoglycaemia
4. Brain death
5. Do-not-resuscitate status
6. Terminal illness
7. Pregnancy
8. Postcardiac arrest
9. Burns
10. Seizures within the past 6 months
11. Liver transplant
12. Readmission to the ICU within the same hospitalization
13. Enrollment in a competing trial
14. Oral feeding
15. Total parenteral nutrition
Sample size: authors estimated a relative difference of 50% in ICU mortality between
participants receiving .90% of caloric requirements and those receiving 60% to70% of
caloric requirements (28% compared with 14%). Quote: “on the basis of an estimated
28-d mortality rate of 25%, a power of 0.8, and an α of 0.05, the number of subjects
needed to show a reduction in mortality was 120 in each group.”
Age (years): intervention group: 50.3 ± 21.3; Control group: 51.9 ± 22.1
Sex (male, %): intervention group: 71.1; Control group: 65
Primary disease of the participants Intervention; Control group
Admission category (n (%))
Nonoperative 95 (79.2); 103 (85.8)
Postoperative 25 (20.8); 17 (14.2)
Traumatic brain injury 35 (29.2); 31 (25.8)
Disease severity score: APACHE II Intervention group: 25.2 ± 7.5; Control group: 25.
3 ± 8.2
Mechanical ventilation n (%) Intervention group: 119 (99.2); Control group: 119 (99.
2)
Comorbidities: not available
Nutrition status: intervention group; Control group: Not available
Level of inflammation: not available
Interventions Intervention Group 1 (n = 120)
1. Permissive-underfeeding group: caloric goal 60% to 70% of caloric requirements
Control Group 2 (n = 120)
1. Target-feeding group: 90% to 100% of caloric requirements
Quote: “for both groups, caloric requirement was estimated by the dietitian using the
Harris-Benedict equations and adjusting for stress factors. The selection of formula was
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Arabi 2011 (Continued)
left to discretion of the attending physician as long as it satisfied the total caloric intake
criteria and was not enriched with immunonutrients. Calculation of caloric intake took
into account intravenous dextrose and propofol infusions.”
Quote: “the patients were followed until discharge from the ICU, except if the patient
tolerated oral feeding, had a do-not-resuscitate order written (after enrolment), or became
brain dead (after enrolment). In the latter situations, the intervention was stopped but
the outcome data were collected.”
Co-interventions
Quote:“The protein requirement was calculated as 0.8-1.5 g/kg on the basis of patient
condition and underlying diseases. To avoid protein malnutrition in the permissive un-
derfeeding group, additional protein (Resource Beneprotein; Nestle Healthcare Nutri-
tion Inc, Minneapolis, MN) was added tomaintain the full protein requirement without
affecting the assigned caloric intake.”
Outcomes Primary outcome
1. 28-day all-cause mortality
Secondary outcomes
1. 180-day mortality
2. ICU mortality
3. Hospital mortality
4. ICU length of stay
5. Hospital length of stay
6. Mechanical ventilation duration
7. Hypoglycaemic episodes
8. Packed red blood cell transfusion
9. Renal replacement therapy
10. Hypokalaemic episodes
11. Health care-associated infections: bacteraemia, catheter-related bloodstream
infection, urinary tract infection, ventilator-associated pneumonia, and skin and
soft tissue
How measured or definition and time point measured
1. 28-day mortality: mortality rate at 28 days of ICU admission
2. 180-day all-cause mortality: mortality rate at 180 days of ICU admission
3. ICU mortality: mortality rate at ICU discharge
4. Hospital mortality: mortality rate at hospital discharge
5. Health care-associated infections:according to the National Nosocomial Infection
Surveillance (NNIS) System (Emori 1991)
6. Hypoglycaemia: defined as a blood glucose concentration ≤ 2.2 mmol/L or 40
mg/dL
7. Hypokalaemia: defined as a potassium concentration < 2.8 mmol/L
8. Health care-associated infections: according to Nosocomial Infection Surveillance
(NNIS) System
Subgroups
1. Not available/not performed
Funding sources Funded by King Abdulaziz City for Science and Technology (LG 10-30)
Declarations of interest No potential conflict of interest relevant to this article was reported
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Notes As it was a 2 x 2 factorial trial, the enrolled participants were randomly assigned by
using concealed envelops to 1 of the 4 study groups: 1-permissive underfeeding with
intensive insulin therapy (IIT), 2-permissive underfeeding with conventional insulin
therapy (CIT), 3-target feeding with IIT, and 4-target feeding with CIT. We grouped 1
and 2; 3 and 4
Blood glucose concentration target was 4.4 - 6.1 mmol/L (80 - 110 mg/dL) in the IIT
group and 10 - 11.1 mmol/L (180 - 200 mg/dL) in the CIT group. The frequency of
blood glucose monitoring increased to every 20 mins when blood glucose concentrations
decreased to > 3.2mmol/L (58mg/dL) and reduced to every 2 - 4 hrs whenmeasurements
were stable
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk On the basis of (quote:) “computer-gener-
ated random permuted blocks”
Allocation concealment (selection bias) Low risk The enrolled participants were randomly
assigned by using concealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unblinded study. Details on healthcare
processes to be followed by personnel (e.g.
co-interventions) were not described in or-
der to make an appropriate judgement on
possible performance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not blinded but main and secondary out-
comes well-defined.We judge that the out-
come measurement was probably not in-
fluenced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes: outcome data were available
for all participants
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk No evidence of other bias
Arabi 2015
Methods Study design: prospective, randomized controlled trial
Study dates: November 2009 to September 2014
Setting: 7 tertiary care centres
Country: Saudi Arabia and Canada
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Participants Inclusion criteria
1. Age 18 to 80 years, admitted to ICU and starting enteral feeding within 48 hours
of ICU admission; expected to remain in ICU ≥ 72 hours
Exclusion criteria
1. Lack of commitment to ongoing life support
2. Brain death
3. A pre-existing condition with expected 6-month mortality > 50%
4. Post-cardiac arrest
5. Use of total parenteral nutrition
6. Previous enrolment in this study
7. Pregnancy
8. Liver transplantation
9. Burns
10. Receipt of high-dose vasopressors (norepinephrine > 0.4 µg/ kg/min, epinephrine
> 0.4 µg/kg/min, dopamine > 20 µg/kg/min, phenylephrine > 300 µg/min,
vasopressin > 0.04 unit/min, or 50% of these doses for participants who received 2 or
more vasopressors)
Sample size
With 432 participants in each group; with an estimated 3% loss to follow-up, the final
calculated sample size was 892 participants. Permissive underfeeding would be associ-
ated with an absolute risk reduction in mortality of 8 percentage points. Assuming an
estimated 90-day mortality of 25%with standard feeding, they estimated that enrolment
of 432 participants in each group would give the study 80% power
Age (years): intervention group: 50.2 ± 19.5; Control group: 50.9 ± 19.4
Sex (male, %): intervention group: 65.2; Control group: 63.2
Primary disease of the participants Intervention; Control group
Medical no. (%) 336 (75.0); 335 (75.1)
Surgical no. (%) 19 (4.2); 12 (2.7)
Nonoperative trauma no. (%) 93 (20.8); 99 (22.2)
Severe sepsis at admission no. (%) 159 (35.5); 133 (29.8)
Traumatic brain injury no. (%) 55 (12.3); 63 (14.1)
Disease severity score: APACHE II
Intervention group: 21.0 ± 7.9; Control group: 21.0 ± 8.2
Mechanical ventilation no. (%)
Intervention group: 436 (97.3); Control group: 429 (96.2)
Comorbidities: not available
Nutrition status: intervention group; Control group
Albumin g/litre 28 ± 7; 28 ± 6
Prealbumin g/litre 0.15 ± 0.13; 0.14 ± 0.12
Transferrin g/litre 1.36 ± 0.49; 1.38 ± 0.50
24-hour urinary nitrogen excretion mmol 284 ± 176; 303 ± 219
Level of inflammation : not available
Interventions Intervention Group (n = 448)
1. Permissive-underfeeding group: caloric goal 40% to 60% of caloric requirements
Control group (n = 446)
1. Standard-feeding group: 70% to 100% of caloric requirements
For both groups, the calculationof caloric requirementswas using the PennState equation
for mechanically-ventilated participants who had a BMI < 30 and using the 1992 Ireton-
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Jones equation for mechanically-ventilated participants who had a BMI of 30 or higher
and for spontaneously-breathing participants. Protein requirements were calculated at
1.2 to1.5 g per kilogram of body weight a day, in accordance with clinical practice
guidelines
Co-interventions
Quote. “to ensure that enteral protein and volume delivery in the permissive-underfeed-
ing group would be similar to those in the standard-feeding group, the permissive-under-
feeding group received additional protein (Beneprotein, Nestlé Nutrition) and normal
saline or water at a dose of 2 ml per kilogram every 4 hours unless otherwise specified
by the clinical team. The assigned intervention was continued for up to 14 days or until
ICU discharge, initiation of oral feeding, death, or withholding of nutrition as part of
palliation.”
The study protocol provided suggestions on the selection of enteral formulas on the basis
of published guidelines; however, the decision was left to the clinical team. Study centres
used their own insulin protocols, with a target blood glucose level of 4.4 to 10 mmol
Outcomes Primary outcome
1. 90-day all-cause mortality.
Secondary outcomes
1. Mortality in the ICU
2. 28-day mortality
3. In-hospital mortality
4. 180-day mortality
5. Serial SOFA scores.
Tertiary outcomes
1. Days free from mechanical ventilation
2. ICU-free days
3. Hospital length of stay
4. Hypoglycaemia
5. Hypokalaemia
6. Hypomagnesaemia
7. Hypophosphataemia
8. Transfusions of packed red cells
9. Infectious complications (ICU-associated infections documented by the
research co-ordinator according to published definitions)
10. Non-infectious complications (feeding intolerance: vomiting, abdominal
distention, or a gastric residual volume of more than 200 ml and diarrhoea)
How measured or definition and time point measured
1. 90-day all-cause mortality: mortality rate at 90 days from ICU admission
2. ICU mortality: mortality rate at ICU discharge
3. 28-day mortality: mortality rate at 28 days from ICU admission
4. In-hospital mortality: mortality rate at hospital discharge
5. 180-day mortality: mortality rate at 180 days from ICU admission
Subgroups
1. Non-surgical admission /surgical admission
2. Diabetic/non-diabetic
3. APACHE II ≤ 18 /APACHE II > 18
4. Admitted with severe sepsis/admitted with no severe sepsis
5. Traumatic brain injury/no traumatic brain injury
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6. Vasopressors/no vasopressors
7. Randomization blood glucose ≤ 9.2 mmol/L/ > 9.2 mmol/L
Funding sources Funded by the King Abdullah International Medical Research Center
Declarations of interest No potential conflict of interest relevant to this article was reported
Notes The total caloric intake included calories from propofol, intravenous dextrose and par-
enteral nutrition
The author provided additional information about mean and standard deviation values
of length of hospital and ICU stay and of mechanical ventilation
In2017, the researchers published a subgroup analysis using aNutritionRisk InCritically
ill (NUTRIC) score. However these subgroup analyses did not contribute to our review
objectives
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “the randomization list was com-
puter-generated”
Allocation concealment (selection bias) Low risk Quote: “enrolled patients were randomly
assigned to the permissive-underfeeding
group or the standard-feeding group with
the use of opaque, sealed, sequentially
numbered envelopes.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk PermiT was a multicentre, pragmatic,
open-label international randomized clini-
cal trial
Blinding of outcome assessment (detection
bias)
All outcomes
High risk There was no blinding of outcome assess-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes: outcome data were available
for 445/448 and 440/446 participants in
the intervention and control group respec-
tively
Selective reporting (reporting bias) Low risk Authors reported all protocol outcomes.
Other bias Low risk No evidence of other bias
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Methods Study design: prospective, randomized controlled trial
Study dates: September 1992 to July 1994
Setting: Trauma surgery service. University of California, Davis, Medical Center
Country: USA
Participants Inclusion criteria
1. Polytrauma participants,18 to 50 years old, requiring total parenteral nutrition at
the 5th post-injury day
Exclusion criteria
1. If able to tolerate > 10% of their caloric requirement as enteral feeding at the time
of randomization
2. If clinical evidence of fatty acid deficiency, hepatic cirrhosis, HIV, malignancy
3. If receiving steroids or nonsteroidal anti-inflammatory agents.
Sample size: 60 participants randomized, data analysed of 57 participants
Age (years; mean ± SD). Group 1: 32 ± 9; Group 2: 33 ± 10
Sex (male, %). Group 1: 85%; Group 2: 80%
Type of injury (blunt trauma %): Group 1: 85%; Group 2: 80%
APACHE II score (mean ± SD). Group 1: 22 ± 5; Group 2: 23 ± 6
Injury severity score (mean ± SD). Group 1: 30 ± 9; Group 2: 27 ± 8
Nutrition status. On admission no participants weighted less than ideal body weight
Interventions Participants randomized at the 5th post-injury day. 10 days study period with parenteral
nutrition
No lipid group (Group 1) (n = 27)
1. Parenteral nutrition without lipid emulsion. Same formulation but without lipids
during 10 days (no added calories to replace the fat calories), so the formulae were
isonitrogenous but hypocaloric in relation to the control (lipid) group.
Lipid group (Group 2) (n = 30)
1. Standard total parenteral nutrition: goal of 30 nonprotein kcal/kg ideal body
weight/day (25% provided by lipids) and 1.5 grams amino acids/kg/day, during 10 days
Outcomes 1. Length of ICU stay
2. Length of hospital stay
3. Length of mechanical ventilation
4. Infectious complications: total infectious complications (pneumonia, line sepsis,
wound infections, acalculous cholecystitis, intra-abdominal abscess, empyaema,
bacteraemia)
Outcomes evaluated after 10 days of parenteral nutrition
Other outcomes
1. Clinical signs of fatty acid deficiency; immune function assays (T-cell function:
lymphokine activated killer cell activity and natural killer cell activity; T-cell
phenotype: CD4/CD8)
Funding sources Study supported in part by National Institutes of Health Grant P30 DK-35747
Declarations of interest Not reported
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Reasonable explanation: quote: “Of the 60
patients enrolled, only 57 had data that
could be analysed. One patient was ineligi-
ble for the study because he had been ad-
mitted for management of an entero-cuta-
neous fistula that had resulted as a compli-
cation of a remote trauma and two patients
died before being randomized (before the
fifth post injury day)”
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk No evidence of other bias.
Charles 2014
Methods Study design: prospective, randomized controlled trial
Study dates: March 2008 to November 2011
Setting: Surgical/trauma ICU at a tertiary-care hospital. Department of Surgery, Uni-
versity of Virginia Health System. Charlottesville, Virginia
Country: USA
Participants Inclusion criteria
1. Age ≥ 18 years; projected need for nutrition support > 48 hrs and for ICU stay >
48 hrs according to the attending intensivist
Exclusion criteria
1. Participants aged < 18 years, expected to die or ICU discharge within 48 hours,
pregnancy and primary diagnosis of burn
Sample size: From 2892 admissions to the ICU 83 participants were enrolled and
randomized: 41 to the hypocaloric group and 42 to the eucaloric group (detailed flow
diagram given of the randomization, exclusion and study end)
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Age (years; mean ± SD). Hypocaloric group 50.4 ± 2.8; Eucaloric group 53.4 ± 2.7
Sex (male, %). Group 1: 58.3; Group 2: 73.8
Primary disease. Trauma admission (%). Group 1: 68.3; Group 2: 59.5. The other
participants in the surgical ICU were abdominal, vascular, orthopaedic and liver trans-
plant surgery
Disease severity, APACHE II score (mean ± SD) Group 1: 16.6 ± 0.9; Group 2: 17.3
± 0.8
Mechanical-ventilation dependence (%). Group 1: 68.3; Group 2: 57.1
Comorbidities. Diabetes mellitus and coronary artery disease (%). Group 1. 19.5
and 17.1 respectively; Group 2: 14.3 and 11.9 respectively
Nutrition status BMI (kg/m2, mean ± SD). Group 1: 32.9 ± 2.0; Group 2: 28.1 ± 0.9
Risk of refeeding syndrome at admission (due to weigh loss, poor caloric intake or alcohol
abuse) (%). Group 1: 31.7; Group 2: 54.8
Level of inflammation: not available
Interventions Group 1 hypocaloric (n = 41)
1. The hypocaloric target was 50% of the calculated daily caloric requirement: 12.5
to 15 kcal/kg actual weight/day
Group 2 eucaloric (n = 42)
1. The goal was 100% of the calculated caloric requirements: 25 to 30 kcal/kg actual
weight/day
Co-interventions: the protein goal of the 2 groups was 1.5 grams protein/kg/day. If
the participant’s actual weight was > 130% of ideal weight, adjusted weight was used.
Participants with severemalnutrition not able to receive enteral nutritionwere considered
for parenteral nutrition, all others received enteral nutrition. In cases of enteral feeding
intolerance, parenteral nutrition was started after 5 to 7 days
Outcomes Primary outcome
1. Development of hospital-acquired infectious complications. The diagnosis of all
the infections was done according to the criteria of US Centers for Disease Control and
Prevention.
Secondary outcomes
1. Glucose control during the study period: mean overall glucose values, mean
morning glycaemia at 06.00 hours and mean daily insulin requirements
2. Length of stay in ICU
3. Length of stay in hospital
4. Hospital mortality: all causes of in-hospital mortality
5. The study protocol was followed during 10 to 12 days
6. The analysis of participants was done on an intention-to-treat basis
Subgroups
1. The authors analysed but did not report subgroups of trauma and non-trauma
participants, and men versus women
Funding sources Supported by grant 5-T32-AI-078875-03 from the National Institute of Health, USA
Declarations of interest The authors stated that “No conflicts of interest were reported”
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Notes Due to slow enrolment, the study was closed before the planned enrolment of 116
participants
Enteral nutrition was given initially. Participants were considered for parenteral nutrition
if they were severely malnourished and could not receive enteral feeding, or in case of
continuous intolerance of enteral nutrition lasting more than 5 to 7 days
The author provided additional information: mean and standard deviation of the length
of mechanical ventilation and to complete the ’Risk of bias’ table
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly allocated 1:1
by using a computer-based random num-
ber generator
Allocation concealment (selection bias) Low risk Quote: “investigators were blinded to
the preparation of the randomization en-
velopes, and the randomization assign-
ment was determined by opening sequen-
tial opaque security envelopes containing
the randomization assignment.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk There was no blinding of participants or
personnel.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessment was blinded (written
information provided by the author)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes: outcome data were available
for all participants
Selective reporting (reporting bias) Low risk The study protocol is not available but it
is clear that the published reports include
all expected outcomes, including those that
were prespecified
Other bias Low risk No evidence of other bias
46Prescribed hypocaloric nutrition support for critically-ill adults (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Choban 1997
Methods Study design: prospective, randomized controlled trial
Study dates: Not stated
Setting: participants referred to the Nutrition Support Service of the Ohio State Uni-
versity Hospital. Departments of Surgery and Medical Dietetics. College of Medicine.
Ohio State University. Columbus, Ohio
Country: USA
Participants Inclusion criteria
1. Participants weighing > 130% of ideal body weight (formula of Hamwi) and
requiring PN.
Exclusion criteria
1. Pre-existing renal disease
2. Hepatic disease
3. Adrenal disease
4. Receiving exogenous steroids
5. Minors, prisoners, pregnant women, mental or physical retardation
Sample size: 30 participants, stratified according their hospitalization in ICU (n = 13)
or regular floor (n = 17) (randomized with separate randomization tables)
Age (years; mean ± SD; whole sample): Group 1: 52 ± 19; Group 2: 52 ± 15
Sex (male, %: whole sample): Group 1: 31.25; Group 2: 14.29
Primary disease of the participants, surgical diseases. 70% of the whole-sample diag-
nosis were cancer with or without enterocutaneous fistulae and pancreatic disease
Nutrition status. Body weight/BMI (kg and kg/m2 respectively; mean ± SD; whole
sample). Group 1: 97 ± 19 and 36 ± 5. Group 2: 90 ± 17 and 34 ± 6
Comorbidities. Diabetes type 1 and 2 (n of ICU participants) Group 1: 2 and 1;
Group 2: 2 and 2
Disease severity score. APACHE II score at the time of enrolment (mean ± SD of the
ICU participants). Group 1: 13 ± 5; Group 2: 15 ± 5
Level of inflammation Initial urinary urea nitrogen (grams/24 hours; mean ± SD of the
ICU participants). Group 1: 10.1 ± 9.0; Group 2: 10.0 ± 4.2
Duration of PN (days; mean ± SD). Group 1: 10 ± 3; Group 2: 12 ± 2
Interventions Group 1 hypocaloric PN (whole sample n = 16; n of ICU participants = 6) has 50%
of the carbohydrate and lipid compared with the standard PN
Group 2 standard PN (whole sample n = 14; n of ICU participants = 7)
Co-interventions: both PN solutions were isonitrogenous, providing 2 grams of pro-
tein/kg ideal body weight/day, added with electrolytes, vitamins and trace elements, ad-
ministered during ≤ 14 days or until they could receive enteral or oral feeding
Outcomes 1. Mortality at hospital (events)
2. Hospital length of stay (days; mean ± SD)
3. Carbohydrate metabolic outcomes: glucose control (glycaemia and glycosuria)
and insulin requirements (mean daily IU insulin dose ± SD)
4. Protein metabolic outcome:overall nitrogen balance (grams/day; mean ± SD )
5. Nutrition status: weigh (kg) and albumin change (gr/L) during hospital stay
Time points reported
1. Results during the administration of PN
Subgroups
1. The authors reported most of the results for the whole sample populations. Some
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results of both intervention groups were reported separately for the ICU and regular-
care participants.
Funding sources Supported by funds from the Bremer Foundation, Department of Surgery Medical Re-
search Development Fund, and Surgical Research, Inc
Declarations of interest Not available
Notes Both groups of participants in ICU had moderate severity of diseases by APACHE II
scores, the initial urinary urea nitrogen and the mortality rate (15%)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were then randomly assigned
to receive either the control parenteral nu-
trition (PN) formula or the hypoenergetic
PN formula by using separate randomiza-
tion tables by the investigational pharma-
cist in the research pharmacy of the hospi-
tal
Allocation concealment (selection bias) Low risk Participants randomly assigned to receive
either the control PN formula or the hy-
poenergetic PN formula by using separate
randomization tables (ICUor regular floor)
by the research pharmacist of the hospital
(Central allocation)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk All care providers as well as participants
were blinded to the nutrient composition
of the parenteral formulas
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Double-blinded. All care providers as well
as participants were blinded to the nutrient
composition of the parenteral formulas
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes: outcome data were available
for all participants
Selective reporting (reporting bias) Low risk Not clearly described research outcomes,
although: (quote:) “this study was designed
to determine whether a restricted energy
parenteral formulation providing 2 gr pro-
tein/kg ideal body weight could be admin-
istered to acutely ill obese participants with
the same degree of efficacy as a standard
parenteral nutrition solution provided to
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a comparable group of patients”. Partic-
ipants located in the intensive care unit
and those with diabetes mellitus were in-
cluded in the study population to deter-
mine the efficacy of this treatment in crit-
ically-ill participants and to assess the ef-
fect on glycaemic control in obese diabetic
participants. Results were reported regard-
ing this description andmore detailedmea-
surement methods described in the appro-
priate section
Other bias Unclear risk Not clear if any bias could have been intro-
duced by some of the funders
Ibrahim 2002
Methods Study design: prospective, randomized controlled trial
Study dates: May 1999 to December 2000
Setting: Medical ICU, Barnes-Jewish Hospital, affiliated to Washington University
School of Medicine. St. Louis, Missouri
Country: USA.
Participants Inclusion criteria
1. ICU participants > 18 years, expected to require mechanical ventilation for > 24
hrs
Exclusion criteria
1. Transferred to the medical ICU for lack of beds in the other hospital ICUs
2. Expected to die or extubated within 24 hours of ICU admission
3. With prior mechanical ventilation during the same hospitalization
4. With contraindication of enteral feeding (e.g. pancreatitis, short gut,
malabsorption)
5. Classified as malnourished at hospital admission
6. With enteral or parenteral nutrition prior to admission to the medical ICU
7. Different strategy of nutrition support according to the prescription of the
attending physician
8. Refusal to give informed consent to participate in the study
9. Without tolerance of the placement of oral or naso-gastric tube (e.g. severe
coagulopathy, oesophageal varices)
Sample size
189 consecutive participants were evaluated for enrolment, with 39 not included for
different reasons, and150finally included and analysed. 75 participants were randomized
to each study group. The estimated sample size for a significant reduction of the incidence
of pneumonia (primary outcome) was 82 participants in each study group
Age (years, mean ± SD). Group 1: 59.1 ± 19.0; Group 2: 56.5 ± 15.6
Sex (% of male). Group 1: 46.7; Group 2: 37.3
Primary reason for ICU admission. Respiratory diseases (%). Group 1: 58.7; Group
2: 64.0
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Disease severity: APACHE II score. Group 1: 25.6 ± 8.3; Group 2: 24.7 ± 8.4
PaO2/FiO2 (mean ± SD). Group 1: 204 ± 108; Group 2: 207 ± 126
Predicted mortality based on APACHE II score (%, mean ± SD). Group 1: 48.7 ±
24.9; Group 2: 49.6 ± 23.9
Process of care variables: with 2 exceptions, all of them had statistically non-significant
differences between the study groups: Duration of enteral nutrition and of mechanical
ventilation (days, mean ± SD respectively). Group 1: 5.2 ± 5.9 and 8.1 ± 7.4; Group 2:
9.9 ± 12.3 and 12.9 ± 15.7 respectively
Comorbidities, nutrition status and level of inflammation: not reported
Interventions Group 1 late feeding-hypocaloric (n = 75)
1. Participants scheduled to receive 20% of their estimated daily requirements for
the first 4 days of mechanical ventilation (to prevent atrophy of the intestinal mucosa)
and full requirements beginning at day 5 of mechanical ventilation.
Group 2 early feeding-normocaloric (n = 75)
1. Participants scheduled to receive their estimated total daily enteral nutrition
requirements starting on day 1 of mechanical ventilation.
Co-interventions
The goal for enteral nutrition daily requirements were defined as 25 kcal/kg ideal body
weight/day and 1 to 1.3 grams of protein/kg ideal bodyweight/day. The enteral nutrition,
with a polymeric iso-osmolar formula, was administered in the stomach by bolus feeding,
through an orogastric tube inserted on day 1 of mechanical ventilation. In case of 3
consecutive gastric residual volumes > 150 ml, a post-pyloric enteral tube was inserted
for continuous drop enteral nutrition
Outcomes Primary outcome
1. Occurrence of ventilator-associated pneumonia. Diagnosis of pneumonia done
by one of the investigators blinded to the group assignment, based on predetermined
and well-defined clinical diagnostic criteria of pneumonia; they also registered several
described potential risk factors for the development of ventilator-associated pneumonia.
Secondary outcomes
1. Hospital mortality
2. Length of stay in ICU
3. Length of stay in hospital
4. Length of mechanical ventilation
5. Diarrhoea associated with clostridium difficile infection (rectal swab for
culture of the clostridium difficile)
6. 6. Need for a gastrostomy tube
7. Total number of antibiotic days in the ICU
How measured or defined
1. The authors defined most of the study items.
Time of measurements
1. During the first 5 days of mechanical ventilation
Subgroups
1. No subgroups were analysed in the study.
Funding sources Supported in part by a grant from the Barnes-Jewish-Christian Health Care Innovations
Program
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Declarations of interest Information not available
Notes The total calories andprotein received by the participants showed a statistically significant
difference between the study groups, but participants in each group only received a
percentage of the defined goals during the first 5 days of mechanical ventilation: in the
hypocaloric group the participants received 7% of their estimated caloric requirements
and 7.7% of the estimated protein requirements, and in the control group they received
27.9% and 26.9% respectively
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk The study allocated participants to treat-
ment groups based on the date of their ICU
admission using a quasi-randomized design
(odd/even-numbered days)
Allocation concealment (selection bias) High risk The study allocated participants to treat-
ment groups based on the date of their ICU
admission using a quasi-randomized design
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unblinded study. Details on healthcare
processes to be followed by personnel (e.g.
co-interventions) were not described in or-
der to make an appropriate judgement on
possible performance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not blinded but main and secondary out-
comes well-defined.We judge that the out-
come measurement was probably not in-
fluenced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes: outcome data were available
for all participants
Selective reporting (reporting bias) High risk Some prespecified secondary outcomes
(duration of mechanical ventilation, need
for gastrostomy tube) not reported
Other bias Low risk No evidence of other bias
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Methods Study design: prospective, randomized, controlled non-blinded trial
Study dates: Not stated
Setting: single-centre, university-affiliated teaching hospital with a dedicated total par-
enteral nutrition (TPN) service. Beth Israel Deaconess Medical Center and Harvard
Medical School, Boston, Massachusetts
Country: USA
Participants Inclusion criteria
1. Sequential participants requiring TPN according to standard hospital criteria
Exclusion criteria
1. Severely underweight (< 50 kg)
2. Home TPN
3. Malnutrition requiring specific pre-operative TPN
4. Reinstitution of TPN for a setback of the current illness
Sample size
48 participants were initially included, but 4 in each group were excluded from the
analysis because of PN duration ≤ 4 days, leaving 21 participants in the hypocaloric
group and 19 in the control group
Age (years; mean ± SD). Group 1 hypocaloric: 57.5 ± 14.9; Group 2 control: 56.6 ± 20.
4
Sex (% male): Group 1: 57; Group: 53
Primary disease of the participants. Mainly surgical participants with different types of
complications. Major differences between groups: Group 1 acute pancreatitis and bowel
surgery/postoperative ileus: n = 6 and 3 participants respectively; Group 2 n = 1 and 6
respectively
Mechanically-ventilated participants (n). Hypocaloric group: 11; Control group: 6
Comorbidities. Diabetes (n). Group 1: 5 participants; Group 2: 2 participants. Obesity:
4 participants in each group
Nutrition status. BMI (mean ± SD). Group 1: 27.6 ± 8.1; Group 2: 25.7 ± 6.2
Interventions Group 1 hypocaloric (n = 21)
1. Administration of 1 litre of fat-free TPN, providing 70 grams protein, 210 grams
of dextrose and ~ 1000 kcal when maximally concentrated
Group 2 control (n = 19)
1. Standard TPN regimen with a maximum of 25 total kcal/kg actual weight/day
(adjusted weight in obese participants). Goal of 20 to 25 kcal/kg/day with 1.5 gr
protein/kg/day. Fat could account for up to
of the calories.
Co-interventions
1. After 10 days the participants were removed from the experimental protocol and
fed in the traditional manner.
Outcomes 1. Reduction of hyperglycaemia: frequency rate of glycaemia > 220 mg/d
(measured by fingerstick and confirmed in the laboratory), average capillary glycaemia
during the TPN administration
2. Incidence of in-hospital infections: pneumonia, venous catheter infection,
wound infection, abdominal collection/abscess. Infection diagnoses were done by well-
defined common clinical objective methods
3. Nitrogen balance at day 5 of TPN (difference of measured 24-hr urinary urea
nitrogen plus 4 gr/day and TPN nitrogen)
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Time points of measurements
1. The outcomes were evaluated during the time of TPN.
2. Nitrogen balance was measured in only 12 participants (57%) in the hypocaloric
and 10 (53%) of the control group, usually because of an error during collection.
Funding sources Not available
Declarations of interest Not available
Notes Due to a protocol violation, fat was given to 1 participant in the hypocaloric group
Some results associated with hospital rules to avoid iatrogenic hyperglycaemia by gradual
increase of nutrients to avoid complications.The hypocaloric group also received less
protein than the control group
More participants in the hypocaloric group had acute pancreatitis and mechanical ven-
tilatory support than in the control group
The hypocaloric group received 14 ± 3 kcal/kg/day and the control group 18 ± 4 kcal/
kg/day (also hypocaloric). The hypocaloric group not only received significantly fewer
calories than the control group (due to fewer dextrose and fat calories), but also less
protein (1.1 ± 0.2 versus 1.3 ± 0.2 in the control group)
If the infection rate trend observed were to persist, they calculated the study would have
required ~174 participants to see a statistical difference between the 2 groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding: the standard group received
parenteral nutrition as 3-in-1 bags, and the
hypocaloric group received 1 litre of fat-free
parenteral nutrition. Outcomes could have
been influenced by different performance
of clinical personnel
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding and not clearly-defined and
objective outcomes that would warrant a
low risk of detection bias
Incomplete outcome data (attrition bias)
All outcomes
High risk 4 participants in each group were excluded
from the data analysis because of a TPN
duration of ≤ 4 days (not prespecified ex-
clusion criteria)
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Selective reporting (reporting bias) High risk Nitrogen balance was only measured in 12
participants (57%) in the hypocaloric and
10 (53%) of the control group, usually be-
cause of an error during collection
Other bias Unclear risk The lack of detail in the description of the
Methods section could not warrant a low
risk of other sources of bias
NHLBI 2012
Methods Study design: prospective, randomized controlled trial
Study dates: January 2008 to April 2011
Setting: 44 ICUs of the National Heart, Lung, and Blood Institute Acute Respiratory
Distress Syndrome (ARDS) Clinical Trials Network
Country: USA
Participants Inclusion criteria
1. participants within 48 hours of Acute Lung Injury onset who had received
mechanical ventilation < 72 hours and indication for enteral nutrition
Exclusion criteria
1. Chronic lung disease
2. Unable to provide consent
3. Outside acute lung injury time window
4. Outside mechanical ventilation time window
5. Fatal underlying disease
6. Severe liver disease
7. Moribund
8. Refractory shock
9. Physician refusal
10. Intracranial haemorrhage
11. Total parenteral nutrition
12. Not committed to full support
13. Refused consent
14. Severe neuromuscular disease
15. Severe malnutrition
16. Other
Sample size
500 participants for each arm, to detect a 2¼-day difference in ventilator-free days
(VFDs), assuming a mean of 14 ± 10.5 VFDs. power: 91% α: 0.05
Age (years): intervention group: 52 ± 17; Control group: 52 ± 16
Sex (male, %): intervention group: 53; Control group: 49
Primary disease of the participants
Diagnosis:% intervention group/% control group
Medical ICU: 61; 63
Primary lung injury category % intervention group/control group
Pneumonia 67; 63
Sepsis 16; 13
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Aspiration 8; 11
Trauma 3; 4
Transfusion 1; 2
Disease severity score: APACHE III Intervention group: 92 ± 28; Control group: 90 ±
27
Mechanical ventilation 100% in each group (inclusion criterion)
Comorbidities: % intervention group; % control group Diabetes: 27; 29
No other data available
Nutrition status: not available
Level of inflammation: not available
Interventions Intervention (trophic) Group 1 (n = 508)
1. Initial feeding at 10 ml/hr (10 to 20 kcal/hr for the first 272 participants who also
received the omega-3 or control supplement (240 ml volume a day)
2. After the Data and Safety Monitoring Board stopped the OMEGA portion of the
factorial design, the initial trophic feeding rate was changed to 20 kcal/hr to
approximate the calories that had been delivered in the OMEGA study
3. Enteral nutrition was advanced to full-energy feeding rates following the same
protocol used for the full-feeding group if they were still receiving mechanical
ventilation at 144 hrs
Control Group 2 (n = 492)
1. Enteral nutrition was initiated at 25 mL/hr and advanced to goal rates as quickly
as possible
2. Full feeding rates were calculated with goals of 25 to 30 kcal/kg a day of
nonprotein calories and 1.2 to 1.6 g/kg a day of protein
Co-interventions
1. Both feeding strategies specified when and for how long to hold enteral nutrition
for GRVs greater than 400 mL and for other gastrointestinal intolerances. As in usual
ICU practice, participants were maintained in the semirecumbent position whenever
possible.
2. Blood glucose control was accomplished using institution-specific insulin
protocols targeting ranges of 80 to 150 mg/dL (to convert to mmol/L, multiply by 0.
0555), with tighter control allowed.
Outcomes Primary outcome
1. Ventilator-free days (VFDs) through day 28
Secondary outcomes
1. Failure-free days: cardiovascular, renal, hepatic, coagulation
2. ICU-free days
3. 60-day mortality
4. Development of infections: ventilator-associated pneumonia, clostridium
difficile colitis, bacteraemia
How measured or definition
1. VFDs: defined as the number of days from the time of initiating UAB to day 28
after randomization
2. ICU-free days: calculated similarly to VFDs
3. 60-day mortality: mortality rate at 60 days
Subgroups
1. Not available
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Funding sources Supported by National Heart, Lung, and Blood Institute (NHLBI) contracts
HHSN268200536165C and HHSN268200536179C
Declarations of interest Authors have not disclosed any potential conflicts of interest
Notes The initial 272 participants were also simultaneously randomized to a separate trial (the
OMEGA study) comparing a nutritional supplement containing omega-3 fatty acids
and antioxidants with an isocaloric, isovolemic control in a 2 x 2 factorial design. After
the Data and Safety Monitoring Board stopped the OMEGA portion of the factorial
design, participants randomized to the initial trophic-feeding group received additional
calories to compensate for the calories that had been received in theOMEGA study (240
ml volume a day)
We asked the first author for some data not reported in themanuscript or reported differ-
ently.He gave us the datawe used in themeta-analysis for the following outcomes: 28-day
mortality, length of ICU stay (days from randomization to first ICU discharge); length
of mechanical ventilation (ventilator days up to day 28); hyperglycaemia (participants
with any on-study glucose > 200 mg/dl); incidence of total infectious complications and
of diarrhoea, and the amount of calories received by both groups of participants. The
author also informed they did not have duplicate participants with the Rice 2011 study.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomized by a web-
based randomization system, stratified by
site and presence of shock at enrolment, to
receive either trophic or full enteral feeding
for the first 6 days of mechanical ventila-
tion
Allocation concealment (selection bias) Low risk Participants were randomized by a web-
based randomization system, stratified by
site and presence of shock at enrolment, to
receive either trophic or full enteral feeding
for the first 6 days of mechanical ventila-
tion
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unblinded study. Details on healthcare
processes to be followed by personnel (e.g.
co-interventions) were not described in or-
der to make an appropriate judgement on
possible performance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessment was not blinded but
most outcomes were objective
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 1 participant lost, from the control
group. All analyses were by intention-to-
treat
Selective reporting (reporting bias) Low risk All planned outcomes were reported. All
analyses were by intention-to-treat
Other bias Low risk No evidence of other bias
Norouzy 2013
Methods Study design: single-centre double-blind, randomized controlled trial
Study dates: Not stated
Setting: Nutrition and neurosurgery departments. Mashad University of Medical Sci-
ences. Mashad
Country: Islamic Republic of Iran
Participants Inclusion criteria
1. Adults head trauma participants admitted to the ICU
Exclusion criteria
1. Not reported
Sample size
60 participants randomized
Age: not reported
Sex: not reported
Primary disease: head trauma
Disease severity: not reported
Mechanical ventilation: number of participants not reported
Comorbidities: not reported
Nutrition status: not reported
Level of inflammation: not reported
Interventions Group 1 permissive underfeeding (n = not reported )
1. Initial caloric goal of 30% to 50% of calculated requirements (not defined)
Group 2 standard full calorie (n = not reported)
1. Initial caloric goal of 90% to 100% of calculated requirements (not defined)
All participants received enteral nutrition
Outcomes Primary outcome
1. 28 day all-cause mortality.
Secondary outcomes
1. Hyperglycaemia
2. Length of hospital stay
3. Duration of mechanical ventilation
4. Gastro intestinal intolerance
5. Diarrhoea
6. Liver enzymes
No information about measures or definition of the outcomes
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The participants in the permissive-underfeeding group received full enteral feeding after
the 7th day of the study
No subgroups reported
Funding sources Not available
Declarations of interest None declared
Notes Available only in abstract form. Poster presentation in the 35th ESPEN Congress
(Leipzig, Germany, August 2013)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Only mentioned in the abstract (quote:
) “head trauma randomly assigned to a
double-blind randomized controlled clini-
cal trial”
Allocation concealment (selection bias) Unclear risk Same as above
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Mentioned that was double-blind, but did
not report the methodology
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Mentioned that was double-blind, but did
not report the methodology
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not mentioned in the abstract
Selective reporting (reporting bias) Unclear risk Not mentioned in the abstract
Other bias Unclear risk Insuficient information to make judge-
ment (abstract only)
Petros 2016
Methods Study design: prospective, randomized controlled trial
Study dates: July 2008 to December 2010
Setting: 1 tertiary medical ICU
Country: Germany
Participants Inclusion criteria
1. Participants with presumed need for artificial nutrition support for at least 3 days
and informed consent
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Exclusion criteria
1. Pre-existent malnutrition (BMI < 18.5 kg/m2)
2. Age < 18 years or > 80 years
3. Pregnancy
4. Active malignant disease
5. Current immunosuppressive therapy
6. Readmission to the ICU liver transplantation
7. Do-not-resuscitate decision
8. Refusal of study inclusion by the participant or the guardian, or consent given too
late for study inclusion
Sample size: not available
Age (years): intervention group: 67.6 ± 11.5; Control group: 64.3 ± 11.5
Sex (male, %): intervention group: 70; Control group: 63
Primary disease of the participants
Diagnosis: % intervention group; % control group
Sepsis: 25; 28
Acute cardiovascular dysfunction: 30; 46
Acute respiratory insufficiency: 22; 33
Other: 9; 11
Disease severity score: APACHE II
Intervention group: 28.6 ± 6.5; Control group: 27.7 ± 8.4
Mechanical ventilation: not available
Comorbidities: % intervention group; % control group
Underlying chronic disease:
None: 26; 43
Diabetes mellitus: 33; 20
Respiratory: 31; 22
Cardiovascular: 19; 20
Neuropsychiatric: 0; 20
Other: 9; 13
Nutrition status: not available
Level of inflammation: not available
Interventions Intervention group 1 (n = 54)
1. Hypocaloric group: 50% of daily energy expenditure during the 1st week of ICU
admission
Control group 2 (n = 46)
1. Normocaloric group: 100% of daily energy expenditure
For both groups, energy expenditure was measured with an indirect calorimeter (Delta-
trac II, Datex Ohmeda, Helsinki, Finland). If this was not possible, the Ireton-Jones
prediction equation was used
Co-interventions
Quote: “artificial nutrition support was started within 24 hours of ICU admission. En-
teral feeding was favoured in every case if there was no sign of gastrointestinal intolerance
(defined as gastric aspirate > 300 mL/d) and/or diarrhoea. Diarrhoea was defined as at
least 3 watery bowel movements per day or continuous watery stool. In case of enteral
feeding, the target energy supply was to be achieved on day 3 at the latest. A commer-
cially available standard solution with a caloric concentration of 1 kcal/mL was used in
every case. If at least 70% of the target caloric supply was considered not to be achieved
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on day 3 via the enteral route based on gastrointestinal tolerance and the consensus of
the managing physicians together with members of the trial group, participants received
supplementary parenteral nutrition. The expected deficit was calculated everyday during
the morning hours by one of the study authors and supplementary PN prescribed as re-
quired. If enteral nutrition (EN) was to be interrupted for unforeseen reasons during the
course of the day (diagnostic or therapeutic procedures), adjustment of the supply rate
was carried out depending on clinical judgment as to whether an increased rate would be
tolerated by the participant. In such cases, possible caloric deficits were not compensated
with PN. Causes of the feeding interruptions were recorded if the interruption lasted at
least an hour. The blood glucose level was monitored every 3 hours. The insulin dose
was adjusted to a target blood glucose level of 6-8 mmol/L.”
Outcomes Primary end point
1. Rate of nosocomial infections during the ICU stay
Secondary end points
1. Insulin demand
2. ICU mortality rate
3. Hospital mortality rate
4. 28-day mortality rate
Funding sources None declared
Declarations of interest None declared
Notes Study originally published as a congress abstract with few results. The first author an-
swered several questions, so some of the results originally included in the review came
from the information provided by him. During the editorial process the study was pub-
lished (Petros 2016). All the published data were the same as the first author had origi-
nally reported to us
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Electronic randomization list
Allocation concealment (selection bias) Low risk Quote: ”yes, the allocation was concealed.
The electronic randomization was man-
aged by coauthors not directly involved in
the management of the patients” (written
information provided by the author)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The study was single-blinded (participants
were blinded, the ICU personnel were not)
. Details on healthcare processes to be fol-
lowed by personnel (e.g. co-interventions)
were not described in order to make an
appropriate judgement on possible perfor-
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mance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessment was not blinded but
outcomes were objective (written informa-
tion provided by the author)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes: outcome data were avail-
able for all participants (written informa-
tion provided by the author)
Selective reporting (reporting bias) Low risk All outcome assessed were reported (writ-
ten information provided by the author)
Other bias Low risk No evidence of other bias
Rice 2011
Methods Study design: prospective, randomized controlled trial
Study dates: August 2003 to July 2009
Setting: 2 ICUs at a single academic centre
Country: USA
Participants Inclusion criteria
1. Participants expected to require mechanical ventilation ≥ 72 hrs and indication
for enteral nutrition
Exclusion criteria
1. > 48 hours elapsed since inclusion criteria met
2. Participant, legal representative, or physician refuses consent or is unavailable to
provide consent
3. Participant, legal representative, or physician not committed to full support
4. Presence of malignant or irreversible condition and estimated 28-day mortality >
50%
5. Severe or refractory shock
6. Chronic respiratory disease that requires home oxygen or results in severe exercise
restriction
7. Moribund participants not expected to survive 24 hours from start of enteral
nutrition (as decided by primary medical team)
8. Child-Pugh score > 9
9. Presence of partial or complete mechanical bowel obstruction, or ischaemia, or
infarction
10. Current parenteral nutrition use or intention to use within 7 days
11. Severe malnutrition with BMI < 18.5 and/or loss of > 30% total body weight in
the previous 6 months
12. Neuromuscular disease impairing the ability to ventilate spontaneously
13. Laparotomy expected within 7 days
14. Unable to raise head of bed 45 °
15. > 30% total body surface area burns
16. Absence of GI tract/short-bowel syndrome (defined as entire length of small
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bowel totaling 4 feet or less)
17. Presence of high-output (> 500 cc/day) enterocutaneous fistula
18. Age < 13 years
19. Allergy to enteral formula
Sample size
94 participants were randomized in each arm. An independent sample t test, designed to
demonstrate a 15% relative increase of 3.0 VFDs with 80% power and a 2-sided P value
of 0.05. The study enrolled 200 to allow for a 5% withdrawal rate and compensate for
the single interim analysis
Age (years): intervention group: 53 ± 19; Control group: 53 ± 19
Sex (male, %): intervention group: 39.8; Control group: 46.1
Primary disease of the participants: 100% medical diagnosis
Acute lung injury: 21; 20
Pneumonia: 15; 19
Altered mental status/neurologic: 14; 15
Sepsis: 10; 12
Overdose: 10; 7
Disease severity score: APACHE II
Intervention group: 26.9 ± 8.1; Control group: 26.9 ± 6.6
Mechanical ventilation 100% in each group (inclusion criteria)
Comorbidities: % intervention group/ % control group
Hypertension 42; 37
Cardiac disease 24; 23
Diabetes 22; 23
Chronic renal insufficiency 18; 12
Chronic obstructive pulmonary disease 16; 18
Immunosuppression 14; 16
Peptic ulcer disease 4; 4
Gastroesophageal reflux 4; 4
Nutrition status: not available
Albumin concentration (g/dL) 2.8± 0.6; 2.8± 0.7
Level of inflammation: not available
Interventions Group 1 (n = 98): trophic group
1. Initial feeding at 10ml/hr; the same feeding rate for 6 days. In participants still
ventilated after 6 days, enteral nutrition was advanced to full-energy target feeding
rates using the same protocol as for the full-energy feeding group. Most participants
received a commercially-available standard formula containing 1 to 1.2 kcal/cm3.
Group 2 (n = 102): control group
1. Full feeding rate targeting 25 to 30 kcal/kg ideal body weight/day of non-protein
energy and 1.2 to 1.6 g/kg ideal body weight/day of protein. Most participants received
a commercially-available standard formula containing 1 to 1.2 kcal/cm3. Initial feeding
at 25 ml/hr; feeding rate increased by 25 ml/hr every 6 hrs until full-energy feeding
rate was reached.
Co-interventions
For both groups, in participants who were extubated and then required re-intubation,
enteral nutrition was started and managed according to the study protocol through study
day 28
Elevated gastric residual volumes (GRV) were defined as > 300 cc of gastric contents
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withdrawn from the gastric tube at one time. GRVs were checked every 6 hours while
feeding rates were being increased to full-energy rates and every 12 hours if the participant
was receiving trophic rates or once full-energy rate was achieved. Gastric residuals were
only measured in participants with post-pyloric feeding tubes if a separate gastric port
on the feeding tube or separate gastric tube was in place. Since a single, isolated elevated
GRV has been shown to be a poor predictor of enteral nutrition intolerance, feeding
rates were not adjusted after a single elevated GRV. After the first episode of elevated
GRV, 300 cc was replaced and the feeding rate was maintained. GRV was rechecked in 2
hours. If this recheck was also above 300 cc, feeds were held until GRV decreased below
300 cc and restarted at a rate of 25 cc/hr < the previous rate in the full-energy group and
at 10 cc/hr in the trophic group
Outcomes 1. Length of mechanical ventilation
2. Ventilator-free days (VFDs)
How measured or definition
1. Defined as the number of days from the time of initiating UAB to day 28 after
randomization, assuming survival for at least 48 consecutive hours of UAB
Time points measured and time points reported
1. If a participant survived for > 48 hours after UAB, but required assisted breathing
again (for any reason) before day 28, only the number of days of UAB prior to day 28
were included. Participants who died prior to the earlier of 28 days or hospital
discharge were counted as having zero VFDs, regardless of whether or not they ever
achieved UAB
2. Length of stay (ICU): ICU-free days: calculated similarly to VFDs
3. Hospital mortality: hospital mortality: mortality rate at hospital discharge
Subgroups
1. Subgroup: acute lung injury, sepsis, or pneumonia
2. Subgroup: BMI of ≥ 35
Funding sources Supported, in part, by grants K23HL81431(TWR), P30DK058404 (TWR), and 1UL1
RR024975 (TWR, GRB) from the National Institutes of Health (Bethesda, MD)
Declarations of interest Dr Rice, Dr Bernard, and Dr Wheeler received funding from the National Institutes of
Health. The remaining authors have not disclosed any potential conflicts of interest
Notes Variables were assessed by intention-to-treat analyses. Upon our request, the data for
the following outcomes was provided by the first author: hospital and 28-day mortality,
length of mechanical ventilation, length of ICU stay and incidence of infectious compli-
cations. None of the participants included in this study was included in NHLBI 2012.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Permuted block scheme with a random
block size of 2, 4 or 6 participants
63Prescribed hypocaloric nutrition support for critically-ill adults (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rice 2011 (Continued)
Allocation concealment (selection bias) Low risk Assignments were placed in consecutively-
numbered, opaque envelopes that were
sealed before the start of the study by per-
sonnel not associated with the trial
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unblinded study. Details on healthcare
processes to be followed by personnel (e.g.
co-interventions) were not described in or-
der to make an appropriate judgement on
possible performance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Open-label study but most outcomes were
objective. The number of ventilator-free
days to study day 28 was the primary
efficacy measure. Secondary end points
included 28-day and hospital all-cause
mortality, organ-failure-free days, ICU-free
days, and hospital-free days to study day
28. Only gastrointestinal intolerance and
infections are more subjective
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants had complete follow-up to
death or hospital discharge
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk No evidence of other bias
Rugeles 2013
Methods Study design: prospective, randomized controlled trial
Study dates: August 2011 to July 2012
Setting: 30-bed ICU of a tertiary-level university hospital
Country: Colombia
Participants Inclusion criteria
1. Age ≥18 years
2. Admission to an ICU
3. Expected to require EN through nasoenteric tube for at least 96 hours
Exclusion criteria
1. Participants with previous nutritional support in the same hospitalization
2. Participants with concomitant parenteral nutrition
3. Participants in transplantation programme
4. Pregnancy
5. Chronic renal failure
6. Uraemic encephalopathy
7. Diabetes
8. Morbid obesity
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9. Do-not-resuscitate orders
Sample size
80 participants: 40 participants in each group to detect an absolute difference in the
SOFA score between the 2 measurements of 15% (8.0 expected total score and 1.2 for
expected delta SOFA) and a SD between the difference of the means of 3.0. 80% power
α error of 0.05
Age (years): intervention group: 53.3 (19.5); Control group: 55.7 (19.5)
Sex (male, %): intervention group: 55; Control group: 60
Primary disease of the participants
Reasons for admission- Intervention/Control group n (%)
Respiratory disease 16 (40); 14 (35)
CNS disorder 13 (33); 12 (30)
Cardiac disease 2 (5); 4 (10)
Gastrointestinal disease 0 (0); 3 (8)
Other 9 (23); 7 (18)
Disease severity score: APACHE II
Intervention group: 13.9 ± 4.8; Control group: 15.1 ± 6.2
Mechanical ventilation no. (%) Not available
Comorbidities: not available
Nutrition status: not available
Level of inflammation: not available
Interventions Intervention Group 1 (n = 40)
1. Hypocaloric group: 15 kcal/kg/day, with more than 1.5 g of protein per kg of
body weight
Control Group 2 (n = 40)
1. Control group: received standard nutritional regimen with a goal of 25 kcal/kg/
day
Co-interventions
“for both groups, it was used an enteral formula in continuous feeding. To reach the
protein goal, the study group regimen was enriched with additional protein modules,
based on soy protein diluted in water and administered in two daily boluses. Participants
in the study group received hyperproteic regimen until day 7, if they needed any further
enteral nutrition they were switched to standard nutritional regimen with a goal of 25
kcal/kg/day without protein boluses.”
Outcomes Primary outcome
1. Delta SOFA at 48 hours
Secondary outcomes
1. SOFA score at baseline
2. SOFA score at 48 hours
3. SOFA score at 96 hours
4. Participants achieving a delta SOFA of 2 or more
5. Insulin requirements
6. Hyperglycaemic events per day
7. ICU length of stay, days
8. Ventilator requirement (days)
Subgroups
Not available
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Funding sources This research was supported by an unrestricted grant from Lafrancol Colombia
Declarations of interest No potential conflict of interest relevant to this article was reported
Notes The first author sent us the finalmanuscript of the study before publication, and answered
our questions about the average time of the participants on enteral nutrition, the standard
deviation of the calories and proteins received by both groups, why they did not report
mortality and the way they gave the protein supplements to achieve the double blinding
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomization was performed using dark
sealed envelopes with computer-generated
random allocations
Allocation concealment (selection bias) Low risk Randomization was performed using dark
sealed envelopes with computer-generated
random allocations
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-blind clinical trial. Although one
of the investigators was not blind: (quote:
) “only one of the members of the team
(JDR) knew patient allocation, prescribed
the formulations, and supervised the ad-
ministration of the regimens; but ICU staff,
who decided on daily care patient, was
blind to patient allocation”. The authors,
upon request, gave further explanations
about how there was low risk of blinding
being broken
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Double-blind clinical trial. Although one
of the investigators was not blind (quote:
) “only one of the members of the team
(JDR) knew patient allocation, prescribed
the formulations, and supervised the ad-
ministration of the regimens; but ICU staff,
who decided on daily care patient, was
blind to patient allocation”. The authors,
upon request, gave further explanations
about how there was low risk of blinding
being broken
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “only patients who completed 96
hours of follow-up were considered for the
analysis; patients who did not fulfil the fol-
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low-up period were excluded, and the en-
velope was returned to the sequence for
patient replacement, until completion of
the sample size (40 in each group)”. Al-
though the inclusion criteria stated that
“Study population consisted of adult pa-
tients (18 years or older) admitted in the
ICU, who were expected to require enteral
nutrition through nasoenteric tube for at
least 96 hours.”, having participants ran-
domized, intervened, and then excluded if
they did not have 96 hours of enteral feed-
ing could lead to a high risk of selection
bias. Especially if the primary endpoint was
“change in SOFA score at 48 hours”. The
number of excludedparticipantswas signif-
icant: “In total, 115 potential patients met
the initial inclusion criteria for enrolment,
but only 80 completed the follow-up and
were included in the per protocol analysis”
Selective reporting (reporting bias) High risk Mortality, a secondary outcome, was not
reported. Nevertheless, upon request, the
authors responded that given that they ex-
cluded participants that did not fulfil the
96 hours of enteral nutrition requirement,
they did not report mortality because this
result would have been biased (they only
measured mortality in participants who
completed the 96 hours). This is why they
did not report it. This is correct, although
the best thing would have been to perform
an intention-to-treat analysis and also re-
port premature deaths
Other bias Low risk No evidence of other bias
Rugeles 2016
Methods Study design: prospective, randomized controlled trial
Study dates: December 2013 to July 2015
Setting: 30-bed ICU of a tertiary-level university hospital
Country: Colombia
Participants Inclusion criteria
1. age ≥18 years
2. admission to an ICU
3. expected to require EN through nasoenteric tube for at least 96 hours
Exclusion criteria
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1. participants with previous nutritional support in the same hospitalization
2. participants with concomitant parenteral nutrition
3. participants in transplantation programme
4. pregnancy
5. chronic renal failure
6. uraemic encephalopathy
7. diabetes
8. morbid obesity
9. do-not-resuscitate orders
Sample size
60 participants in each group to detect a 15% (1.7 points) difference in SOFA at 48
hours between the 2 groups with an SD of 1.9 with a 2-tailed t test. 80% power α error
of 0.05
Age (years): intervention group: 53.8 ± 19.0; Control group: 51.8 ± 20.3
Sex (male, %): intervention group: 45; Control group: 55
Primary disease of the participants
Reasons for admission- Intervention/Control group n (%)
Cardiovascular 7 (12%); 7 (12%)
Gastrointestinal 4 (7%); 6 (10%)
Hematology 4 (7%); 1 (2%)
Orthopaedics 0 (0%); 1 (2%)
Respiratory 31 (52%); 22 (37%)
Central nervous system 8 (13%); 18 (30%)
Trauma 1 (2%); 1 (2%)
Urology 1 (2%); 0 (0%)
Other 4 (7%); 4 (7%)
Disease severity score: APACHE II Intervention group: 13.5 ± 6.4; Control group: 13.
7 ± 6.8
Mechanical ventilation no. (%) Not available
Comorbidities: not available
Nutrition status: intervention group; Control group
Subjective global assessment nutritional status, n (%) b
A 4 (7%); 4 (7%)
B 36 (60%); 43 (72%)
C 20 (33%); 13 (22%)
Level of inflammation: not available
Interventions Intervention Group 1 (n = 60)
1. Hypocaloric group: 15 kcal/kg per day of total calories and high protein intake (1.
7 g of protein/kg a day)
1. Control Group 2 (n = 60)
1. Normocaloric group: 25 kcal/kg per day with high protein intake (1.7 g of
protein/kg a day).
For both groups, ideal bodyweightwas used to calculate caloric andprotein requirements.
A commercial enteral formula was adjusted to achieve caloric goals and was enriched
with additional modules of whey and soy protein diluted in water, given in 3 or 4 daily
boluses. All participants received allocated nutritional regimen until day 7. If further EN
was necessary, all participants received normocaloric nutrition
Co-interventions
1. Not available
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Outcomes Primary outcome
1. Change in SOFA score from baseline at 48 hours.
Secondary outcomes
1. SOFA at 96 hours
2. Insulin requirements (mean daily units of insulin)
3. Frequency of hyperglycaemia episodes (glycaemic measurements
180 mg/dL) or hypoglycaemia episodes (glycaemic measurements < 45 mg/dL)
4. Length of ICU stay
5. Days on ventilator
6. Days to start nutrition
7. Mortality within 28 days of randomization
Subgroups
1. Not available
Funding sources This research was supported by an unrestricted grant from Lafrancol Colombia and
Hospital Universitario San Ignacio
Declarations of interest No potential conflict of interest relevant to this article was reported
Notes The study sponsor (Lafrancol S.A) provided an unrestricted grant and was not involved
in any of the stages of the study
The authors sent us the full paper of this clinical trial before it was indexed inMEDLINE
(registered in clinicaltrials.gov with the Identifier: NCT02577211). They gave us the
mean and SD values for length of ICU stay and of mechanical ventilation, and also some
additional information to complete the ’Risk of bias’ table
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomization was performed using dark
sealed envelopes with computer-generated
random allocations
Allocation concealment (selection bias) Low risk Randomization was performed using dark
sealed envelopes with computer-generated
random allocations
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The authors considered 1 limitation of the
study could be lack of proper blinding of
ICU staff. One investigator knew partici-
pant allocation and prescribed and super-
vised the administration of nutritional regi-
mens after randomization. Participants and
ICU staff deciding on the rest of medi-
cal care were blinded to participant alloca-
tion. Nutritional information and regimen
formulation were not registered in clini-
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cal records, except for general information
such as total liquids administered
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is not clear if outcome assessors were
blinded to participant allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcome data were reported for non-
excluded participants
Selective reporting (reporting bias) Low risk All the outcomes were registered and re-
ported (written information provided by
the author)
Other bias Low risk No other bias (written information pro-
vided by the author)
Theodorakopoulou 2016
Methods Study design: prospective, randomized controlled trial
Study dates: period of one year, but study dates not available
Setting: single centre. ICU at Attikon University Hospital. Athens. Greece
Participants Inclusion criteria
1. Mechanically-ventilated septic participants
Exclusion criteria
1. Obese patients
Sample size
Total number of participants enrolled: 74
Age (years): whole group age of 68.4 ± 18.4 years
Sex (male, %): 38 men included (100%)
Primary disease of the participants: all participantsmet the consensus criteria for sepsis.
Disease severity score: at entry overall APACHE II score 22 ± 4. etc. and SOFA score
8 ± 4
Mechanical ventilation: 100% of the participants were mechanically ventilated
Comorbidities: not reported
Nutrition status: non-obese participants. Overall BMI 21.5 ± 3.4 kg/m2
Interventions Permisive underfeeding group (n = not available )
1. Caloric goal 50% to 70% of calculated caloric requirements. During the study
period the participants received 962 ± 314 kcal/day or 51 ± 14% of the caloric
requirements, and 57 ± 24 grams protein day.
Standar protocol feeding group (n = not available)
1. 80% to 100% of calculated caloric requirement. During the study period the
participants received 1308 ± 513 kcal/day or 82 ± 14% of the caloric requirements,
and 59 ± 25 grams of protein day.
Same protein intake for both groups: 1.5 gr protein/kg/day
Each participant monitored for 14 days
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Outcomes Primary outcome
1. 28-day mortality
Funding sources Not available.
Declarations of interest Not available
Notes This information was extracted from an abstract. We contacted Dr. Maria Theodorak-
oupoulou to request the missing data (including outcome data)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information for judgement
(abstract only)
Allocation concealment (selection bias) Unclear risk Insufficient information for judgement
(abstract only)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information for judgement
(abstract only)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information for judgement
(abstract only)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information for judgement
(abstract only)
Selective reporting (reporting bias) Unclear risk Insufficient information for judgement
(abstract only)
Other bias Unclear risk Insufficient information for judgement
(abstract only)
Abbreviations:
APACHE = acute physiology and chronic health evaluation; BMI = Body Mass Index ; CD = cluster of differentiation; CIT =
conventional insulin therapy; dl = decilitre; EN = enteral nutrition; gr = gram; GRV = gastric residual volumes; hr = hour; ICU
= intensive care unit; IIT = intensive insulin therapy; IVFE = Intravenous fat emulsion; kcal = kilocalories; kg = kilograms; mg =
milligrams; NHLBI = National Heart, Lung, and Blood Institute; NNIS = National Nosocomial Infection Surveillance; OMEGA =
OMEGA study (Rauch 2010); PN = parenteral nutrition; SD = standard deviation; SOFA = sequential organ failure assessment; TPN
= total parenteral nutrition; UAB = unassisted breathing; VFD = ventilator-free days
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alberda 2009 Non-randomized or quasi-randomized controlled trial. Observational cohort study to examine the relationship
between the amount of energy and protein administered and clinical outcomes
Arabi 2010 Non-randomized or quasi-randomized controlled trial assessing hypocaloric nutrition versus control. It is a nested
cohort study of participants enrolled in a randomized controlled clinical trial that compared intensive to conven-
tional insulin therapy. The clinical outcomes were analysed according to tertiles of caloric administration
Berg 2013 Study of whole-body protein turnover with d5-phenylalanine and 13C.leucine tracers. The only clinical parameter
evaluated was nitrogen balance
Casadei 2006 Non-randomized nor quasi-randomized controlled trial. Retrospective study
Desachy 2008 Not primarily hypocaloric nutrition support study; the goal was to evaluate caloric intake and tolerability of 2
early enteral nutrition protocols in which the optimal flow rate was introduced either immediately or gradually
Dickerson 2002 Non-randomized or quasi-randomized controlled trial. Retrospective study
Dissanaike 2007 Not hypocaloric nutrition support study. Not randomized clinical trial (cohort study)
Doig 2013 Multicentre, randomized, single-blind clinical trial in critically-ill adults with relative contraindications to early
enteral nutrition. Random allocation to pragmatic standard care or early parenteral nutrition. The objective was
different from prescribed hypocaloric nutrition (determine if early parenteral nutrition alters outcomes). No
numerical data of calories administered to the groups (only in 1 figure)
Esterle 2010 Hypocaloric nutrition support was not evaluated. Their goal was to evaluate if volume-based enteral nutrition
causes less caloric deficit than rate-base feeding in critically-ill ventilated participants
Fiaccadori 2005 Not hypocaloric nutrition support trial. Open-label, cross-over trial in critically-ill people with acute renal failure
and renal replacement therapy, comparing iso-nitrogenous parenteral nutrition providing 30 and 40 kcal/kg/day
(normocaloric versus hypercaloric parenteral nutrition)
Garrel 1995 Not hypocaloric nutrition support trial. They compared isocaloric enteral nutrition with less fat (but more
carbohydrates) in people with burns
Iapichino 1990 Non-randomized or quasi-randomized controlled trial assessing hypocaloric nutrition versus control. During 3
days, the participants received randomly 4 different types of parenteral nutrition (2 types of amino acids and 2
different doses of glucose). The authors only assessed metabolic outcomes (no clinical outcomes)
Lau 2010 Retrospective study to evaluate 3 different caloric regimes on the incidence of hyperglycaemia and hypoglycaemia
in critically-ill participants on intensive insulin treatment
Mackenzie 2005 Not a prospective controlled trial of hypocaloric nutrition support. Prospective study to evaluate the proportion of
participants meeting their caloric goals with the implementation of an evidence-based enteral nutrition protocol
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Moses 2009 Hypocaloric nutrition support was not evaluated against normo- or hypercaloric feeding. Prospective controlled
randomized trial realized exclusively in ventilated participants with acute organophosphate poisoning, to evaluate
if enteral nutrition could be possible (due to the treatment with high dose of atropine) and had different clinical
outcomes than the participants on intravenous fluids
Müller 1995 Not randomized trial to study the metabolic effects of different caloric regimens in medical participants with
multiple organ failures. The participants received 7 parenteral nutrition regimens with different amounts of
calories, carbohydrates, amino-acids and lipids, for 12 hours each regimen
Owais 2014 Single-blinded randomized clinical trial of 50 consecutive participants requiring parenteral nutritional support;
permissive underfeeding in participants requiring parenteral nutrition. Participants were randomized to receive
either normocaloric or hypocaloric feeding (respectively 100% vs 60% of estimated requirements). The primary
end point was septic complication and the secondary end points included themetabolic, physiological and clinical
outcomes to the 2 feeding protocols
Only 26% (12 out of 46) of included participants were ICU participants and the results did not distinguish
between ICU and non-ICU participants
Rodríguez 2005 Hypocaloric nutrition support was not evaluated. They assess clinical results with 2 different calories/protein
relationships
Schricker 2005 Not critically-ill participants . Surgical participants (hemicolectomy, sigmoid colectomy) to assess if hypocaloric
nutrition could induce anabolism in participants with perioperative epidural analgesia
Wewalka 2010 Hypocaloric nutrition support was not evaluated. The aim of the study was the evaluation of 2 nutrition support
programmes: isocalorically right from the beginning compared with a hypocaloric beginning (50% of the dose in
the first day, 75% the second day and 100% from the third day): abstract with no results of the clinical outcomes
Abbreviations:
kcal = kilocalories; kg = kilograms
Characteristics of ongoing studies [ordered by study ID]
NCT01665664
Trial name or title Hypocaloric vs full-energy enteral feeding in critically ill patients guided by indirect calorimetry, a prospective,
blinded, randomized controlled trial
Methods Study design: randomized controlled double-blind trial with measurement of REE by indirect calorimetry
to establish the exact amount of calories to be delivered to the intervention and control groups
Participants Inclusion criteria
1. Participants ≥ 18 years with mechanical ventilation ≥ 72 hrs
Exclusion criteria
1. Abdominal surgery with inability to feed enterally
2. FiO2 > 80%
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3. Bronchopleural fistula
4. Haemodynamic instability in spite of the use of vasopressors
Interventions Group 1 hypocaloric feeding group
1. Only 20% of REE will be provided but not less than 300 kcal/day
Full energy feeding group
1. 100% of REE will be provided
Outcomes Primary outcomes
1. All-cause mortality
2. ICU mortality
3. Hospital mortality
Secondary outcomes
1. ICU and hospital length of stay
2. Length of mechanical ventilation
3. Rate of infections
Starting date September 2012
Contact information Arie Soroksky: soroksky@gmail.com (Israel)
Notes Unknown state of the trial up to the end of June 2016. The principal investigator did not answer a question
about the state of the trial. Clinical trial record states: (quote:) “the recruitment status of this study is unknown.
The completion date has passed and the status has not been verified in more than two years.” “Verified August
2012 by Soroksky Arie, Wolfson Medical Center. Recruitment status was: not yet recruiting”
Ochoa 2017
Trial name or title Hypocaloric high-protein enteral nutrition improves glucose management in critically ill patients
Methods Study design: prospective, randomized, multicenter clinical trial
Settings and countries: ICU of 7 academic centres at USA and Canada. In USA: Wake Forest University,
Winston-Salem, North Carolina; University of Kentucky, Lexington, Kentucky; Emory University, Atlanta,
Georgia;Medicine, University of Chicago, Hinsdale, Illinois; PulmonaryMedicine, Regions Hospital, St Paul,
Minnesota; Vanderbilt University, Nashville, Tennessee. In Canada: Kingston Hospital, Kingston, Ontario
Funding: Nestlé Health Science
Participants Inclusion criteria
1. Mechanically-ventilated critically-ill, obese and overweight participants requiring enteral nutrition.
Exclusion criteria
1. Not reported.
Sample size: calculated sample size of 100 participants per group, based in a reduction of “out-of-range”
glycaemic events and their standard deviation (glucose variability). Sample size of each arm of the study not
reported. “Ninety-eight subjects were randomized into the study at the time of interim analysis. Of these
subjects, 40 had at least 5 days of data collected. The remaining subjects withdrew primarily due to removal
of the feeding tube”
Age (years, mean ± SD): Group 1: hypocaloric: 60.7 ± 15.07; Group 2: 62.6 ± 12.09
Sex (% of women): Group 1: 42.9; Group 2: 55.1
74Prescribed hypocaloric nutrition support for critically-ill adults (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ochoa 2017 (Continued)
Primary disease of the participants. Not reported
Disease severity: APACHE II score (mean ± SD). Group 1: 25.1 ± 9.0; Group 2: 26.3 ± 9.24
Nutrition status: BMI (kg/m2; mean ± SD). Group 1: 33.7 ± 4.57; Group 2: 32.5 ± 5.65
Mechanical ventilation: not available
Comorbidities: not available
Level of inflammation: not available
Interventions Group 1 hypocaloric (n = not available)
1. Enteral nutrition with a hypocaloric, high-protein formulation
Group 2 (n = not available)
1. Enteral nutrition with a normocaloric, high-protein formulation
Co-interventions
In both study groups the quantity of the assigned formula was enough to provide 1.5 grams of protein/kg
ideal body weight/day
Outcomes Primary endpoint
1. Number of glycaemic events in the first 7 days in ICU > 150 mg/dL or < 110 mg/dL
Other endpoints
1. Not defined, but reported results of mean daily glycaemia, blood glucose variability, hypoglycaemia (<
81 mg/dl) and insulin administered
Outcomes and time points: not clearly defined
Subgroups: not available
Starting date Not available
Contact information Juan.Ochoa@US.nestle.com. We contacted the study author and he replied that he would send us the study
results
Notes An interim analysis was scheduled when 40 participants completed at least 5 days of data collection. All the
current information comes from the abstract of a congress presentation (ASPEN, CNW, Orlando, Florida,
18 to 21 February, 2017) regarding the preliminary analysis of the intention-to-treat data
Abbreviations:
APACHE = Acute Physiology And Chronic Health Evaluation II; BMI = Body Mass Index; ICU = Intensive Care Unit; REE = resting
energy expenditure; SD = standard deviation; µg/kg/min = micrograms/kilograms/minute
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D A T A A N D A N A L Y S E S
Comparison 1. Hypocaloric nutrition (intervention) vs. Control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality in hospital 9 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Mortality in ICU 4 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Mortality at 30 days 7 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Length of Hospital stay (days) 10 Mean Difference (IV, Random, 95% CI) Totals not selected
5 Length of ICU stay (days) 11 Mean Difference (IV, Random, 95% CI) Totals not selected
6 Infectious complications 10 Risk Ratio (M-H, Random, 95% CI) Totals not selected
7 Length of mechanical ventilation
(days)
12 Mean Difference (IV, Random, 95% CI) Totals not selected
8 Non-infectious complications
(diarrhoea)
3 Risk Ratio (M-H, Random, 95% CI) Totals not selected
9 Hyperglycaemia 6 Risk Ratio (M-H, Random, 95% CI) Totals not selected
10 Hypoglicaemia 5 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
11 Nitrogen balance (g/day) 3 Mean Difference (IV, Random, 95% CI) Totals not selected
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Analysis 1.1. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 1 Mortality in
hospital.
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 1 Mortality in hospital
Study or subgroup Hypocaloric nutrition Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arabi 2011 36/120 51/120 0.71 [ 0.50, 1.00 ]
Arabi 2015 108/447 123/445 0.87 [ 0.70, 1.09 ]
Battistella 1997 2/27 0/30 5.54 [ 0.28, 110.42 ]
Charles 2014 3/41 4/42 0.77 [ 0.18, 3.22 ]
Choban 1997 0/6 2/7 0.23 [ 0.01, 4.00 ]
Ibrahim 2002 20/75 15/75 1.33 [ 0.74, 2.40 ]
McCowen 2000 2/21 3/19 0.60 [ 0.11, 3.23 ]
Petros 2016 17/46 17/54 1.17 [ 0.68, 2.03 ]
Rice 2011 22/98 20/102 1.14 [ 0.67, 1.96 ]
0.005 0.1 1 10 200
Favours Hypocaloric Favours Control
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Analysis 1.2. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 2 Mortality in ICU.
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 2 Mortality in ICU
Study or subgroup Hypocaloric nutrition Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arabi 2011 21/120 26/120 0.81 [ 0.48, 1.35 ]
Arabi 2015 72/448 85/446 0.84 [ 0.63, 1.12 ]
Battistella 1997 2/27 0/30 5.54 [ 0.28, 110.42 ]
Petros 2016 10/46 12/54 0.98 [ 0.47, 2.05 ]
0.005 0.1 1 10 200
Favours Hypocaloric Favours Control
Analysis 1.3. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 3 Mortality at 30
days.
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 3 Mortality at 30 days
Study or subgroup Hypocaloric Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arabi 2011 22/120 28/120 0.79 [ 0.48, 1.29 ]
Arabi 2015 93/447 97/444 0.95 [ 0.74, 1.23 ]
NHLBI 2012 99/508 95/492 1.01 [ 0.78, 1.30 ]
Norouzy 2013 3/30 1/30 3.00 [ 0.33, 27.23 ]
Petros 2016 18/46 18/54 1.17 [ 0.70, 1.98 ]
Rice 2011 22/98 20/102 1.14 [ 0.67, 1.96 ]
Rugeles 2016 18/60 16/60 1.13 [ 0.64, 1.99 ]
0.05 0.2 1 5 20
Favours Hypocaloric Favours control
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Analysis 1.4. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 4 Length of Hospital
stay (days).
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 4 Length of Hospital stay (days)
Study or subgroup
Hypocaloric
Nutrition Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Norouzy 2013 30 19.9 (11) 30 35.6 (25) -15.70 [ -25.47, -5.93 ]
Battistella 1997 27 27 (16) 30 39 (24) -12.00 [ -22.50, -1.50 ]
Ibrahim 2002 75 16.7 (12.5) 75 22.9 (19.7) -6.20 [ -11.48, -0.92 ]
Arabi 2015 448 48.3 (67.5) 446 54.4 (73.9) -6.10 [ -15.38, 3.18 ]
Ahrens 2005 20 23.4 (23.92) 20 27.8 (17.4) -4.40 [ -17.36, 8.56 ]
McCowen 2000 21 19 (14) 19 17 (15) 2.00 [ -7.02, 11.02 ]
Arabi 2011 120 70.2 (106.9) 120 67.2 (93.6) 3.00 [ -22.42, 28.42 ]
Choban 1997 6 48 (30) 7 45 (38) 3.00 [ -34.00, 40.00 ]
Charles 2014 41 35.2 (4.9) 42 31 (2.5) 4.20 [ 2.52, 5.88 ]
Petros 2016 46 38.1 (33.4) 54 27.4 (21.9) 10.70 [ -0.58, 21.98 ]
-50 -25 0 25 50
Favours Hypocaloric Favours Control
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Analysis 1.5. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 5 Length of ICU stay
(days).
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 5 Length of ICU stay (days)
Study or subgroup
Hypocaloric
Nutrition Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Battistella 1997 27 18 (12) 30 29 (22) -11.00 [ -20.08, -1.92 ]
Ahrens 2005 8 16.75 (10.35) 10 23 (15.2) -6.25 [ -18.09, 5.59 ]
Ibrahim 2002 75 9.8 (7.4) 75 13.6 (14.2) -3.80 [ -7.42, -0.18 ]
Arabi 2011 120 11.7 (8.1) 120 14.5 (15.5) -2.80 [ -5.93, 0.33 ]
Rugeles 2013 40 9.5 (5.5) 40 10.4 (5) -0.90 [ -3.20, 1.40 ]
Arabi 2015 448 15.8 (11.6) 446 16.4 (12.1) -0.60 [ -2.15, 0.95 ]
Rugeles 2016 60 13.23 (6.03) 60 13.45 (8.33) -0.22 [ -2.82, 2.38 ]
Rice 2011 98 8.1 (6.1) 102 7.6 (5.9) 0.50 [ -1.16, 2.16 ]
NHLBI 2012 508 11.5 (11) 492 11 (9.8) 0.50 [ -0.79, 1.79 ]
Charles 2014 41 16.7 (2.7) 42 13.5 (1.1) 3.20 [ 2.31, 4.09 ]
Petros 2016 46 22.4 (25.5) 54 17 (16.1) 5.40 [ -3.13, 13.93 ]
-20 -10 0 10 20
Favours Hypocaloric Favours Control
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Analysis 1.6. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 6 Infectious
complications.
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 6 Infectious complications
Study or subgroup Hypocaloric nutrition Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Ahrens 2005 5/20 2/20 2.50 [ 0.55, 11.41 ]
Arabi 2011 53/120 56/120 0.95 [ 0.72, 1.25 ]
Arabi 2015 161/448 169/446 0.95 [ 0.80, 1.13 ]
Battistella 1997 13/27 22/30 0.66 [ 0.42, 1.03 ]
Charles 2014 23/41 24/42 0.98 [ 0.67, 1.43 ]
Ibrahim 2002 23/75 37/75 0.62 [ 0.41, 0.94 ]
McCowen 2000 6/21 10/19 0.54 [ 0.24, 1.21 ]
NHLBI 2012 96/508 79/492 1.18 [ 0.90, 1.54 ]
Petros 2016 13/46 6/54 2.54 [ 1.05, 6.16 ]
Rice 2011 30/98 33/102 0.95 [ 0.63, 1.42 ]
0.05 0.2 1 5 20
Favours Hypocaloric Favours control
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Analysis 1.7. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 7 Length of
mechanical ventilation (days).
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 7 Length of mechanical ventilation (days)
Study or subgroup Hypocaloric nutrition Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Norouzy 2013 30 4.7 (4) 30 17.9 (21) -13.20 [ -20.85, -5.55 ]
Battistella 1997 27 15 (12) 30 27 (21) -12.00 [ -20.77, -3.23 ]
Ahrens 2005 8 11.13 (9.43) 8 20.25 (16.12) -9.12 [ -22.06, 3.82 ]
Ibrahim 2002 75 8.1 (7.4) 75 12.9 (15.7) -4.80 [ -8.73, -0.87 ]
Arabi 2011 120 10.6 (7.6) 120 13.2 (15.2) -2.60 [ -5.64, 0.44 ]
Arabi 2015 448 11.3 (9.2) 446 13.5 (22.3) -2.20 [ -4.44, 0.04 ]
Rugeles 2013 40 8.5 (4.6) 40 9.7 (4.9) -1.20 [ -3.28, 0.88 ]
Rice 2011 98 5.67 (5.53) 102 6.21 (6.58) -0.54 [ -2.22, 1.14 ]
Rugeles 2016 60 10.8 (6.63) 60 10.8 (7.82) 0.0 [ -2.59, 2.59 ]
NHLBI 2012 508 10.5 (8.7) 492 10.2 (8) 0.30 [ -0.74, 1.34 ]
Charles 2014 41 10.76 (16.24) 42 8.29 (6.21) 2.47 [ -2.84, 7.78 ]
Petros 2016 46 20.73 (26.6) 54 12.37 (15.68) 8.36 [ -0.39, 17.11 ]
-20 -10 0 10 20
Favours Hypocaloric Favours control
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Analysis 1.8. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 8 Non-infectious
complications (diarrhoea).
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 8 Non-infectious complications (diarrhoea)
Study or subgroup Hypocaloric nutrition Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Arabi 2015 97/448 117/446 0.83 [ 0.65, 1.04 ]
NHLBI 2012 81/508 92/492 0.85 [ 0.65, 1.12 ]
Petros 2016 9/46 33/54 0.32 [ 0.17, 0.60 ]
0.01 0.1 1 10 100
Favours Hypocaloric Favours control
Analysis 1.9. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 9 Hyperglycaemia.
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 9 Hyperglycaemia
Study or subgroup
Hypocaloric
Nutrition Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Ahrens 2005 5/20 14/20 0.36 [ 0.16, 0.80 ]
McCowen 2000 4/21 5/19 0.72 [ 0.23, 2.31 ]
NHLBI 2012 124/508 168/492 0.71 [ 0.59, 0.87 ]
Petros 2016 39/46 49/54 0.93 [ 0.80, 1.08 ]
Rugeles 2013 6/40 10/40 0.60 [ 0.24, 1.49 ]
Rugeles 2016 27/60 33/60 0.82 [ 0.57, 1.17 ]
0.1 0.2 0.5 1 2 5 10
Favours Hypocaloric Favours control
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Analysis 1.10. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 10 Hypoglicaemia.
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 10 Hypoglicaemia
Study or subgroup
Hypocaloric
Nutrition Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ahrens 2005 3/20 2/20 1.50 [ 0.28, 8.04 ]
Arabi 2011 25/120 21/120 1.19 [ 0.71, 2.01 ]
Arabi 2015 6/448 7/446 0.85 [ 0.29, 2.52 ]
Petros 2016 12/46 8/54 1.76 [ 0.79, 3.93 ]
Rugeles 2016 0/60 0/60 Not estimable
0.01 0.1 1 10 100
Favours Hypocaloric Favours control
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Analysis 1.11. Comparison 1 Hypocaloric nutrition (intervention) vs. Control, Outcome 11 Nitrogen
balance (g/day).
Review: Prescribed hypocaloric nutrition support for critically-ill adults
Comparison: 1 Hypocaloric nutrition (intervention) vs. Control
Outcome: 11 Nitrogen balance (g/day)
Study or subgroup Hypocaloric nutrition Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
McCowen 2000 12 -8.3 (9.2) 10 -0.6 (4.8) -7.70 [ -13.70, -1.70 ]
Battistella 1997 27 -9 (5) 30 -9 (7) 0.0 [ -3.14, 3.14 ]
Choban 1997 6 4 (4) 7 2 (3) 2.00 [ -1.90, 5.90 ]
-20 -10 0 10 20
Favours Hypocaloric Favours control
A D D I T I O N A L T A B L E S
Table 1. Differences in participants, interventions and outcomes across included studies
Study ID Type
of partici-
pants
Primary
outcomes
Arm Num-
ber of ICU
partici-
pants
APACHE
II score
mean±SD
Route
(enteral or
par-
enteral)
Duration
of PN or
EN (days)
Mechani-
cal ventila-
tion
(% of par-
ticipants)
ICU mor-
tality %
Hospi-
tal mortal-
ity %
Ahrens
2005
Surgi-
cal partici-
pants with
PN re-
quirement
Incidence/
sever-
ity hyper-
glycaemia
and insulin
received by
the partici-
pants
Hypoc. 8 (other 12
non-ICU)
20 ± 9 Parenteral 6 (4 to 10) 100 Not
reported
Not
reported
Control 10 (other
10 non-
19 ± 11 7 (5 to 10) 80
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Table 1. Differences in participants, interventions and outcomes across included studies (Continued)
ICU)
Arabi
2011
Medical
(mainly)
and surgi-
cal partici-
pants with
EN. 2 x 2
fac-
torial trial
with In-
tensive In-
suline
therapy
28 days all-
cause mor-
tality
Hypoc. 120 25 ± 8 Enteral Not
reported
99 18 30
Control 120 25 ± 8 99 22 43
Arabi
2015
Critically-
ill partici-
pants
(75%
medical)
90-day all-
cause mor-
tality
Hypoc. 448 21 ± 7.9 Enteral 9.1 ± 4.6 97.3 16.1 24.2
Control 446 21 ± 8.2 9.4 ± 4.4 96.2 19.1 27.6
Battistella
1997
Trauma
partic-
ipants with
PN re-
quirement
Length
of hospital
stay, length
of stay in
the ICU,
number
of days on
mechani-
cal ventila-
tion
and infec-
tious com-
plications
Hypoc. 27 22 ± 5 Parenteral 10 Not
reported
7.4 Not
reported
Control 30 23 ± 6 10 0
Charles
2014
Critically-
ill surgi-
cal partici-
pants
Hypoc. 41 16.6 ± 0.9 Enteral &
parenteral
12.6 ± 2.8 68 N/A 7.3
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Table 1. Differences in participants, interventions and outcomes across included studies (Continued)
Hospital-
acquired
infection
Control 42 17.3 ± 0.8 10.4 ± 1.1 57 N/A 9.5
Choban
1997
Obese par-
tic-
ipants with
PN re-
quirement.
Predomi-
nantly sur-
gical
diseases
Achieve-
ment of ni-
trogen bal-
ance
Hypoc. 6 (other 10
non-ICU)
13 ± 5 Parenteral 10 ± 3 Not
reported
Not
reported
0
Control 7 (other 7
non-ICU)
15 ± 5 11 ± 2 28.6
Ibrahim
2002
Medical
ICU par-
ticipants
with EN
Incidence
of ventila-
tor-associ-
ated pneu-
monia
Hypoc. 75 26 ± 8 Enteral 5 ± 6 100 Not
reported
27
Control 75 25 ± 8 10 ± 12 100 20
McCowen
2000
Partic-
ipants with
predomi-
nantly sur-
gical
diseases re-
quiring
PN
Glycaemic
con-
trol and In-
fections
Hypoc. 21 not
reported
Parenteral ≥ 5 50 10 Not
reported
Control 19 not
reported
≥ 5 33 16
NHLBI
2012
Acute lung
injury pre-
dom-
inantly due
to medical
dis-
eases (61%
and 63%
Hypoc. 508 APACHE
III 92 ± 28
Enteral 6 100 Not
reported
22.4
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Table 1. Differences in participants, interventions and outcomes across included studies (Continued)
of partici-
pants)with
EN
Ventilator-
free days at
study day
28
Control 492 APACHE
III 90 ± 27
Enteral 6 100 19.6
Norouzy
2013
Critically-
ill head
trauma
partici-
pants
28 days
of all-cause
mortality
Hypoc. 30 Not
reported
Enteral 7 Not
reported
Not
reported
10.7a
Control 30 7 3.8a
Petros
2016
Medical
ICU with
EN and/or
PN re-
quirement
Glycaemic
control
and mor-
tality
Hypoc. 46 31 ± 9 Enteral &
parenteral
7 not
reported
22 37
Control 54 28 ± 8 7 22 31
Rice 2011 Acute lung
injury, pre-
dom-
inantly due
to medi-
cal diseases
with EN
Ventilator-
free days at
study day
28
Hypoc. 98 27 ± 8 Enteral 6 ± 4 100 Not
reported
22
Control 102 27 ± 7 5 ± 3 100 20
Rugeles
2013
Medical
ICU par-
tic-
ipants with
EN re-
quirement
Change in
SOFA
score at 48
hours
Hypoc. 40 14 ± 5 Enteral 7 Not
reported
Not
reported
Not
reported
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Table 1. Differences in participants, interventions and outcomes across included studies (Continued)
Control 40 15 ± 6
Rugeles
2016
Medical
ICU par-
tic-
ipants with
EN re-
quirement
Change in
SOFA
score at 48
hours
Hypoc. 60 13.5 ± 6.4 Enteral 7 Not
reported
Not
reported
30a
Control 60 13.7 ± 6.8 27a
Theodor-
akopoulou
2016
Septic,me-
chani-
cally venti-
lated criti-
cally-
ill partici-
pants
28-day
mortality
Hypocal. Total sam-
ple
of 74 par-
ticipants
Total sam-
ple
22 ± 4
Enteral Not
reported
Not
reported
Not
reported
Not
reported
Control
a28-day mortality.
EN = Enteral nutrition; ICU = Intensive Care Unit; N/A: not available; PN = Parenteral nutrition; SOFA = Sequential Organ Failure
Assessment
Table 2. Calories and protein received in both study groups
Studies How data was
reported
Hypocaloric
(intervention)
group
Control group Calories
received by the
“hypocaloric”
intervention
group (kcal/kg/
day)
Calories
received by the
“normocaloric”
control
group (kcal/kg/
day)
Cat-
egories denom-
inated by the
calories really
received
in the interven-
tion and
the control
groups a
Ahrens 2005 Total calo-
ries/kg/day (me-
dian (IQ))b
26.6 (26.2 to 27.
5)
37 (36.0 to 38.4) 26.60 (median) 37.00 (median) Normocaloric vs
hypercaloric
Protein g/kg/day
(mean± SD)
1.61 ± 0.13 1.53 ± 0.26
Arabi 2011 Calories/day
(mean ± SD)
1066.6 ± 306.1 1251.7 ± 432.5 13.85 16.40 Hypocaloric vs
hypocaloric
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Table 2. Calories and protein received in both study groups (Continued)
Protein g/day
(mean ± SD)
47.5 ± 21.2 43.6 ± 18.9
Arabi 2015 Calories/day
(mean ± SD)
835 ± 297 1299 ± 2470 10.56 16.04 Hypocaloric vs
hypocaloric
Protein g/day
(mean ± SD)
57 ± 24 59 ± 25
Battistella 1997 Calories/kg ideal
body weight/day
(mean ± SD)
27.4 ± 2 34.4 ± 2 27.4 (of ideal
body weight)
34.4 (of ideal
body weight)
Normocaloric
vs. normocaloric
Pro-
tein g/kg ideal
body weight/day
(mean± SD)
1.6 ± 0.1 1.6 ± 0.2
Charles 2014 Calories/kg/day
(mean ± SD)
12.3 ± 0.7 17.1 ± 1.1 12 17 Hypocaloric vs
hypocaloric
Protein g/kg/day
(mean ± SD)
1.1 ± 0.1 1.1 ± 0.1
Choban 1997 Kcal/kg actual
body weight/day
(mean ± SD)
Kcal/kg ideal
body weight/day
(mean ± SD)
8.6 ± 2.39
13.88 ± 2.87
17.45 ± 4.06
27.99 ± 3.83
14.00 (of ideal
body weight)
28.00 (of ideal
body weight)
Hypocaloric vs
normocaloric
Protein g/kg ac-
tual
body weight/day
(mean ± SD)
Pro-
tein g/kg ideal
body weight/day
(mean ± SD)
1.2 ± 0.2
2.0 ± 0.1
1.2 ± 1.2
2.0 ± 0.1
Ibrahim 2002 Calories/day
(mean ± SD)
126 ± 115 474 ± 400 1.53 5.81 Very hypocaloric
vs very
hypocaloric
Proteins g/day
(mean) (mean ±
SD)
5.3 ± 5.3 18.7 ± 15.4
McCowen 2000 Calories/kg/day
(mean ± SD)
14 ± 3 18 ± 4 14.30 18.40 Hypocaloric vs
hypocaloric
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Table 2. Calories and protein received in both study groups (Continued)
Proteins g/kg/
day (mean ± SD)
1.1 ± 0.2 1.3 ± 0.2
NHLBI 2012 Calories/day
(mean ± SD)
399 ± 225 1365 ± 596 4.64 (estimated
by kcal/day di-
vided
by weight from
the baseline ta-
ble)
15.69 (estimated
by kcal/day di-
vided
by weight from
the baseline ta-
ble)
Very hypocaloric
vs hypocaloric
Proteins: infor-
mation not col-
lected
- -
Norouzy 2013 Calories/kg/day
(mean ± SD)
Not reported Not reported N/A N/A N/A
Protein g/kg/day
(mean ± SD)
Not reported Not reported
Petros 2016 Calories/kg/day
(mean ± SD)
11.3 ± 3.1 19.7 ± 5.7 11.30 19.70 Hypocaloric vs
hypocaloric
Protein Data not
reported
Data not
reported
Rice 2011 Calo-
ries/day (mean ±
SD of study days
1 to 5)
300 ± 149 1418 ± 686 3.60 17.31 Very hypocaloric
vs hypocaloric
Proteins g/
day (mean ± SD
of study days 1 to
5)
10.9 ± 6.8 54.4 ± 33.2
Rugeles 2013 Calories/kg/day
(mean ± SD)
12 ± 3.9 14 ± 6.2 12.00 14.00 Hypocaloric vs
hypocaloric
Protein g/kg/day
(mean ± SD)
1.4 ± 0.44 0.76 ± 0.32
Rugeles 2016 Total calories/kg
ideal
body weight/day
(mean ± SD)
12.6 ± 3.4 20.5 ± 5.1 13 21 Hypocaloric vs
hypocaloric
Protein g/
kgIBW/day
(mean ± SD)
1.4 ± 0.4 1.4 ± 0.3
Theodor-
akopoulou
Calories/day
(mean ± SD)
962 ± 314 1308 ± 513 Not reported
Estimatedc
Not reported
Estimatedc
Estimatedc
Hypocaloric vs
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Table 2. Calories and protein received in both study groups (Continued)
2016 16.63 kcal/kg/
day
22.62 kcal/kg/
day
normocaloric
Protein g/day
(mean ± SD)
57 ± 24 59 ± 25 Not reported
Estimatedc
0.99 g/kg/day
Not reported
Estimatedc
1.02 g/kg/day
aCategories denominated by the amount of calories really received by both study groups, according to the following: very hypocaloric
= < 10 kcal/kg/day; hypocaloric = ≥ 10 to < 25 kcal/kg/day; normocaloric = ≥ 25 to < 35 kcal/kg/day; hypercaloric = ≥ 35 kcal/
kg/day.
bIQ: interquartile range - Median total calories received by all 20 participants (ICU and non-ICU participants) in each group (the total
calories received by the 8 and 10 ICU participants in each group were not reported).
cNot reported in the abstract. The numbers are a crude estimation of kcal and grams of protein/kg/day from the whole sample data of
height and BMI.
BMI = Body Mass Index; g = gram; ICU = Intensive Care Unit; kcal = kilocalories; N/A: not available; SD = standard deviation; vs =
versus
Table 3. Main outcomes in individual studies ordered by the magnitude of the differences in calories received between the
control and hypocaloric groups
Study Difference
in calories
between
groups
(kcal/kg/
day)
Hospital
mortality
(%)
IG vs CG
ICU mor-
tality
(%)
IG vs CG
Mortality
at 30 days
(%)
IG vs CG
Infectious
complica-
tions
(%)
IG vs CG
Length of
hospital
stay
(days)a
IG vs CG
ICU
length
of stay
(days)a
IG vs CG
Length of
mechani-
cal
ventila-
tion
(days)a
IG vs CG
Cate-
gories de-
nom-
inated by
the calo-
ries really
received in
the inter-
vention
and
the
control
groupsb
Rugeles
2013
2.00 N/A N/A N/A N/A N/A 9.5 vs 10.4 8.5 vs 9.7
Hypocaloric
vs
hypocaloric
Arabi
2011
2.55 30% vs 42.
5%
17.5% vs
21.7%
18.3% vs
23.3%
44.2% vs
46.7%
70.2 vs 67.
2
11.7 vs 14.
5
10.6 vs 13.
2 Hypocaloric
vs
hypocaloric
McCowen
2000
4.10 9.5% vs
15.8%
N/A N/A 28.6% vs
52.6%
19 vs 17 N/A N/A
Hypocaloric
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Table 3. Main outcomes in individual studies ordered by the magnitude of the differences in calories received between the
control and hypocaloric groups (Continued)
vs
hypocaloric
Ibrahim
2002
4.28 26.7% vs
20%
N/A N/A 30.7% vs
49.3%
16.7 vs 22.
9
9.8 vs 13.6 8.1 vs 12.9 Very
hypocaloric
vs very
hypocaloric
Charles
2014
5.00 7.3% vs 9.
5%
N/A N/A 56.1% vs
57.1%
35.2 vs 31 16.7 vs 13.
6
10.8 vs 8.3
Hypocaloric
vs
hypocaloric
Arabi
2015
5.48 24.2% vs
27.6%
16.1% vs
19.1%
20.8% vs
21.8%
35.9% vs
37.9%
48.3 vs 54.
4
15.8 vs 16.
4
11.3 vs 13.
5 Hypocaloric
vs
hypocaloric
Battistella
1997
7.00 7.4% vs
0%
7.4% vs
0%
N/A 48.2% vs
73.3%
27 vs 39 18 vs 29 15 vs 27 Nor-
mocaloric
vs nor-
mocaloric
Rugeles
2016
7.90 N/A N/A 30% vs 26.
7%
N/A N/A 13.2 vs 13.
5
10.8 vs 10.
8 Hypocaloric
vs
hypocaloric
Petros
2016
8.40 37% vs 31.
5%
21.7% vs
22.2%
39.1% vs
33.3%
28.3% vs
11.1%
38.1 vs 27.
4
22.4 vs 17 20.7 vs 12.
4 Hypocaloric
vs
hypocaloric
Ahrens
2005
10.40 N/A N/A N/A 25% vs
10%
23.4 vs 27.
8
16.8 vs 23 11.1 vs 20.
3
Nor-
mocaloric
vs hyper-
caloric
NHLBI
2012
11.05 N/A N/A 19.5% vs
19.3%
18.9% vs
16.1%
N/A 11.5 vs 11 10.5 vs 10.
2
Very
hypocaloric
vs
hypocaloric
Rice 2011 13.71 22.4% vs
19.6%
N/A 22.4% vs
19.6%
30.6% vs
32.4%
N/A 8.1 vs 7.6 5.7 vs 6.2 Very
hypocaloric
vs
hypocaloric
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Table 3. Main outcomes in individual studies ordered by the magnitude of the differences in calories received between the
control and hypocaloric groups (Continued)
Choban
1997
14.00 0%vs 29% N/A N/A N/A 48 vs 45 N/A N/A
Hypocaloric
vs nor-
mocaloric
Norouzy
2013
N/A N/A N/A 10% vs 3.
3%
N/A 19.9 vs 35.
6
N/A 4.7 vs 17.9 N/A
Theodor-
akopoulou
2016
N/A N/A N/A 18.4% vs
28.9%
N/A N/A N/A N/A
Hypocaloric
vs nor-
mocaloric
aLengths of hospital, ICU stays and of mechanical ventilation presented in mean days.
bCategories denominated by the amount of calories really received by both study groups, according to the following: very hypocaloric
= < 10 kcal/kg/day; hypocaloric = ≥ 10 to < 25 kcal/kg/day; normocaloric = ≥ 25 to < 35 kcal/kg/day; hypercaloric = ≥ 35 kcal/kg/
day.
IG = Intervention Group; CG = Control Group; N/A = Not available; vs = versus
Table 4. Subgroup analyses
Subgroup N participants (n studies) Subgroup testing
1. Nutrition status
1.1. Length of hospital stay
Obese 13 (1 RCT) I2 = 0%, P = 0.76
General 1664 (9 RCTs)
2. Route of nutrition support
2.1. Length of hospital stay
Parenteral 150 (4 RCTs) I2 = 0%, P = 0.72
Enteral 1725 (6 RCTs)
2.2. Length of ICU stay
Parenteral 75 (2 RCTs) I2 = 83.3%, P < 0.01
Enteral 2867 (9 RCTs)
2.3. Infectious complications
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Table 4. Subgroup analyses (Continued)
Parenteral 137 (3 RCTs) I2 = 0%, P = 0.35
Enteral 2667 (7 RCTs)
2.4. Length of mechanical ventilation
Parenteral 73 (2 RCTs) I2 = 85.4%, P < 0.01
Enteral 2927 (10 RCTs)
3. Type of participant
3.1. Length of hospital stay
Surgical participants 223 (5 RCTs) I2 = 0%, P = 0.55
Medical participants 1354 (5 RCTs)
3.2. Length of ICU stay
Surgical participants 158 (3 RCTs) I2 = 0%, P = 0.52
Medical participants 2784 (8 RCTs)
3.3. Infectious complications
Surgical participants 220 (4 RCTs) I2 = 0%, P = 0.45
Medical participants 2584 (6 RCTs)
3.4. Length of mechanical ventilation
Surgical participants 156 (3 RCTs) I2 = 0%, P = 0.45
Medical participants 2854 (9 RCTs)
4. Amount of calories received by each study group
4.1. Length of hospital stay
Normo-hypercaloric 97 (2 RCTs) I2 = 84.1%, P < 0.01
Hypocaloric 1370 (6 RCT)
Very hypocaloric 150 ( RCT)
4.2. Length of ICU stay
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Table 4. Subgroup analyses (Continued)
Normo-hypercaloric 75 (2 RCTs) I2 = 0%, P = 0.42
Hypocaloric 1517 (6 RCTs)
Very hypocaloric 1350 (3 RCTs)
4.3. Infectious complications
Normo-hypercaloric 97 (2 RCTs) I2 = 0%, P = 0.94
Hypocaloric 1357 (5 RCTs)
Very hypocaloric 1350 (3 RCTs)
4.4. Length of mechanical ventilation
Normo-hypercaloric 73 (2 RCTs) I2 = 73.1%, P = 0.02
Hypocaloric 1517 (6 RCTs)
Very hypocaloric 1350 (3 RCTs)
RCT = randomized controlled trial; ICU = Intensive care unit
A P P E N D I C E S
Appendix 1. Search strategy for CENTRAL, The Cochrane Library
#1 MeSH descriptor: [Critical Illness] explode all trees
#2 stressed:ti,ab,kw
#3 critical* next ill*:ti,ab,kw
#4 MeSH descriptor: [Critical Care] explode all trees
#5 MeSH descriptor: [Intensive Care Units] explode all trees
#6 #1 or #2 or #3 or #4 or #5
#7 (feeding or food or nutrition* or diet* or intake*) .ti
#8 (eucalor* or hypoenerg* or underfeed* or (low calor*) or hypocalor*):ti,ab,kw
#9 MeSH descriptor: [Diet] explode all trees
#10 MeSH descriptor: [Parenteral Nutrition] explode all trees
#11 MeSH descriptor: [Enteral Nutrition] explode all trees
#12 #7 or #8 or #9 or #10 or #11
96Prescribed hypocaloric nutrition support for critically-ill adults (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 2. Search strategy for MEDLINE (Ovid SP)
1 exp Critical Illness/
2 stressed.ti,ab.
3 (critical adj3 ill*).mp.
4 Critical Care/
5 Intensive Care/
6 Intensive Care Units/
7 1 or 2 or 3 or 4 or 5 or 6
8 (feeding or food or nutrition* or diet* or intake*).ti.
9 (eucalor* or hypoenerg* or underfeed* or (low adj3 calor*) or h?pocalor*).mp.
10 Diet/ or Parenteral-Nutrition/ or Enteral-Nutrition/
11 8 or 9 or 10
12 7 and 11
13 “Randomized Controlled Trial”.pt.
14 “Controlled Clinical Trial”.pt.
15 randomi?ed.ti,ab.
16 placebo*.ti,ab.
17 “drug therapy”.sh.
18 randomly.ti,ab.
19 trial.ti,ab.
20 groups.ti,ab.
21 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20
22 Animals/ not (Humans/ and Animals/)
23 21 not 22
24 12 and 23
Appendix 3. Search strategy for Embase (Ovid SP)
1 eucalor*.ti,ab.
2 hypoenerg*.ti,ab.
3 underfeed*.ti,ab.
4 (low adj3 calor*).ti,ab.
5 h?pocalor*.ti,ab.
6 1 or 2 or 3 or 4 or 5
7 (feeding or food or nutrition* or diet* or intake*).ti.
8 *diet/
9 *parenteral nutrition/
10 6 or 7 or 8 or 9
11 critical*.ti,ab.
12 stressed.ti,ab.
13 *intensive care unit/
14 *intensive care/
15 *critical illness/
16 11 or 12 or 13 or 14 or 15
17 10 and 16
18 random.tw. or placebo.mp. or double-blind.tw.
19 17 and 18
97Prescribed hypocaloric nutrition support for critically-ill adults (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 4. Search strategy for LILACS, (BIREME)
(tw:((“ENFERMEDAD CRITICA” OR “UNIDADES DE TERAPIA intensiva” OR “CUIDADOS INTENSIVOS” OR trauma*
OR “TRAUMA multiple” OR “SEPSIS” OR septicemia* OR “ENFERMEDAD AGUDA” OR “cuidados criticos” OR “cuidado
critico” OR “cuidado intensivo” OR “cuidados intensivos” OR icu* OR uti*)))
AND
(tw:((desnutricion* ORhypocalor*ORhipocalor*ORhypoenerg*ORhipoenerg*ORunderfeed*OR subaliment* OR “bajas calorias”
OR “bajo valor” OR hiponutr* OR malnutr* OR calorimetr*)))
AND
(instance:“regional”) AND (instance:“regional”) AND ( db:(“LILACS”) AND type˙of˙study:(“clinical˙trials”))
Appendix 5. Meta-regression
STATA 14.1 outputs exploring the effect of several explanatory variables on the primary outcomes with the highest number of included
studies: mortality in hospital, infectious complications, length of hospital stay and length of ICU stay. The covariates included in the
models were: type of participants [typepatient]; calories received by the intervention group in three categories categorized [catcal];
difference in the amount of calories received by the control groups minus the intervention group [difcal].
The explanatory variables were defined as follow:
1. typepatient: surgical participant vs medical participant (all surgical participants received parenteral nutrition and medical
received enteral nutrition) (See Table 1).
2. catcal: categories denominated by the amount of calories really received by the intervention groups, according to the following:
very hypocaloric ≤ 10 kcal/kg/day (icatcal 2); hypocaloric ≥ 10 to < 25 kcal/kg/day (icatcal 1); normocalcaloric or hypercaloric ≥
25 kcal/kg/day (icatcal 0) (see Table 2).
3. difcal: absolute difference in kcal/kg/day received by the control minus the intervention groups (see Table 3).
We analysed several different models for each outcome. We only presented the model with the three covariates of each outcome,
including the full output of the STATA 14.1 statistics.
In each model the covariates were typed in bold (see above definitions). The other codes in tables were:
1. logrr: Relative risk of dichotomic outcomes.
2. ES: Mean difference of continuous outcomes.
3. Coef.: Value of the relative risk or the mean difference in their units
4. P > t: Probability that the Logrr difference adjusted by other covariates could be related to chance if P is higher than 0.05
5. Std. Err: Standard error of the coefficient.
6. t: test.
7. P > t: Probability that the Logrr difference adjusted by other covariates could be related to chance if P is higher than 0.05 (not
significant).
8. 95% conf. interval: 95% confidence interval of the Logrr or ES values.
It is important to state the limitations of this meta-regression because of the limited number of studies for the number of covariates in
the model. Meta-regression should generally not be considered when there are fewer than 10 studies in a meta-analysis.
1. Mortality in hospital
xi: metareg logrrdifcal i.catcal typepatient, wsse(selogrr) bsest(reml)
i.catcal ˙Icatcal˙0-2 (naturally coded; ˙Icatcal˙0 omitted)
note: ˙Icatcal˙1 dropped because of collinearity
numerical derivatives are approximate
nearby values are missing
Meta-regression Number of observations = 7
REML estimate of between-study variance tau2 = 0
% residual variation due to heterogeneity I-squared˙res = 0.00%
Proportion of between-study variance explained Adj R-squared = 100.00%
Joint test for all covariates Model F(3,3) = 1.16
With Knapp-Hartung modification Prob > F = 0.4542
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logrra Coef. Std. Err. t P > t (95% Conf. Interval)
difcal .0237277 .0333315 0.71 0.528 −.0823481 .1298035
Icatcal 2 .2621164 .2656104 0.99 0.396 −.5831745 1.107407
typepatient −.3222415 .8614032 −0.37 0.733 −3.063611 2.419128
cons −.2805905 .1894936 −1.48 0.235 −.8836437 .3224628
aRelative Risk
Interpretationof hospital mortality.None of the covariates had a statistically significant influence on the size of the intervention effect
on hospital mortality (P > 0.05).
2. Infectious complications
xi: metareg logrr difcal i.catcal typepatient, wsse(selogrr) bsest(reml)
i.catcal ˙Icatcal˙0-2 (naturally coded; ˙Icatcal˙0 omitted)
Meta-regression Number of obs = 10
REML estimate of between-study variance tau2 = .0115
% residual variation due to heterogeneity I-squared˙res = 40.22%
Proportion of between-study variance explained Adj R-squared = 24.55%
Joint test for all covariates Model F(4,5) = 1.48
With Knapp-Hartung modification Prob > F = 0.3346
logrra Coef. Std. Err. t P > t (95% Conf. Interval)
difcal .0660771 .0343893 1.92 0.113 −.0223233 .1544776
Icatcal 1 −.1032021 .5736509 −0.18 0.864 −1.577819 1.371415
Icatcal 2 −.511068 .5948386 −0.86 0.430 −2.040149 1.018013
typepatient −.5686713 .502095 −1.13 0.309 −1.859348 .7220049
cons −.209952 .6345331 −0.33 0.754 −1.841071 1.421167
aRelative Risk
Interpretation of infectious complications.None of the covariates had a statistically significant influence on the size of the intervention
effect on infectious complications (P > 0.05).
3. Hospital length of stay
xi: metareg ˙ES difcal i.catcal typepat, wsse(˙seES) bsest(reml)
i.catcal ˙Icatcal˙0-2 (naturally coded; ˙Icatcal˙0 omitted)
Meta-regression Number of obs = 9
REML estimate of between-study variance tau2 = .1866
% residual variation due to heterogeneity I-squared˙res = 84.83%
Proportion of between-study variance explained Adj R-squared = -0.95%
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Joint test for all covariates Model F(4,4) = 0.95
With Knapp-Hartung modification Prob > F = 0.5178
ESa Coef. Std. Err. t P > t (95% Conf. Interval)
difcal .0227448 .0664972 0.34 0.750 −.1618811 .2073708
Icatcal 1 .5450151 .5673605 0.96 0.391 −1.03023 2.12026
Icatcal 2 −.1219102 .7756573 −0.16 0.883 −2.27548 2.03166
typepat −.2502513 .5116285 −0.49 0.650 −1.67076 1.170257
cons −.3512504 .7353122 −0.48 0.658 −2.392804 1.690304
aMean difference
Interpretation of length of hospital stay.None of the covariates had a statistically significant influence on the size of the intervention
effect on hospital length of stay (P > 0.05).
4. ICU length of stay
xi: metareg ˙ES difcal i.catcal typepat, wsse(˙seES) bsest(reml)
i.catcal ˙Icatcal˙0-2 (naturally coded; ˙Icatcal˙0 omitted)
note: typepat dropped because of collinearity
Meta-regression Number of obs = 11
REML estimate of between-study variance tau2 = .2453
% residual variation due to heterogeneity I-squared˙res = 83.29%
Proportion of between-study variance explained Adj R-squared = -3.80%
Joint test for all covariates Model F(3,7) = 0.99
With Knapp-Hartung modification Prob > F = 0.4503
ESa Coef. Std. Err. t P > t (95% Conf. Interval)
difcal .0459442 .0578779 0.79 0.453 −.0909154 .1828038
Icatcal 1 .8943999 .5321506 1.68 0.137 −.3639364 2.152736
Icatcal 2 .4275402 .5473569 0.78 0.460 −.8667533 1.721834
cons −.9390958 .6599035 −1.42 0.198 −2.49952 .621328
aMean difference
Interpretation of length of ICU stay. None of the covariates had a statistically significant influence on the size of the intervention
effect on length of ICU stay (P > 0.05).
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Appendix 6. Database for meta-regression
We conducted the meta-regressions of each of the outcomes according to the following databases. The codes used to identify each
column of the databases were:
1. trialnam: study ID.
2. cases1: number of events in the intervention group.
3. cases0: number of events in the control group.
4. tot1: number of participants in the intervention group.
5. tot0: number of participants in the control group.
6. mean 1: mean value in the intervention group.
7. SD 1: standard deviation in the intervention group.
8. total 1: total number of participants in the intervention group.
9. mean 2: mean value in the control group.
10. SD 2: standard deviation in the control group.
11. total 2: total number of participants in the control group.
12. difcal: absolute difference in kcal/kg/day between the control minus the study group.
13. catcal: categories according the amount of calories received by the intervention groups. 0 ≥ 25 kcal/kg/day; 1 ≥ 10 to < 25 kcal/
kg/day; 2 < 10 kcal/kg/day.
14. typepatient: medical participants 0; surgical participants 1 (also equivalent to enteral nutrition and parenteral nutrition
respectively)
15. n/a: not available.
Database of mortality in hospital
Mortality in hospital
trial name cases1 tot1 cases0 tot0 difcal catcal typepatient
Arabi 2011 36 120 51 120 2.55 1 0
Arabi 2015 108 447 123 445 5.48 1 0
Battistella
1997
2 27 0 30 7 0 1
Charles 2014 3 41 4 42 5 1 0
Choban 1997 0 6 2 7 14 1 1
Ibrahim
2002
20 75 15 75 4.28 2 0
McCowen
2000
2 21 3 19 4.1 1 1
Petros 2016 17 46 17 54 8.4 1 0
Rice 2011 22 98 20 102 13.71 2 0
Database of infectious complications
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Infectious complications
trial name cases1 tot1 cases0 tot0 difcal catcal typepatient
Ahrens 2005 5 20 2 20 10.4 0 1
Arabi 2011 53 120 56 120 2.55 1 0
Arabi 2015 161 448 169 446 5.48 1 0
Battistella
1997
13 27 22 30 7 0 1
Charles 2014 23 41 24 42 5 1 0
Ibrahim
2002
23 75 37 75 4.28 2 0
McCowen
2000
6 21 10 19 4,1 1 1
NHLBI 2012 96 508 79 492 11.05 2 0
Petros 2016 13 46 6 54 8.4 1 0
Rice 2011 30 98 33 102 13.71 2 0
Database of length of hospital stay
Length of hospital stay
trial name Mean 1 SD 1 total 1 mean 2 SD 2 total 2 difcal catcal typepatient
Ahrens
2005
23.4 23.92 20 27.8 17.4 20 10.4 0 1
Arabi
2011
70.2 106.9 120 67.2 93.6 120 2.55 1 0
Arabi
2015
48.3 67.7 448 54.4 73.9 446 5.48 1 0
Battistella
1997
27 16 27 39 24 30 7 0 1
Charles
2014
35.2 4.9 41 31 2.5 42 5 1 0
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(Continued)
Choban
1997
48 30 6 45 38 7 14 1 1
Ibrahim
2002
16.7 12.5 75 22.9 19.7 75 4.28 2 0
McCowen
2000
19 14 21 17 15 19 4.1 1 1
Norouzy
2013
19.9 11 30 35.6 25 30 n/a n/a 0
Petros
2016
38.1 33.4 46 27.4 21.9 54 8.4 1 0
Database of length of ICU stay
Length of ICU stay
trial name mean 1 SD 1 total 1 mean 2 SD 2 total 2 difcal catcal typepatient
Ahrens
2005
16.75 10.35 8 23 15.2 10 10.4 0 1
Arabi
2011
11.7 8.1 120 14.5 15.5 120 2.55 1 0
Arabi
2015
15.8 11.6 448 16.4 12.1 446 5.48 1 0
Battistella
1997
18 12 27 29 22 30 7 0 1
Charles
2014
16.7 2.7 41 13.5 1.1 42 5 1 0
Ibrahim
2002
9.8 7.4 75 13.6 14.2 75 4.28 2 0
NHLBI
2012
11.5 11 508 11 9.8 492 11.05 2 0
Petros
2016
22.4 25.5 46 17 16.1 54 8.4 1 0
Rice 2011 8.1 6.1 98 7,6 5.9 102 13.71 2 0
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(Continued)
Rugeles
2013
9.5 5.5 40 10.4 5 40 2 1 0
Rugeles
2016
13.23 6.03 60 13.45 8.33 60 7.9 1 0
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Background section
1. The original Background section contained a single description without subheadings. We updated the references and divided
them into level two subheadings according to the Cochrane Handbook for Systematic Reviews of Interventions recommendations
(Higgins 2011).
Objectives and outcomes
1. Modifications in order to comply with the latest MECIR standards (Higgins 2016): we modified the wording of the objectives
in order to comply with Standard R5 and R22; we provided additional detail for the definition of outcomes in order to comply with
Standard R32; we provided detail on the GRADE methods in order to comply with Standard C23 and R98; we provided detail on
subgroup analysis (Standard R52)
2. In order to have only three primary outcomes (according to Higgins 2011), we changed the order of the primary and secondary
outcomes stated in the protocol (Perman 2009), while maintaining all the predefined ones. The primary outcomes for this review
were: mortality (in hospital, in lCU and at 30 days); length of stay (in hospital and in ICU) and infectious complications. The
secondary outcomes we were able to evaluate were: length of mechanical ventilation, non-infectious complications, carbohydrate
metabolic outcomes (hyperglycaemia, hypoglycaemia), protein metabolic outcomes (nitrogen balance). However, we include seven
outcomes in the ’Summary of findings’ table. These main outcomes were considered for the subgroup analysis.
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Criteria for inclusion of studies
1. We provided further detail on the inclusion criteria for the Types of interventions that initially was broadly defined as “ 1)
normo- or hypercaloric NS: equal or more than the measured REE or 25 kcal/kg/day (with the same characteristics as above); or 2)
no nutrition support at all: fasting or dextrose solutions”. We added “We evaluated results of trials designed to compare prescribed
hypocaloric enteral or parenteral nutrition support (or permissive underfeeding) with standard nutrition support, or with no
nutrition, even if those trials did not reach their caloric goals in the intervention or control groups (intention-to treat analysis). We did
not include trials that planned to provide full nutrition support but resulted in unintended hypocaloric provision (for any reason).”
Search methods
In Electronic searches we made some changes: we applied the trial filter for therapy, maximizing sensitivity developed by HIRU (Health
Information Research Unit at McMaster University: hiru.mcmaster.ca/hiru/HIRU Hedges EMBASE Strategies.aspx. We consulted
the following trial registries: ClinicalTrials.Gov: clinicaltrials.gov/ct2/home; International Clinical Trials Registry Platform (WHO):
apps.who.int/trialsearch/); and ISRCTN Registry: www.isrctn.com/. The LILACS strategy was improved (Appendix 4). We did not
perform ISI SciSearch due to lack of access to the database. We did not contact relevant societies to identify abstracts, since we checked
the conference proceedings of those societies directly.
Data collection and analysis
1. We updated the sections Selection of studies, Data extraction and management, Assessment of risk of bias in included studies
according to the latest MECIR standards (2016) and Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). They
were initially in different subheadings and now use the current recommended subheadings.
2. We added the sections Measures of treatment effect, Unit of analysis issues, Dealing with missing data and Assessment of
reporting biases that were not present in the original protocol.
3. We constructed the section Assessment of heterogeneity and Data synthesis with the information present in “Analysis” in the
original protocol.
4. We modified the sections Assessment of heterogeneity and Data synthesis, to adjust the cut-off points to classify and report
heterogeneity according to Higgins 2011 (Section 9.5.2).
5. We added a section for the methods used to develop the ’Summary of findings’ table using the GRADE approach (see Sensitivity
analysis).
Methods not implemented
1. Several outcomes stated in the protocol were not reported in the trials; for this reason we were not able to conduct some
predefined subgroup analyses. We did a subgroup analysis not prespecified in the protocol to assess the effect of the route of nutrition
support (enteral or parenteral). We considered this to be relevant after the search strategy was performed, but before we had
conducted any analysis.
Post hoc analysis
1. After collecting the data about the calories received by both groups of participants in the included studies, and before the
analysis of results, we decided to perform the subgroup analysis of the amount of calories received according to the following
categories: very hypocaloric, hypocaloric, normocaloric and hypercaloric.
2. We performed two sensitivity analyses not previously stated in the protocol. In one of them we excluded three studies (Ibrahim
2002; NHLBI 2012; Rice 2011) with a different primary goal: they evaluated early initiation of low-dose enteral nutrition
(hypocaloric trophic feeding) against full enteral dose from the beginning (normocaloric standard feeding). In the other sensitivity
analysis, we excluded a study (Battistella 1997), primarily designed to compare parenteral nutrition without the administration of
intravenous lipid emulsion (hypocaloric) and with lipids (normocaloric).
3. When we found high levels of clinical and statistical heterogeneity, we performed a non-prespecified meta-regression using
STATA 13.1 to explore the effect of several covariates on the main outcomes (Appendix 5).
106Prescribed hypocaloric nutrition support for critically-ill adults (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Change in authorship
1. Juan VA Franco has joined the review team.
107Prescribed hypocaloric nutrition support for critically-ill adults (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
